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 One of the most versatile methods for the formation of aryl-aryl bonds is the 
palladium-catalyzed cross-coupling reaction.  Previous work in the DeShong laboratory 
has demonstrated the utility of aryl siloxanes for the palladium-catalyzed cross-coupling 
of aryl iodides, bromides, and chlorides, as well as new synthetic methods for the 
formation of aryl siloxanes.  The work reported herein details (1) the synthesis of aryl 
siloxanes using ortho-metallation techniques (2) the coupling of aryl bis(catechol) 
silicates with aryl triflates, and (3) the application of aryl siloxane coupling technology to 
the synthesis of colchicine and allocolchicine derivatives. 
      The synthesis of aryl siloxanes had previously been performed using either 
metal-halogen exchange, or transition metal-catalyzed silylation.  These techniques 
necessitate the use of an aryl halide as the starting material. The application of ortho-
metallation conditions avoids this requirement and allows for the synthesis of siloxanes 
directly from the unfunctionalized arene.  Using this approach, ortho-ether and carbamate 
siloxanes were prepared in good yields, however, o-benzamide siloxanes could not be 
prepared using this method. 
 The coupling of aryl triflates with aryl siloxanes had previously proven 
problematic due to competitive hydrolysis of the triflate.  The use of aryl bis(catechol) 
silicates as siloxane surrogates facilitated the coupling of aryl triflates and iodides bearing 
a range of functional groups in excellent yield.  Additionally, aryl bromides could be 
successfully coupled by switching from conventional heating to microwave irradiation. 
 The use of aryl siloxanes in the synthesis of the natural products colchicine and 
allocolchine was explored.  It was found that the carbocyclic framework of colchicine 
could be constructed using an aryl siloxane coupling reaction; however, the reaction 
required the use of a stoichiometric amount of the palladium “catalyst.”  This amount of 
catalyst was required because of the competition between a slow oxidative addition step, 
and a fast protodesilylation pathway that lead to the decomposition of the siloxane.  The 
synthesis of the allocolchicine carbocyclic framework was successful utilizing a siloxane 
coupling reaction, and a phenanthrol ring expansion protocol as the key steps.   
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Chapter 1 – The Development and Use of Palladium(0)-
Catalyzed Coupling Reactions in the Synthesis of Biaryl 
Natural Products 
 INTRODUCTION 
The biaryl moiety is the central structural element of a wide range of structurally 
and biologically interesting, as well as pharmacologically promising natural products.1  
These biaryls range in complexity from the simple diterpenoid biaryl I-1, to the 
multifaceted vancomycin (I-2). 
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 The development of synthetic techniques and methodology for the formation of 
biaryls has seen many great advances and inventions since the discovery of copper-
 2
promoted reductive coupling of aromatic halides by Ullmann in 1901,2 and the subject 
has been comprehensively reviewed.3,4 The most useful and widely employed techniques 
for the synthesis of biaryls involves the palladium-catalyzed coupling of an aryl halide or 
triflate with an organometal compound (e. g. B, Sn, Zn, Mg, Si).  These techniques have 
facilitated the synthesis of a vast array of biaryl natural products, due in part to their 
tolerance for functional groups, mild reaction conditions, and high yields.5 Of these 
techniques, the two most commonly used are the Suzuki (organoboron) and the Stille 
(organotin) coupling reactions.  Coupling reactions involving organosilanes has become 
more popular in recent years due to the development of new and more versatile reagents 
and milder reaction conditions.   
 Palladium-catalyzed cross-coupling reactions to form biaryls follow the general 
catalytic cycle presented in Scheme 1.  The active catalyst is Pd (0) I-3, which undergoes 
oxidative addition into the bond of the aryl halide (bromide shown).  The resulting aryl 
Pd (II) complex I-4 participates in transmetallation with an aryl metalloid compound (M 
= B, Sn, Zn, Mg, Si, etc.) to form the biaryl Pd (II) adduct I-5.  Reductive elimination 
provides the biaryl, while at the same time regenerating the Pd (0) catalyst. I-3.   
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Scheme 1 
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STILLE COUPLING 
The coupling of an organostannane reagent I-6 with aryl halides and triflates is 
known as the Stille reaction (Scheme 2).6-10  Even though the reaction employs toxic 
trialkyltin reagents, the ability to conduct this reaction under mild conditions with very 
complicated substrates has led to its use in many biaryl natural product total syntheses.  
The mild reaction conditions for the Stille reaction are exemplified by Danishefsky’s 
synthesis of himastatin (I-7).11,12 
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 Himastatin (I-7) is an antitumor antibiotic that displays activity against leukemia 
and melanoma cells, in addition to antibiotic activity toward Gram-positive bacteria.13,14 
Himastatin is a structurally complex  (C72H104N14O20)  metabolite whose central core 
consists of a biaryl which was assembled by Danishefsky using a Stille coupling reaction 
(Scheme 3).  Coupling of aryl stannane I-8 with aryl iodide I-9 provided the biaryl I-10 
in excellent yield.  It is important to note that the reaction conditions were compatible 
with many functional groups present, and preserved the highly sensitive pyrroloindoline 
core present in both of the coupling partners.  This allowed for a more convergent and 
ultimately shorter synthetic design for himastatin.11 
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Scheme 3  
N
N
TBSO
H
Cbz
Cbz
CO2tBu
I
N
N
TBSO
H
Cbz
Cbz
CO2tBu
Me3Sn
+
N
N
TBSO
H
Cbz
Cbz
CO2tBu
N
N
OTBS
H
Cbz
Cbz
ButO2C
I-8 I-9
I-10
Pd2dba3, PPh3As
DMF, 45 oC
83%
himastatin I-7
 
SUZUKI COUPLING 
The Suzuki reaction is by far the most popular and versatile coupling reaction for 
the formation of unsymmetrical biaryls (Scheme 4).15-19  Boronic acids (I-11) are useful 
reagents because they are generally thermally stable and are inert to water and oxygen, 
and are relatively non-toxic.  However, purification of these reagents can be 
problematical due to their incompatibility with silica gel chromatography, and 
decomposition upon recrystallization.20  Despite this potential drawback, Suzuki 
couplings have been utilized in the synthesis of many complex natural products. 
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Scheme 4 
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Boger and coworkers utilized a double Suzuki reaction as a key step in their 
synthesis of ningalin D (I-12).21  This unique compound consists of a biphenylene 
quinone methide superimposed on an oxidized pentasubstituted pyrrole core.   Ningalin 
displayed promising activity against multidrug resistant cancer cell lines when used in 
conjunction with an existing antitumor therapeutic (taxol, vinblastine).21  This activity is 
due to the ability of nigalin to suppress the P-gy drug efflux pump, which is responsible 
for the majority of drug resistant tumors.22,23    
N
O O
HO OH HO OH
HO
HO
OH
OH
HO
OH
ningalin D (I-12)  
 In Boger’s synthesis of ningalin D, reaction of symmetrical alkyne I-13 with 
tetazine I-14 in a [4+2] cycloaddition provided the symmetrical diazine I-15 in excellent 
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yield (Scheme 5).21  Conversion of diazine I-15 proceeded uneventfully through a series 
of steps to provide bistriflate I-16.  This triflate was treated with a palladium(0) catalyst 
in the presence of boronic acid I-17 to carry out the key double Suzuki coupling reaction. 
Scheme 5 
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 The coupling reaction proceeded in excellent yield to give the coupled product I-
18.  Oxidation of the esters to the quinone methide moiety, followed by global 
demethylation provided synthetic ningalin D (I-12). 
 Another recent example of the Suzuki reaction in natural product synthesis 
involves the synthesis of dragmacidin F (I-19) by Stoltz and coworkers.24-26 Instead of a 
phenyl biaryl bond, the synthesis of this compound involves the Suzuki coupling of 
heteroaryl substrates.  These substrates have traditionally proven difficult to cross-couple 
by other methods.27,28  Dragmacidin, a structurally complex indole alkaloid containing a 
pyrazinone core, possesses potent antiviral activity against herpes simplex virus, and 
HIV.29 
N
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HO
H
 
 Stolz’s synthesis revolved around a series of halogen selective Suzuki reactions.  
The first coupling involved the coupling of pyrazine I-20 with indole boronic acid I-21 
(Scheme 6).26  This reaction entailed the selective coupling of an iodide in preference to a 
bromide.  After considerable experimentation, conditions were developed to allow for the 
reaction to proceed selectively in good yield.  At room temperature, the reaction of the 
bromide with the catalyst was significantly slower than the iodide.  If the temperature is 
raised, however, the reaction became less selective, and a mixture of bromide and iodide 
coupled products was obtained.26 
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Scheme 6 
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Having attained coupling product I-22, attention turned to the coupling of the 
bromide (Scheme 7).  A pinacol boronate ester I-23 was used in place of a boronic acid 
coupling partner.  In this case, reaction using the corresponding boronic acid gave poor 
selectivity for the pyrazole bromide, versus the indole bromide.24  The coupling reaction 
proceeded in good yield with excellent selectivity for the pyrazine bromide to produce 
the indolopyrazine I-24.  This selectivity was obtained again through careful control of 
the reaction temperature.  Heating at 50 ˚C for 65 h led to coupling of the pyrazine 
bromide.  Attempts to shorten the reaction time by elevating the temperature led to 
competitive coupling of the indole bromide.  The selective, sequential Suzuki couplings 
of bromo-iodo-pyrazole I-20 and dibromo-pyrazoleindole I-24 followed for the facile 
construction of the complex heteroaromatic skeleton of dragmacidin F, which eventually 
was converted to dragmacidin F. 
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Scheme 7 
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HIYAMA COUPLING  
   The silicon-based alternative to the Suzuki and Stille coupling reactions has been 
termed Hiyama coupling.30-36  The use of silicon has several distinct advantages over 
other organometal reagents (boron, tin): silicon has a low molecular weight, silicon-based 
reagents are easily prepared and are stable toward many types of reaction conditions.   
The silicon reagents are readily activated for cross-coupling, and the by-products are 
harmless.32  Hiyama demonstrated that aryl(fluoro)silanes I-25 cross-couple with aryl 
iodides and bromides in moderate to good yields (Scheme 8).35  These reactions required 
the use of a fluoride activator, such as KF.  Fluoride is used because of the unusually 
strong bond that is formed between fluoride and silicon.37-39  Several sources of fluoride 
ion can be employed in silane coupling reactions including, alkali fluoride salts, 
 11
tris(diethylamino)sulfonium trimethyldifluorosilcate (TASF), tetramethylammonium 
fluoride (TMAF), tetrabutyl ammonium fluoride (TBAF), and 
tetrabutylammonium(triphenylsilyl)difluorosilicate (TBAT).40    TBAT itself has the 
ability to efficiently cross couple.  This fact was uncovered when it was found that TBAT 
was able to phenylate allylic benzoates.41   
Scheme 8 
Si(Et)F2
I/BrR1
R2
+
Pd(0)
KF
DMF
R2
R140-94%
I-25  
 Denmark and Ober reported the coupling of organosilanols I-26 with aryl iodides 
(Scheme 9).42  This protocol necessitated the use of an expensive and toxic catalyst-
ligand system ([allylPdCl]2, Ph3As).  In addition, a controlled amount of water was 
required in order for the reaction to be reproducible. For example, the use of anhydrous 
Cs2CO3 failed to provide coupled product, and commercially available hydrated Cs2CO3 
also failed to provide product.  However, when 3 equiv of water was added to anhydrous 
Cs2CO3 the reaction reproducibly provided coupled product.42 
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Scheme 9 
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Tamao and Ito pioneered the use of a different type of silane.43 Instead of using 
moisture sensitive chloro- or fluoro-silanes that were employed by Hiyama, siloxanes 
were developed (Scheme 10).  The coupling of alkenylalkoxysilanes proceeded in good 
yields with mono- and dialkoxysilanes (I-27, and I-28, respectively), however, yields 
were moderate when trialkoysilanes (I-29) were employed.   
Scheme 10 
R
R = SiMe2OEt I-27
R = SiMe(OEt)2 I-28
R = Si(OEt)3 I-29
I
Pd(0)
TBAF
I-30
95%
96%
54%  
 In 1997 Shibata reported the coupling of aryl siloxanes I-31 with aryl bromides 
(Scheme 11).44  In these reactions, tetrabutylammonium fluoride (TBAF) was used as the 
fluoride activator.  The reaction gave high yields for electron-deficient aryl bromides, 
however, yields were moderate (60%) for electron-rich aryl bromides.44 
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Scheme 11 
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  Work in the DeShong laboratory has focused on the development of a 
generalized set of reaction conditions for the efficient cross-coupling of aryl siloxanes 
with aryl iodides,45 bromides,45-49 chlorides,46 and triflates.50,51  Recently, Fu and 
coworkers developed conditions for the room temperature couplings of aryl siloxanes 
with alkyl bromides.52,53   
 Mowery and coworkers demonstrated that aryl siloxanes I-31 readily couple in 
high yields with aryl iodides, bromides and chlorides (Scheme 12).45-47 Later, this 
methodology was extended to include aryl triflates using silatranes I-32 and bis(catechol) 
silicates I-33 as siloxane surrogates.50,51 The preparation and cross-coupling of silicates I-
33 is presented in Chapter 3.  These methodologies allow for the coupling of virtually any 
aryl halide or triflate with an aryl siloxane to produce an unsymmetrical biaryl. 
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Scheme 12 
Si(OEt)3
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O
O
Si
O
O
Et3NH
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R
Si
N
O
O
O
I-32  
 Nolan and Lee have modified the aryl siloxane coupling methodology to include 
the use of palladium-imidazolium catalyst systems.54  Imidazolium ligands such as I-34, 
are phosphine ligand alternatives.  Using ligand I-34, Nolan found that aryl bromides 
could be coupled in excellent yields with phenyl trimethoxysilane, but only electron-
deficient aryl chlorides could be coupled using this catalyst system.  The use of ligand I-
34 did, however, allow Nolan to reduce the catalyst loading from 5-10% reported by 
Mowery and DeShong,45,46 to 3 mol%.54 
N N
Cl-
I-34  
 15
 Recently, Wolf and Lerebours reported the coupling of aryl siloxanes under 
aqueous conditions using a palladium-phosphinous acid catalyst I-35.55 Using this 
catalyst, efficient coupling of aryl and heteroaryl halides was achieved.  More 
importantly, the authors found that the use of an expensive fluoride activating agent (such 
as TBAF) could be avoided, and NaOH could be used as a substitute.  Unfortunately, the 
coupling reactions required heating to high temperatures (140 ˚C) in a sealed tube for 24 
h, limiting the functional group tolerance of the reaction.55    
Pd
L
L
P
O
tBu
tBu
I-35  
Several complementary methods are available for the synthesis of aryl siloxanes.  
The most common method utilizes aryl bromide precursors.  Aryl bromides are 
metallated (Mg or Li) to form the corresponding organomagnesium (Grignard) or lithium 
reagent, and the aryl metal derivative is added to tetraethylorthosilicate (Scheme 13).56  
This protocol enjoys high yields, with the siloxane products readily purified via 
distillation or chromatography.  A closely related synthesis of aryl siloxanes involves 
directed ortho-metallation and this topic is addressed in Chapter 2.57  This technique 
allows for the synthesis of ortho-substituted aryl siloxanes, without the need for an aryl 
halide precursor.  
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Scheme 13 
Br
Mg0 Si(OEt)4
R
MgBr
R
Si(OEt)3
R
55-88%  
 Another approach to aryl siloxanes involves the use of metal-catalyzed 
hydrosilylation (Scheme 14).  Masuda and coworkers initially developed a Pd(0) catalyst 
system for this silylation reaction,58 which was later improved by Manoso and 
DeShong.59 Masuda then developed a more powerful Rh(I) catalyst.60  These metal-
catalyzed silylation reactions are tolerant of functional groups (e. g. esters) which would 
not be suitable for the Grignard or organolithium conditions.  
Scheme 14 
I/Br
R
Si(OEt)3
R
Pd(0) or Rh(I)
H-Si(OEt)3
 
 The use of aryl silanes in biaryl natural product synthesis has been limited.  
McElroy and DeShong have developed conditions for the coupling of bromopyridines I-
36 with aryl siloxanes to provide 4-arylpyridines I-37 (Scheme 15).48  It is expected that 
this coupling reaction can be used in the construction of the biaryl bonds present in 
streptonigrin (I-38) and lavendamycin (I-39).  
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Scheme 15 
Pd(0)
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N
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R Me
MeMeO N
Ar
R Me
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H2N
CO2H
Me
OH
OMe
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MeO
H2N
streptonigrin (I-38)
N
N
O
O
HN
CO2H
Me
H2N
lavendamycin (I-39)  
 In addition to streptonigrin and lavendamycin, the use of aryl siloxanes is 
currently being studied for the synthesis of colchicine (I-40) and allocolchicine (I-41) and 
is discussed in Chapter 4.  The synthesis of these two natural products, when combined 
with the synthesis of streptonigrin and lavendamycin, will provide a suitable testing 
ground for the application of aryl siloxanes technology to biaryl natural product 
synthesis. 
O
OMe
OMe
MeO
MeO
NHAc
(-)-(aR, 7S)-colchicine (I-40)
OMe
MeO
MeO
NHAc
CO2Me
(-)-(aR, 7S)-allocolchicine (I-41)  
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CONCLUSIONS 
 The formation of unsymmetrical biaryls using Stille and Suzuki cross-coupling 
reactions has received great attention.  These methodologies have been applied to the 
synthesis of structurally diverse and highly functionalized natural products.  The 
development of aryl siloxane coupling methodology is in its relative infancy.  While aryl 
siloxanes have been proven to cross-couple efficiently with simple substrates, their 
application to complex natural product synthesis has yet to be completed.    
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Chapter 2 - Application of Directed Ortho-Metallation Toward 
the Synthesis of Aryl Siloxanes 
INTRODUCTION 
Many methods have been developed for the addition of functional groups onto the 
basic aromatic ring.  These techniques include electrophilic and nucleophilic substitution, 
sigmatropic rearrangements, and metal-catalyzed substitutions.  These methods often 
suffer from poor regioselectivity or harsh reaction conditions.  The concomitant 
discovery of directed ortho-metallation by Gilman and Wittig in 1939 opened the door to 
a new range of regiospecific chemical transformations that would allow the selected 
addition of chemical groups onto aromatic rings.61 
 Directed ortho-metallation (DOM) (Scheme 1) involves the use of a directing 
group that is able to chelate and direct an organolithium reagent to a position that is ortho 
to the directing group.  Deprotonation then occurs creating the aryl lithium salt which can 
be quenched with an electrophile to give the ortho-substituted product.   
Scheme 1 
ODG
RLi
ODG
Li
ODG
E
ODG = ortho-directing group
E+
 
 A technique that is closely related to ortho-metallation is lithium-halogen 
exchange.62-65  This method involves the metallation of an aryl halide with lithium 
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creating an organolithium reagent.  This lithiated species is then able to attack 
electrophiles in a manner identical to the lithium salts formed from ortho-metallation.  
Lithium-halogen exchange is limited by the obvious fact that a halogen must be present 
in order to carry out the reaction.  The proper regiospecific placement of a halogen on an 
aromatic system is not always a trivial task, especially in the presence of other 
functionalities.  It usually involves multiple steps with a mixture of regioisomers being 
obtained.  In addition, if there are multiple halogens on the aryl system, then all will be 
lithiated, which would lead to a large combination of products upon the addition of the 
electrophile.  Thus, the use of DOM groups, which are ideally a part of the desired 
product, would prove advantageous over the use of lithium-halogen exchange in 
complicated systems.   
 Along a similar vein as the lithium-halogen exchange is the use of magnesium in 
place of an organolithium.  These reactions are known as either the Barbier or Grignard 
reactions.66-69  The Barbier reaction differs from the more common Grignard reaction in 
the manner of addition of the reagents.70  In the Barbier reaction, all the reagents are 
added simultaneously, while in the Grignard reaction, the reagents are added 
sequentially.66,67  These reactions benefit from their simplicity and the facile manner in 
which they are conducted.  However, they have the same drawback as the lithium-
halogen exchange reaction; a halogen must be present to form the anionic reagent.68,69,71 
Ortho-metallation eliminates the need for a pre-existing aryl halide and allows for the 
generation of the aryl lithium reagent directly. 
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Mechanistic Studies       
Ortho-metallation is influenced predominately by two factors: the nature of the 
directing group, and media effects.  It is known that the reactivity of the organolithium 
compound can be enhanced by using polar, coordinating solvents which are able to break 
up lithium aggregates.72-74  However, Slocum has recently shown that a solution of 
THF/hexanes is generally superior in DOM reactions than a solvent system of pure THF, 
which is currently considered the ideal solvent for DOM reactions.75 It was suggested that 
the most active form of the lithium is that of the dimer, as the fastest rates of metallation 
are observed in a solvent mixture that favors dimer formation over the tetrameric or 
monomeric lithium complexes (e.g. THF/hexane).  Other studies by Collum and 
coworkers have supported the hypothesis that the dimeric form of the lithium aggregate is 
the most active in DOM.74  The key importance of the extent of lithium aggregation has 
been observed using di-substituted ortho-directing groups.76  DOM reactions do not 
readily occur in non-coordinating hydrocarbon solvents.  However, using 1,2 
dimethoxybenzene (DMB) in hexane allows for efficient ortho-metallation to occur, 
presumably through a substrate promoted metallation pathway where the  substrate 
(DMB) is capable of dispersing the lithium aggregates.76    
 In addition to the use of polar solvents, the addition of coordinating compounds to 
DOM reactions has been found to greatly enhance the extent of metalation.72,77  One of 
the most commonly used coordination compounds is tetramethylethylenediamine 
(TMEDA).  Hauser has demonstrated that not only is the rate of the reaction increased in 
the presence of TMEDA, but the yields of the metallation reactions are enhanced as 
well.77  In their study, N,N-dimethyl-o-toluidine was ortho-lithiated (D2O quench) in the 
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presence of TMEDA after only 4 hours (90% yield), compared to the reaction without 
TMEDA, which required 30 hours and only proceeded in 50% yield.  Recent ab initio 
studies by Saa and coworkers have shown that the role of TMEDA is to prevent over- 
coordination of the lithium to the DOM group.78   
 Schleyer has indicated that the presence of the DOM group may in fact be more 
important in the transition state, rather than in the initial coordination and direction of the 
organolithium.72,79-82 Without TMEDA present, lithium tends to form large aggregates 
around the directing group and thus slow or hinder the deprotonation.  However, the 
coordination of TMEDA to the lithium frees it from these complexes and allows the brief 
coordination of the lithium to the DOM group only transiently during the deprotonation 
transition state.72,78   Thus, Schleyer concluded that it is the transient coordination, and 
not the initial complexation of the organolithium reagent, that is responsible for the 
accelerating and ortho-directing effect of substituents.   
 In order for the DOM group to efficiently direct metallation, it must have a 
heteroatom available for chelation.  Beak and coworkers discovered that relatively small 
changes in the directing group orientation have a dramatic effect on the rate of 
metallation.83  They studied the effect of altering the position of an amide directing group 
(Scheme 2).   By merely adjusting the distance by a very small amount (0.3Å) between 
the proton and the directing group, large changes in the rate of deprotonation were 
observed.83  Beak was able to explore the effect of proximity in the synthesis of bicylic 
carbamates where it was observed that an increase in the efficiency of metallation when 
the directing group was held in close proximity to the site of deprotonation.84      
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Scheme 2.  Influence of Directing Group Orientation on the Rate of Metallation 
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 A recent study by Clayden and coworkers has provided the first crystallographic 
evidence for the structure of the ortho-lithiated benzamide species.85  Benzamides are one 
of the best directors of ortho- metallation because they possess the two characteristics of 
a good directing group; electron rich heteroatoms to promote lithium chelation,73 and 
electron withdrawing capabilities to withdraw electron density from the aromatic ring and 
facilitate deprotonation.  Despite widespread use of the benzamide as DOM group, the 
exact coordination structure of the lithiated intermediate had not been elucidated.  The X-
ray structure of the lithiated benzamide DOM group exists as a dimer where the lithium is 
coordinated by a solvent molecule, a benzamide oxygen, and the carbanions (Scheme 
3).85  The crystal structure provide evidence that oxygen coordination of the lithium 
center is crucial to the stability of the metallated species.85  Further studies are necessary 
to elucidate the solution properties of this complex, as it is evident that solvent plays a 
major role in the formation of the ortho-lithium complex.    
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Scheme 3.  Proposed Structure of ortho-Lithiated Benzamides 
Li
Li
O O
NEt2
OO
Et2N
 
 Many DOM groups have been discovered and extensively studied throughout the 
years since the discovery of the ortho-metallation of anisole in 1939.  All of these 
directing groups have specific synthetic strengths and weaknesses.  What follows is a 
brief overview of some of the most important directing groups. 
 
 O-Alkyl Directing Groups 
 Since the discovery of ortho-metallation using anisole, oxygen containing 
directing groups have received considerable attention.  Parham in 1948 proposed the 
synthesis of certain phenolic acetals for their use in DOM.86  He concluded that phenolic 
ethers (e. g. anisole) were too difficult to remove and would result in decomposition of 
the compound.  However, more modern techniques of phenolic ether cleavage have been 
realized and the use of acetals87 has largely been replaced by phenolic ethers. 
 Early studies used tetrahydropyranyl ethers II-1 and anisole.88-90  These studies 
demonstrated that these groups were able to direct ortho-metallation in high yields.  
Subsequent studies sought to ascertain the effect of other substituents on the DOM 
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abilities of these ethers.  The presence of alkyl groups ortho to the DOM group would 
lead to a mixture of products; the desired ortho-metallated product, and the deprotonated 
alkyl group in an approximately 5:2 mixture (Scheme 4).91,92  However, if the alkyl group 
was farther away in the ring, then it was not deprotonated.  These results would seem to 
indicate that the DOM group is able to direct deprotonation of the alkyl substituent as 
well, making the presence of ortho-alkyl groups undesirable. 
O
O
II-1  
Scheme 4 
OMe
CH3 1. n-BuLi
2. E+
OMe
CH3
OMe
E
E+
 
  The directing capabilities of anisole have been compared to that of many other 
directing groups.93,94  Slocum concluded that CH2NMe2, CONHMe, SO2NHMe, and 
SO2NMe2 were more powerful ortho- directing groups.  In addition, CH2CH2NMe2, CF3, 
NMe2, and F were all weaker directing groups than anisole.  In these cases, mixtures of 
metallated products were not obtained; metallation occurred exclusively ortho to the 
more powerful group.   
 The use of methoxymethyl (MOM) groups has also been reported.95-99  These 
phenol protecting groups have the advantage over methoxy groups in ease of their 
 26
removal and have been utilized in the synthesis of coumarins100 and polycoumarin101 
compounds.  
 Carbamate Directing Groups  
 Carbamates (-OCONR2) as efficient directors of ortho-metallation were 
discovered in 1983 by Snieckus (Scheme 5).102,103  They were found to be better directing 
groups than O-methyl or MOM, but show lower regioselectivity in the metallation of 
non-equivalent ortho sites.    
Scheme 5.  DOM of Carbamates 
O
O
NEt2 1.  n-BuLi
O
O
NEt2
E2.  E
+
where E = DMF, CO2, TMSCl, MeI
II-2 II-3
 
An additional and unexpected effect was noticed with carbamates.  If, after 
lithiation, the reaction was allowed to warm (-78 ºC to r. t.), without the addition of an 
electrophile, then it was observed that 1,3-acyl migration occurred, termed anionic ortho–
Fries rearrangement (Scheme 6).103 These rearranged compounds were obtained in good 
yields (65-78%) and allow for further DOM reactions because of the presence of the new 
benzamide DOM moiety.102,104,105 
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Scheme 6.  1,3-Acyl Migrations of Carbamates 
O
O
NEt2
Li
OH
O
NEt2
room temperature
II-4 II-5  
 Snieckus utilized this DOM/rearrangement reaction in his synthesis of ochratoxin 
A and B (Scheme 7).106  This use of carbamate ortho-metallation-rearrangement was the 
key step in the synthesis of these bacterial toxins in four steps with 14 and 6 % overall 
yields for ochratoxin A and B, respectively.  The synthesis of other unusually substituted 
isocoumarins was accomplished also.106   Accordingly, ortho-metallation of carbamate 
II-6 allowed for the introduction of electrophile E1 (pathway 1).  This ortho-metallation 
was followed by an anionic ortho-Fries rearrangement (pathway 2).  Another ortho-
metallation of the resulting benzamide derivative positioned electrophile E2 (pathway 3).  
This series of steps generated the highly functionalized arene II-7.  Compound II-7 was 
then converted through a series of steps to ochratoxin B (II-8) and ochratoxin A (II-9). 
Scheme 7.  Carbamate DOM Synthesis of Ochratoxin A and B 
R
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O
R2N
E2
E1
OH O
NR2 O
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O
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H
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R= Cl  Ochratoxin A (II-9)
Steps
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  Chromenes are important heterocyclic components in several natural products 
and are difficult to construct by classical methods such as Friedel-Crafts alkylation.  
Recently, Snieckus and coworkers employed aryl carbamate DOM groups in the 
regiospecific synthesis of chromenes.107  Snieckus first utilized the carbamate as an 
ortho-directing group, followed by rearrangement, to give the chromene products 
(Scheme 8).  For example, ortho-metallation of carbamate II-10 followed by quenching 
the anion with enone II-11 to generate allylic alcohol II-12 which underwent 
intramolecular carbamate migration to generate intermediate II-13.  Compound II-13 was 
cyclized subsequently to chromene II-14.  If R is another ortho-directing group, then the 
molecule is poised for further directed metallation and functionalization. 
Scheme 8.  Carbamate DOM and Synthesis of Chromenes 
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  Aniline and Nitrogen Directing Groups 
 Hauser first observed that tertiary amines are effective directors of metallation.108  
Since then, there have been many aniline derivatives that have been developed to direct 
metallation.  N-pivaloylanilines II-15,109-113 and dimethylureas II-16111 have both been 
widely employed in DOM chemistry.  Deprotonation of the N-H proton of 
pivaloylaniline II-15 occurred with the first equivalent of base to create the oxyanion II-
17 which directed the subsequent metallation (Scheme 9).  This formed dianion II-18 
which was quenched with an electrophile to generate the ortho-substituted product II-19.   
NH
O
II-15
H
N
O
NMe2
II-16  
Scheme 9 
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BuLi N
LiO tBu
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N
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II-18  
 N –Pivaloylanilines have been employed as DOM groups for natural product 
synthesis.  An example of which is the synthesis of β-carbolines (II-20) (Scheme 10).114  
In his synthesis, Queguiner utilized the ortho-directing abilities of N –pivaloylaniline (II-
21) to form the boronic acid II-22 which is able to then cross-couple via Suzuki coupling 
to form II-23 which is then ortho-metallated again, but this time utilizing the fluorine in 
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preference to the N –pivaloylaniline to attach electrophiles to the ring system to produce, 
upon ring closure, substituted β-carboline II-20. 
Scheme 10 
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Benzamide Directing Groups  
 The most important and widely used carboxylic acid derivative in ortho-
metallation chemistry is the benzamide functionality. This directing group yields the 
desired ortho-substituted products in very high yields (80-90%).115,116  o-Metallation of 
benzamides has been applied to the synthesis of a multitude of natural products117-129 
including isocoumarins II-24,130 phthalideisoquinoline alkaloids II-25,131,132 and 
anthraquinones II-26.133  In each of these syntheses, the use of benzamide DOM groups 
allowed for a more facile and shorter synthetic pathway than was available from classical 
reactions.   
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Despite their potent ability to direct ortho-metallation, the benzamides have 
several drawbacks.  First, the possibility of intermolecular condensation with the ortho-
carbanion can occur (Scheme 11).  This is usually avoided by keeping the temperature of 
the reactions below -78°C.134  Secondly, the amide can be resistant to hydrolysis.  
Secondary benzamides are easier to hydrolyze than tertiary amides; however, secondary 
amides require two equivalents of base and suffer from reduced reactivity toward DOM 
and, in some cases, pose solubility problems.134,135  As a result, Phillion has developed a 
tertiary benzamide II-30 which is easy to synthesize, is a good DOM, and is easily 
converted to the secondary amide via HCl in dioxane for hydrolysis.134   
Scheme 11 
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N
O
II-30  
  Application of Directed Ortho-Metallation to the Synthesis of Aryl Siloxanes 
Research in the DeShong group has focused on the use of aryl silane reagents in 
palladium-catalyzed cross-coupling reactions.  This methodology has proven to be 
excellent for aryl-aryl couplings,45-51 and can also be used for the arylation of allylic 
esters.136 The synthesis of aryl siloxanes is accomplished in one of several 
complementary methods.  Classically, the synthesis of  aryl siloxanes is achieved by 
treatment of aryl Grignard or aryllithium reagents with a silicon electrophile, typically 
tetraethylorthosilicate.56  Additionally, Pd (0)58,59 or Rh (I)60 catalyzed silylation reactions 
of aryl halides has been developed.  These transition metal-catalyzed silylation reactions 
are tolerant of functional groups (e.g. ester) that are not suitable for the Grignard 
approach. Eachof these methods, however, requires the use of a suitable aryl halide as the 
substrate.   
As part of the development of the siloxane coupling methodology, we were 
interested in synthesizing highly functionalized aryl siloxane derivatives for application 
in natural product total synthesis.  In several instances, the desired substitution pattern on 
the aromatic ring precluded the efficient synthesis of the requisite aryl halide.  An ortho-
metallation strategy, on the other hand, presened an attractive alternative route for the 
preparation these complex substrates (Scheme 12).  Organoboranes and organostannanes 
have been synthesized by ortho-metallation; however, aryl siloxanes have not been 
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prepared using this method.20  The results presented herein demonstrate the scope and 
limitations of directed ortho-metallation for the synthesis of aryl siloxanes and the 
subsequent coupling reactions of the resulting derivatives. 
Scheme 12 
ODG
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RESULTS AND DISCUSSION 
Our studies have focused on surveying ortho-directing groups (ODG) that have 
previously proven to be most versitile (vide supra).20  The synthesis of siloxanes using 
these groups is summarized in Table 1.  Ethers (entries 1 and 2) and carbamates (entries 3 
and 5, respectively) smoothly yielded the desired siloxanes in good yields.  In addition, 
the N-pivaloylaniline (entry 4) served as a suitable substrate for the formation of the 
requisite siloxane.  However, N,N-diethylbenzamide siloxane proved elusive (entry 6).  
The only product obtained from a multitude of reaction conditions was the benzophenone 
derivative, which arose from nucleophilic attack of  the lithiated benzamide species with 
another benzamide molecule. 
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Table 1.  Synthesis of Aryl Siloxanes via Ortho-Metallation 
MeO Si(OEt)4 MeO
Si(OEt)3
MOMO Si(OEt)4 MOMO
Si(OEt)3
O Si(OEt)4 O
Si(OEt)3
O
Et2N
O
Et2N
O
Et2N
O
Et2N
Si(OEt)4
O
Et2N CH3I
O
Et2N
CH3
Li
Li
Li
Li
Li
a For detailed metalation procedures for each substate see experimental section. b Yield
 of purified product.
HN
O
Si(OEt)4
Li
HN
Si(OEt)3
O
ODG ODG
Si(OEt)3
HN
OO
Li
Si(OEt)4 HN
OO
Si(OEt)3
O
 substratea electrophile product yieldb (%)
62
61
57
94
85
entry
1
2
3
4
5
6
7
63
1.  RLi
2.  Si(OEt)4
61
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In order to show that the lithiated benzamide species was being generated and 
could be efficiently trapped with an electrophile, the reaction was quenched with CH3I 
(entry 7).  This led to the formation of the expected ortho-substituted product in 85% 
yield.   It was thought that the inability to form the desired ortho-substituted benzamide 
siloxane was due to the poor electrophilicity of tetraethylorthosilicate.  Accordingly, we 
hypothesized that a more electrophilic siloxane source would give the desired siloxane in 
preference to the benzophenone adduct. 
To this end, several silicon electrophiles were surveyed and the results are 
presented in Table 2. The most promising proved to be triethoxysilyltriflate.  This reagent 
is readily obtained via treatment of allyltriethoxysilane with triflic acid.137  Yields of the 
o-methoxy, o-MOM, and o-O-carbamate siloxanes were markedly increased with this 
electrophile (entries 1-3, compare to Table 1 entries 1-3)).  Unfortunately, there was no 
reaction with the benzamide substrate (entry 4).   The use of another silane electrophile, 
SiCl4 (entry 5), provided only a marginal increase in yield over Si(OEt)4 (69% versus 
62%).  Like the silyl triflate, no benzamide siloxane product was obtained using SiCl4.  
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Table 2. Use of Alternative Silicon Electrophiles 
MeO
TfO-Si(OEt)3 MeO
Si(OEt)3
MeO
SiCl4a MeO
Si(OEt)3
MOMO
TfO-Si(OEt)3
TfO-Si(OEt)3
MOMO
Si(OEt)3
O
Si(OEt)3
O
Et2N TfO-Si(OEt)3
O
Et2N
ODG Si(OEt)3
ODG
Si(OEt)3
substrate electrophile product yield (%)
88
83
86
0
entry
1
2
3
4
5
1.  RLi
2.  Electrophile
69
OEt2N
O
OEt2N
a Lithiated arene was quenched with SiCl4 followed by the addition of anhydrous EtOH to 
obtain the desired siloxane.  See Experimental section for full reaction details.  
Having synthesized a variety of o-substituted aryl siloxanes, attention turned to 
assessing their ability to participate in palladium-catalyzed cross-coupling.  The results of 
these cross-coupling studies are presented in Table 3, and data indicate that siloxanes 
possessing either o-ether (entries 1 and 3) or o-O-carbamate (entry 2) functionalities 
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couple poorly with aryl bromides using 10 mol % catalyst.  Previous studies in our 
laboratory,138 had shown that the presence of oxygen-base ortho-substituents on the aryl 
siloxane often led to poor yields of coupled product; however, the results can be 
significantly improved by increasing the catalyst loading to 50 mol %.138  
The low yields of coupled product obtained using 10 mol % catalyst with o-
phenolic derivatives (Table 3, entries 1-3) was due to competitive protodesilylation of the 
siloxane (Scheme 13).  However, in the case of the aniline derivatives of the siloxane 
(entries 4 and 5, respectively), excellent yields of coupled products are observed with 
only 10 mol % catalyst, with no detectable protodesilylation.  
Scheme 13 
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Table 3.  Palladium-Catalyzed Cross-Coupling of Aryl Siloxane Derivatives 
tBu tBu
Pd(OAc)2
PPh3
TBAF
DMF
Pd(OAc)2a
Si(OEt)3
OMe
Si(OEt)3 OMe
OCONEt2
OMe
OCONEt2
Si(OEt)3
OMOM OMOM
Ar-Br
Ar
Ph
a In all cases,  ratio of Pd(OAc)2  to PPh3 was 1:2. Reactions performed with 50 mol % catalyst 
were complete in less than 15 min at 90 oC and reactions performed with 10 mol % catalyst were 
complete after 4 h at 90 oC.  b Yield in parenthesis is the yield obtained with 50 mol % catalyst.
Si(OEt)3
NH
O
NH
O
Si(OEt)3
NH
O tBu
O
NH
O tBu
O
+aryl siloxane biaryl product
aryl siloxane
(mole %)
biaryl
product
yieldb (%)
50(10) 39(75)
50(10) 12(49)
50(10)
entry
1
2
3 54(87)
4 10 86
5 10 88
p-OMePh
Ph
Ph
Ph
 
The cross-coupling reactions were found to be extremely sensitive to the presence 
of o-substituents in the aryl halide partners.  For example, cross-coupling of o-methoxy 
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siloxane II-31 to p-bromoanisole (II-32) proceeded in good yield to generate biaryl II-
33; however, attempted coupling of siloxane II-31 to o-bromoanisole (II-34) was not 
successful and the siloxane was protodesilylated (Scheme 14).  The formation of the 
disubstituted biaryl is slow due to steric congestion, providing time for the 
protodesilylation pathway to consume the siloxane.  
Scheme 14 
Si(OEt)3
OMe
Br
MeO TBAF
DMF
MeO
OMe
Si(OEt)3
OMe
Br
OMe
OMe
OMe
TBAF
DMF
+
50% Pd(OAc)2
100% PPh3
90 oC
+
71%
50% Pd(OAc)2
100% PPh3
90 oC
II-31 II-32 II-33
II-31 II-34 II-35  
In an attempt to elucidate the source of the proton and the mechanism of 
protodesilylation of o-substituted derivatives, several control experiments were 
performed.  Studies using deuterium-labeled DMF or THF showed that solvent was not 
the source of the proton.  Commercially available (Aldrich) solutions of TBAF in THF 
contain approximately 5% water and it was initially thought that water in the TBAF may 
be serving as the proton source for protodesilyation.  Accordingly, alternative anhydrous 
fluoride sources were investigated and the results of these studies are presented in Table 
4.  In most cases (entries 1-4, 8-11) neither cross-coupling nor protodesilylation occurred 
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upon treatment with the fluoride reagent, and the siloxane was recovered unchanged.  For 
comparison, p-methoxy siloxane is stable for 24 h in the presence of TBAF•3H2O.      
Table 4.  Use of Alternative Fluoride Sourcesa 
Si(OEt)3
OMe
Br
DMF
OMe
NaF
KF
LiF
CsF
NaBF4
Bu4NBF4
a Reactions were perfomed at 90 oC for 4 h.  b No reaction occurred. c Trace amounts 
of protodesilylated siloxane were present, remainder of siloxane was unreacted. 
d Remainder of siloxane was hydrolyzed. e Greater than 70% of the starting siloxane
 was recovered from the reaction.  f Contains 5% water.g Purchased from Aldrich.
TASF
10 % Pd(OAc)2
20 % PPh3
" F-" source (1 eq.)
+
entry " F- " source yield of coupled product (%)
TBAF (1.0 M in THF)f
TMAF (anhydrous)g
1
2
3
4
5
6
7
8
10
11
TBAF  3H2O 42d
40d
41d
0e
0b
15c
20c
17c
0e
0e
9 0e
TMAF  4H2O
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It was discovered that if the siloxane was heated in the presence of 
tetrabutylammonium fluoride trihydrate (TBAF•3H2O), rapid and efficient 
protodesilylation occurred with the generation of tributylamine (Table 5). This result 
clearly indicated that a proton was abstracted from the tetrabutylammonium cation in a 
Hoffman-like elimination to generate tributyl amine and butene (Scheme 15).139,140  
Further support for the hypothesis that this reaction was the source of the proton for 
protodesilylation was obtained from deuterium studies. TBAF•3H2O was recrystallized 
from D2O to give TBAF•3D2O, the structure of which was confirmed by IR (loss of OH 
peak, appearance of OD peak at 2550 cm-1).  When TBAF•3D2O was utilized in these 
experiments, no deuterium incorporation was observed in the product.   
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Table 5.  Search for the Source of the Proton for Protodesilylation 
OCH3
Si(OEt)3
OCH3
Si(OEt)3
OCH3
Bu3N
OCH3
Bu3N
H
H
OCH3
Si(OEt)3
OCH3
Si(OEt)3
OCH3
H
DMF
a Yields of products are greater than 90%.
Bu4NF  3H2O +
+
No Reaction
aryl siloxane
"F-" Source
90 oC
30 min
products
aryl siloxane "F-" source productsa
Bu4NF  3D2O
Me4NF  4D2O
Bu4NF  3H2O
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Scheme 15 
OCH3
Bu3N+
OCH3
+
H
Bu2
N
H
Bu3N+  
The protodesilylation mechanism was further probed using TMAF•4D2O 
(prepared in an analogous manner to TBAF•3D2O). This reagent does not possess β-
hydrogens and thus would not be able to undergo Hoffman elimination.  However, rapid 
protodesilylation still occurred, also with no deuterium incorporation.  This result 
indicated that the α-proton was abstracted from the tetramethylammonium cation 
generating the yilde, which can then undergo Stevens rearrangement to generate 
dimethylethylamine;141 however, attempts to isolate or identify dimethylethylamine from 
the reaction mixture were unsuccessful.  The ideal test for this side reaction would be to 
use the perdeuterated alkylammonium fluoride.  This experiment would provide direct 
evidence for the elimination pathway, as deuterium would be incorporated into the 
protodesilylated product. 
 
CONCLUSIONS 
 In conclusion, directed ortho-metallation protocols have been developed for the 
synthesis of aryl siloxane derivatives.  Subsequent cross-coupling of the resulting aryl 
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siloxanes has been achieved.  For phenolic derivatives, high catalyst loading is required 
for good yields of product.  On the other hand, aniline derivatives underwent cross-
coupling under standard conditions. 
Synthetic organic chemistry has witnessed the development of many different 
techniques that have allowed the formation of thousands of different molecules.  The 
addition to this repertoire of ortho-metallation by Gilman and Wittig has simplified the 
synthesis of many different natural products, and has opened the door to synthesis of 
novel compounds that were unrealized before.  The combination of this methodology 
with cross- coupling technology has become a powerful tool in the synthesis of countless 
unsymmetric biaryl systems.  Specifically, ortho-metallation has value in palladium-
catalyzed cross-coupling technology where it allows the facile preparation of aryl 
siloxanes which can be coupled to aryl halides in the synthesis of biologically active 
natural products. 
 
EXPERIMENTAL SECTION 
General Experimental 
Thin-layer chromatography (TLC) was performed on 0.25 mm silica gel coated 
plates treated with a UV-active binder with compounds being identified by UV (254 nm).  
Flash chromatography was performed using thick walled columns and medium pressure 
silica gel (Whatman 200-425 mesh), with column length and diameter being determined 
by the method of Still.142 
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Melting points were taken in Kimax soft glass capillary tubes using a Thomas-
Hoover Uni-Melt capillary melting point apparatus (Model 6406K) equipped with a 
calibrated thermometer. 
IR band positions are reported in reciprocal centimeters (cm-1) and relative 
intensities are listed as br (broad), s (strong), m (medium), or w (weak). Nuclear magnetic 
resonance (1H, 13C NMR) spectra were recorded on a 400 MHz spectrometer. Chemical 
shifts are reported in parts per million (δ) relative to tetramethylsilane (TMS).  Coupling 
constants (J values) are reported in hertz (Hz), and spin multiplicities are indicated by the 
following symbols: s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), br s 
(broad singlet).   
Low resolution mass spectrometry (LRMS) and high resolution mass 
spectrometry (HRMS) data are reported in the form of m/z (intensity relative to base peak 
= 100).  The matrix used for fast atom bombardment (FAB) was ethylene glycol. 
Tetrahydrofuran and diethyl ether were distilled from sodium/benzophenone 
ketyl.  Methylene chloride and tetraethylorthosilicate were distilled from calcium 
hydride.  Dimethylformamide and acetonitrile were distilled from calcium hydride.  
Ethanol was fractionally distilled from calcium chloride.  
Palladium (II) acetate (Pd(OAc)2) and tetrabutylammonium fluoride (1M solution 
in THF) were purchased from Acros and used as received.  Triphenylphosphine was 
purchased from Aldrich and recrystallized from hexane prior to use.  All glassware used 
in these reactions was either oven dried at 120 ºC for 12 hours or flame dried prior to use.  
All reactions were conducted under an atmosphere of argon.   
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All compounds were determined to be >95% pure by 1H NMR or GC analysis.  
Previously reported compounds were characterized via 1H and 13C NMR and IR and 
compared to literature values.  All new compounds were characterized using 1H NMR, 
13C NMR, IR, low resolution and high resolution mass spectrometry. 
  
Synthesis of Starting Materials 
Methoxymethoxybenzene (Table 1, entry 2).  Phenol (1.88 g, 20.0 mmol) was 
dissolved in 15 mL of DMF.  The solution was transferred via cannula to a suspension of 
NaH (0.768 g, 20.0 mmol) in 35 mL of DMF at 0 °C with significant evolution of gas.  
The reaction was allowed to warm to room temperature and was stirred for 15 min, then 
cooled to 0 °C.  Chloromethylmethyl ether (3.04 mL, 40.0 mmol) was added, and the 
reaction stirred for 5 min at 0 °C, then 15 min at room temperature.  The cloudy white 
solution was diluted with 50 mL of ether and  poured into 50 mL of water.  The organic 
layer was washed with 1M KOH (50 mL), water (50 mL), dried (MgSO4), and 
concentrated in vacuo to yield a pale yellow oil which was purified via column 
chromatography (19:1 hexanes/EtOAc, TLC Rf = 0.32) to give 2.76 g of the title 
compound as a colorless oil (97%).  The 1H and 13C NMR and IR match that reported by 
LeBel.143 
 
O-Phenyl diethylcarbamate (Table 1, entry 3).  Diethyl carbamoyl chloride (12.6 mL, 
100 mmol) was added to a mixture of K2CO3 (13.8 g, 100 mmol) and phenol (6.31 g, 67.0 
mmol) in 135 mL of MeCN.  The reaction was refluxed for 3.5 h followed by the 
addition of 100 mL of water.   The aqueous layer was extracted with ether (100 mL x3).  
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The combined organic layers were washed with 100 mL of a 1M KOH solution followed 
by 100 mL of water.  The ethereal solution was then dried (MgSO4) and concentrated in 
vacuo to produce a yellow oil. Kugelrohr distillation (95 °C, 0.3 mm Hg) yielded 17.8 g 
of  a colorless oil (92%). 13C NMR (CDCl3) δ 13.4, 14.2, 41.9, 42.2, 121.7, 125.0, 129.2, 
151.6, 154.2.  The 1H NMR and IR match that reported by Snieckus.144 
 
Pivalanilide (Table 1,  entry 4).  Pivaloyl chloride (26.3 mL, 214 mmol) was added 
slowly to a vigorously stirred biphasic solution of Na2CO3 (22.7 g, 214 mmol) in 100 mL 
H2O and aniline (9.78 mL, 107 mmol) in 100 mL of CH2Cl2.  The reaction was refluxed 
for 1 h and diluted with 100 mL of CH2Cl2.  The organic layer was extracted once with 
100 mL of 1M NaOH, and twice with 100 mL of water, dried (MgSO4) and concentrated 
to yield a slightly yellow crystalline solid.  The solid was recrystallized from 
hexanes/EtOAc to produce 18.2 g of white needles (96%) mp 133.1-134.5 °C (lit. 133.8-
135.0 °C)145. IR (CCl4) 3458 (s), 3064 (w), 3026 (w), 2964 (m), 2902 (w), 2871 (w), 
1697 (s), 1597 (s), 1521 (s), 1435 (s), 1435 (s), 1314 (s), 1241 (m), 1148 (s).  The 1H and 
13C NMR match that reported by Lappert.145 
 
tert-Butyl N-phenylcarbamate (Table 1,  entry 5).  Di-tert-butyl dicarbonate (5.14 g, 
23.5 mmol) was added in one portion to a stirred solution of aniline (1.96 mL, 21.4 
mmol) in 25 mL of THF.  The reaction was heated to reflux for 3 h.  The solvent was 
removed in vacuo and the residue dissolved in 50 mL of EtOAc.  The organic layer was 
washed twice with 1M HCl (50 mL), once with water (50 mL), dried (MgSO4) and 
concentrated to yield a slightly yellow solid.  Recrystallization (CH2Cl2) yielded 4.07 g of 
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white flakes (97%) mp 137.1-137.4 °C (lit. 136-137 °C).146  IR (CCl4) 3451 (m), 3061 
(w), 3029 (w), 3012 (w), 2978 (m), 2926 (w), 1735 (s), 1604 (m), 1521 (s), 1435 (s), 
1366 (m), 1307 (m), 1162 (s). The 1H and 13C NMR match that reported by Smith.146 
 
N,N-Diethylbenzamide (Table 1,  entry 6).  To a stirred solution of benzoyl chloride 
(2.48 mL, 21.3 mmol) in 25 mL of THF at 0 °C is added 6.62 mL (64.0 mmol) of 
diethylamine.  The reaction is heated at reflux for 2 h, followed by evaporation of the 
solvent.  The residue is dissolved in 50 mL of EtOAc and washed three times with 1M 
HCl (50 mL), twice with saturated NaHCO3 (50 mL), and once with water (50 mL).  The 
organic layer was then dried (MgSO4) and concentrated to a yellow oil.  Kugelrohr 
distillation (90 °C, 0.2 mm Hg) yielded 3.26 g of a colorless oil (96%). The 1H and 13C 
NMR and IR match that reported by Burke.147 
  
Synthesis of Aryl Siloxanes 
2-(Triethoxysilyl)anisole (Table 1,  entry 1).  To a colorless solution of anisole (0.523 
mL, 5.00 mmol) in Et2O (10 ml), was added 0.906 ml of TMEDA (6.00 mmol).  The 
reaction was cooled to 0 °C and 3.75 ml of a 1.60 M solution n-BuLi in hexane was 
added.  The resulting yellow solution was stirred at room temperature for 1 h.  The dark 
yellow ethereal solution was added to 3.35 mL (15.0 mmol) of Si(OEt)4 in 15 ml of Et2O 
at –78 °C.  The solution was stirred at –78 °C for 1 h then allowed to warm to room 
temperature for an additional hour.  A saturated aqueous solution of NH4Cl (50 mL) was 
added and the aqueous layer extracted with 50 mL of ether (x3), dried (MgSO4), and 
concentrated in vacuo to give a yellow oil.  Kugelrohr distillation (125 °C, 0.9 mmHg) 
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yielded 838 mg of pure siloxane as a colorless oil (62%).  The 1H and 13C NMR and IR 
match that reported by DeShong.59 
 
2-(Triethoxysilyl)-methoxymethoxybenzene (Table 1,  entry 2).  Title compound was 
synthesized using a modified metalation procedure of Barve.15 Methoxymethoxybenzene 
(0.718 g, 5.00 mmol) and TMEDA (0.755 mL, 5.00 mmol) were dissolved in 10 mL of 
ether.  The solution was cooled to 0 °C and 3.13 mL (5.00 mmol) of a 1.60 M n-BuLi 
solution in hexanes was added slowly inducing the formation of a yellow slurry.  The 
mixture was stirred for a further 30 min at 0 °C.  The lithiated arene was then transferred 
via cannulation to a solution of tetraethylorthosilicate (2.23 mL, 10.0 mmol) in 10 mL of 
ether at -78 °C.  The reaction was stirred for 1 h at -78 °C and then allowed to warm to 
room temperature over the period of 1 h.  The reaction was quenched with saturated 
aqueous NH4Cl (50 mL).  The aqueous layer was extracted with ether (50 mL x2), dried 
(MgSO4), and the solvent removed in vacuo to give a pale yellow oil. Kugelrohr 
distillation (130 °C, 0.9 mm Hg) yielded 916 mg of pure siloxane as a colorless oil 
(61%).  IR (CCl4) 2974 (m), 2926 (m), 2895 (m), 1591 (m), 1474 (m), 1230 (m), 1156 
(m), 1105 (s), 1080 (s), 1006 (s); 1H NMR (CDCl3) δ 1.22 (t, J=7.2, 9H), 3.49 (s, 3H), 
3.83 (q, J=7.2, 6H), 5.23 (s, 2H), 6.98 (t, J=7.0, 1H), 7.13 (d, J=7.0, 1H), 7.42 (t, J=7.0, 
1H), 7.60 (d, J=7.0, 1H); 13C NMR (CDCl3) δ 18.2, 56.0, 58.6, 94.2, 113.1, 120.0, 121.5, 
132.1, 137.5, 162.2; LRMS (FAB+) m/z 300 (M+, 25), 255 (60), 210 (100), 163 (35), 139 
(30), 107 (35), 79 (28), 45 (97); HRMS (FAB+, M+) m/z calcd for C14H24O5Si 300.1393, 
found 300.1387. 
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2-(Triethoxysilyl)-O-N,N-diethylcarbamoylbenzene (Table 1,  entry 3).  Title 
compound was synthesized using a modified metalation procedure of Snieckus.16  A 
solution of O-phenyl diethyl carbamate (0.966 g, 5.00 mmol) in 5 mL of THF was added 
dropwise to a stirred solution of sec-BuLi (4.01 mL, 5.50 mmol) and TMEDA (0.830 
mL, 5.50 mmol) in 50 mL of THF at  -78 °C.  The reaction was stirred for 1 h at -78 °C 
and was then slowly added to a stirred solution of tetraethylorthosilicate (3.35 mL, 15.0 
mmol) in 30 mL of THF at -78 °C.  The reaction was stirred at -78 °C for 2 h followed by 
2 h at room temperature.  Saturated aqueous NH4Cl (50 mL) was added to the reaction 
mixture.  The aqueous layer was then extracted with ether (50 mL x2), dried (MgSO4), 
and the solvent removed in vacuo to give a dark yellow oil. Kugelrohr distillation (135 
°C, 0.9 mmHg) yielded 1.01 g of pure siloxane as a colorless oil (57%). IR (CCl4) 2978 
(w), 2929 (w), 2885 (w), 1718 (s), 1421 (m), 1200 (m), 1155 (s), 1103 (s), 1086 (s); 1H 
NMR (CDCl3) δ 1.19-1.28 (m, 15H), 3.38 (q, J=7.2, 2H), 3.53 (q, J=7.2, 2H), 3.82 (q, 
J=7.2, 6H), 7.17-7.26 (m, 2H), 7.43-7.45 (m, 1H), 7.71-7.30 (m, 1H); 13C NMR (CDCl3) 
δ 13.3, 14.0, 18.0, 41.6, 42.0, 58.4, 122.4, 122.9, 124.6, 131.7, 137.0, 154.0, 156.5; 
LRMS (EI+) m/z 355 (M+, 5), 309 (30), 100 (100), 72 (25); HRMS (EI+, M+) m/z calcd 
for C17H29O5NSi 355.1815, found 355.1822. 
 
2-(Triethoxysilyl)-pivalanilide (Table 1, entry 4).  Pivalanilide (886 mg, 5.00 mmol) 
was dissolved in 30 mL of a 50:50 solution of THF:Et2O.  To this colorless solution at 0 
°C was added 12.4 mL of a 1.21 M solution of n-BuLi in hexane (15.0 mmol).  The pale 
yellow solution was stirred at 25 °C for 20 h.  The resulting white slurry was cooled to 0 
°C and diluted with 50 mL of THF.  Tetraethylorthosilicate (3.35 mL, 15.0 mmol) was 
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then added via syringe.   The reaction was stirred for a further 4 h at room temperature.  
The solvent was removed in vacuo and the residue dissolved in ether.  The organic layer 
was washed with saturated aqueous NH4Cl (50 mL) twice, dried (MgSO4), and the 
solvent removed in vacuo to give a pale yellow oil. Column chromatography (9:1 
hexanes/EtOAc, TLC Rf = 0.28) yielded 1.05 g of a pale yellow oil (62%).  IR (CCl4) 
3368 (s),  3054 (w), 2971 (s), 2922 (s), 2895 (s), 1683 (s), 1576 (s), 1535 (s), 1431 (s), 
1300 (s), 1159 (s), 1103 (s), 1076 (s), 962 (s); 1H NMR (CDCl3) δ 1.24 (t, J=8.0, 9H), 
1.30 (s, 9H), 3.88 (q, J=8.0, 6H), 7.07 (t, J=8.0, 1H), 7.41 (m, 1H), 7.55 (m, 1H), 8.33 (d, 
J=8.4, 1H), 8.99 (s, 1H); 13C NMR (CDCl3) δ 18.1, 27.6, 39.8, 59.1, 119.1, 121.0, 123.2, 
131.7, 135.6, 144.1, 177.0; LRMS (FAB+) m/z 339 (M+, 10), 294 (100); HRMS (FAB+, 
M+) m/z calcd for C17H29O4NSi 339.1866, found 339.1860. 
 
2-(Triethoxysilyl)-N-(tert-butoxycarbonyl)aniline (Table 1,  entry 5).  A solution of t-
BuLi (4.20 mL, 6.30 mmol) was added dropwise to a stirred, colorless solution of N-(tert-
butoxycarbonyl)aniline (500 mg, 2.52 mmol) in 10 mL of THF.  The yellow solution was 
stirred at –20 °C for 2 h.  The solution was diluted with 20 mL of THF, cooled to –78 °C, 
and tetraethylorthosilicate (1.69 mL, 7.56 mmol) was added via syringe.  The reaction 
was then allowed to warm to room temperature overnight and quenched with saturated 
aqueous NH4Cl (50 mL).  The aqueous layer was then extracted with ether (50 mL x2), 
decolorized with activated carbon, dried (MgSO4), and the solvent removed in vacuo to 
give a dark yellow oil. Column chromatography (9:1 hexanes/EtOAc, TLC Rf = 0.33) 
yielded 546 mg of a colorless oil (61%). IR (CCl4) 3337 (m), 3054 (w), 2978 (s), 2926 
(m), 2888 (m), 1725 (s), 1580 (m), 1535 (m), 1438 (m), 1369 (m), 1300 (m), 1159 (s), 
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1079 (s), 958 (m); 1H NMR (CDCl3) δ 1.27 (t, J=6.8, 9H), 1.51 (s, 9H), 3.89 (q, J=6.8, 
6H), 7.01 (t, J=7.6, 1H), 7.38-7.42 (m, 1H), 7.49-7.51 (m, 1H), 8.12 (d, J=8.4, 1H), 8.72 
(s, 1H); 13C NMR (CDCl3) δ 18.0, 28.4, 29.5, 59.0, 118.6, 122.0, 131.8, 135.5, 144.7, 
153.1; LRMS (FAB+) m/z 355 (M+, 42), 310 (22), 299 (40), 254 (100), 210 (45), 57 (25); 
HRMS (FAB+, M+) m/z calcd for C17H29O5NSi 355.1815, found 355.1826. 
 
2-(Diethylcarbamoyl)benzophenone (Table 1,  entry 6).  N, N-Diethyl benzamide (500 
mg, 2.82 mmol) in 20 mL of THF was added slowly to a solution of sec-BuLi (2.38 mL, 
3.10 mmol) and TMEDA (0.468 mL, 3.10 mmol) in 40 mL of THF at -78 °C.  The 
reaction was stirred at -78 °C for 1 h.  The reaction mixture was then added to Si(OEt)4 
(1.89 mL, 8.46 mmol) in 100 mL of THF at -78 °C.  The reaction was stirred for 1 h at -
78 °C and quenched with saturated aqueous NH4Cl (100 mL).  The aqueous layer was 
then extracted with ether (50 mL x2), dried (MgSO4), and the solvent removed in vacuo 
to give a dark yellow oil. Column chromatography (1:1 hexanes/EtOAc, TLC Rf = 0.29) 
yielded 310 mg of a white solid (95%) mp 76.8-77.2 °C (lit. 76-77 °C).17 IR (neat) 3059 
(w), 2975 (w), 2935 (w), 2866 (w), 1660 (m), 1620 (s), 1591 (m), 1428 (m), 1268 (s), 
1083 (m), 927 (m); 13C NMR (CDCl3) δ 12.2, 13.7, 38.8, 43.2, 126.8, 128.1, 128.3, 129.8, 
130.3, 130.7, 133.0, 137.0, 137.2, 138.8, 169.9, 196.7; LRMS (FAB+) m/z 282 (M+, 95), 
209 (100), 105 (32), 72 (32), 57 (19); HRMS (FAB+, M+) m/z calcd for C18H20O2N 
282.1499, found 282.1507.  The 1H NMR matches that reported by Snieckus.102 
 
N,N-Diethyl-o-toluamide (Table 1,  entry 7).  Title compound was synthesized using a 
modified metallation procedure of Beak.18  N, N-Diethyl benzamide (570 mg, 3.22 mmol) 
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in 10 mL of THF was added slowly to a solution of sec-BuLi (2.58 mL, 3.53 mmol) and 
TMEDA (0.533 mL, 3.53 mmol) in 40 mL of THF at -78 °C.  The reaction was stirred at 
-78 °C for 1 h.  Methyl iodide (0.501 mL, 8.05 mmol) was then added via syringe. The 
solution was then allowed to warm to room temperature.  The reaction was quenched 
with saturated aqueous NH4Cl (50 mL).  The aqueous layer was then extracted with ether 
(50 mL x2), dried (MgSO4), and the solvent removed in vacuo to give a dark yellow oil. 
Kugelrohr distillation (85 °C, 0.3 mmHg) yielded 523 mg of the title compound as a 
colorless oil (85%).  IR (CCl4) 3061 (w), 3026 (w), 2974 (w), 2933 (w), 2871 (w), 1635 
(s), 1552 (m), 1473 (m), 1455 (m), 1428 (m); 13C NMR (CDCl3) δ 12.9, 14.0, 18.8, 38.7, 
42.6, 125.4, 125.8, 128.5, 130.3, 133.8, 137.1, 170.8.  The 1H NMR matches that reported 
by Beak.148 
 
Palladium-catalyzed cross-coupling reactions of aryl siloxanes with aryl 
bromides, representative procedure: To a solution of siloxane (1.50 mmol), aryl bromide 
(1.00 mmol), Pd(OAc)2 (0.100 mmol), PPh3 (0.200 mmol), in DMF (10 mL) is added 
1.50 mL of TBAF in THF (1.0 M solution, 1.50 mmol).  The reaction is heated at 90 °C 
for 4 h after which time, the reaction is cooled to room temperature and poured into 25 
mL of water, and the aqueous layer extracted with ether (25 mL x3).  The combined 
organic layers are dried (MgSO4) and concentrated in vacuo.  The biaryl product is then 
purified via column chromatography. 
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2-Methoxybiphenyl (Table 3, entry 1).  Column chromatography (19:1 hexanes/EtOAc, 
TLC Rf = 0.37) yielded 71.7 mg of a colorless oil (39%).  The 1H and 13C NMR and IR 
match that reported by Buchwald.149 
 
4′-Methoxy-2-(N,N-diethyl-O-carbamoyl)biphenyl (Table 3,  entry 2).  Column 
chromatography (4:1 hexanes/EtOAc, TLC Rf = 0.27) yielded 35.9 mg of a colorless oil 
contaminated with a small amount of hexanes (12%).  IR (CCl4) 3078 (w), 3036 (w), 
2971 (w), 2926 (w), 2867 (w), 2829 (w), 1718 (s), 1555 (m), 1521 (m), 1417 (m), 1272 
(m), 1248 (m), 1196 (m), 1155 (m); 1H NMR (CDCl3) δ 1.04 (t, J=6.5, 6H), 3.26 (q, 
J=6.5, 4H), 3.83 (s, 3H), 6.92 (d, J=8.0, 2H), 7.18-7.36 (m, 6H); 13C NMR (CDCl3) δ 
13.9, 13.2, 41.6, 41.9, 55.3, 113.5, 123.2, 125.5, 127.9, 130.2, 130.5, 134.7, 148.5, 154.1, 
158.8; LRMS (EI+) m/z 299 (M+, 78), 294 (23), 100 (100), 72 (21); HRMS (EI+, M+) m/z 
calcd for C18H21O3NSi 299.1521, found 299.1518. 
 
2-Methoxymethoxybiphenyl (Table 3, entry 3).  Column chromatography (19:1 
hexanes/EtOAc TLC Rf = 0.28) yielded 116 mg of a colorless oil (54%).  IR (CCl4) 3061 
(w), 3026 (w), 2992 (w), 2954 (w), 2926 (m), 2895 (m), 2847 (m), 1480 (s), 1435 (m), 
1228 (m), 1190 (m), 1148 (m), 1076 (s), 1017 (s).  The 1H and 13C NMR match that 
reported by Reinhoudt.150 
 
2-Pivalanilinebiphenyl (Table 3, entry 4).  Column chromatography (9:1 
hexanes/EtOAc TLC Rf = 0.27) yielded a yellow solid.  Recrystallization from ethanol 
yielded 218 mg of a white solid (86%) mp 70.2-70.5 °C (lit. 69.7-70.1°C).20 1H NMR 
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(CDCl3) δ 1.09 (s, 9H), 7.14-7.16 (m. 1H), 7.24-7.2 (m, 1H), 7.36-7.48 (m, 7H), 8.36 
(1H); 13C NMR (CDCl3) δ 27.4, 39.8, 120.9, 123.9, 128.1, 128.5, 129.1, 129.4, 129.7, 
132.1, 135.2, 138.1, 176.3; LRMS (EI+) m/z 254 (M+, 20), 253 (100), 196 (15), 169 (67), 
168 (25), 57 (45); HRMS (EI+, M+) m/z calcd for C17H20ON 254.1545, found 254.1543.  
The IR matches that reported by Ohashi.151 
 
2-N-(tert-Butoxycarbonyl)biphenyl (Table 3,  entry 5).  Column chromatography (19:1 
hexanes/EtOAc TLC Rf = 0.25) yielded 237 mg of a white solid (88%) mp 72.3-73.1 °C.  
IR (CCl4) 3426 (m), 3067 (w), 3009 (w), 2978 (w), 2926 (w), 2898 (w), 1738 (s), 1590 
(m), 1514 (s), 1493 (m), 1445 (s), 1162 (s); 1H NMR (CDCl3) δ 1.46 (s, 9H), 6.49 (s, 
1H), 7.07-7.12 (m, 1H), 7.18-7.21 (m, 1H), 7.32-7.42 (m, 4H), 7.48 (t, J=7.2, 2H), 8.10 
(d, J=8.4, 1H); 13C NMR (CDCl3) δ 28.3, 30.0, 119.8, 123.1, 127.8, 128.4, 129.1, 129.3, 
130.2, 130.9, 132.0, 135.3, 138.4; LRMS (FAB+) m/z 269 (M+, 65), 214 (100), 170 (78), 
169 (52), 57 (45); HRMS (FAB+, M+) m/z calcd for C17H19O2N 269.1420, found 
269.1429. 
 
4-Methoxy-2′-methoxybiphenyl (3).  Column chromatography (9:1 hexanes/EtOAc 
TLC Rf = 0.30) yielded 152 mg of a white solid (71%) mp 69.7-70.4 °C (lit. 69-70 °C).22  
The 1H and 13C NMR and IR match that reported by Denmark.42 
 
General procedure for the synthesis of aryl siloxanes using triethoxysilyltriflate: 
Triflic acid (3.50 mmol), is added dropwise to a stirred solution of allyltrimethoxysilane 
(3.50 mmol) in 50 mL of CH2Cl2 at -20 °C. After addition is complete, the solution is 
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stirred at -20 °C for 1 h, followed by a further hour at room temperature.  The solvent is 
removed in vacuo and the residue dissolved in 50 mL of THF.  After cooling to -78 °C, 
the silyltriflate is added dropwise to the aryl lithium (3.50 mmol) in 100 mL of THF at –
78 °C.   The resulting solution is stirred at -78 °C for 1 h, room temperature for 1 h, and 
then quenched with 100 mL of saturated aqueous NH4Cl.   The aqueous layer is extracted 
with ether (50 mL x2), dried (MgSO4), and the solvent removed in vacuo.  The siloxane 
is purified as stated above. 
 
General procedure for the synthesis of aryl siloxanes using silicon 
tetrachloride: Lithiated arene (5.00 mmol) is prepared as described above and cooled to -
78 °C.  The lithiated arene is added via cannula to a stirred solution of SiCl4 (10.0 mmol) 
in 100 mL of THF at -78 °C.  The reaction is stirred at -78 °C for 1 h.  Dry EtOH (100 
mmol) is added via syringe and the resulting mixture stirred at room temperature for 15 
min.  The reaction is quenched with 100 mL of saturated aqueous NH4Cl.  The aqueous 
layer is extracted with ether (100 mL x2), dried (MgSO4), and the solvent removed in 
vacuo.  The siloxane is purified as stated above. 
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Chapter 3 - Preparation and Palladium-Catalyzed Cross-
Coupling of Aryl Triethylammonium (Bis)catechol Silicates 
With Aryl Halides and Triflates 
PART 1: Cross-Coupling of Aryl Bis(catechol) Silicates with Aryl 
Triflates. 
INTRODUCTION 
Synthesis and Structure of Bis(catechol) Silicates 
Pentacoordinate bis(catechol) silicates (III-1) were first synthesized by Frye in 
1962.152 Since that time, studies have elucidated the structural properties and unique 
reactivity of these compounds and several comprehensive reviews have appeared.153-157 
Bis(catechol)silicates are readily prepared in excellent yields from alcoholic solutions of 
catechol, phenyl trimethoxysilane, and a variety of amine and tetralkylammonium 
hydroxide bases (Scheme 1).152   
Scheme 1  
Si(OMe)3
+
HO
HO
Base
MeOH O
O
Si
O
O
BH
Base: py, Et3N, R4NOH
78%
III-1
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 The stability of these compounds is exemplified by the fact that they are prepared 
in alcohol solvents, despite the opportunity for solvolysis and reversal of the reaction.152  
In fact, these compounds can even be formed in aqueous solutions.  Although Frye was 
able to synthesize a variety of pentacoordinate silicates, the exact structure of these 
compounds was not known until 1968 when Boer and coworkers were able to obtain a 
crystal structure.158  They were able to confirm the proposed distorted trigonal 
bipyramidal geometry. 
Frye has also studied the silicate salts derived from aliphatic 1,2-diols such as 
bis(pinacol) silicate III-2.159  These compounds proved to be significantly more 
hydrolytically unstable than the catechol analogues.  The aliphatic 1,2-diol silicates could 
only be formed under anhydrous conditions, and were found to be unstable when exposed 
to atmospheric moisture.159  For these reasons, the use of aliphatic 1,2-diol silicates in 
organic synthesis has been limited. 
O
O
Si
O
O Me4N
III-2  
  Tacke and coworkers studied an interesting zwitterionic form of the bis(catechol) 
silicate.160,161  Instead of forming a tetraalkylammonium salt, the starting silane III-3 
contains an amino functionality which could be protonated upon formation of the silicate, 
creating an overall neutral molecule III-4 (Scheme 2).  Tacke has used these zwitterionic 
silicates III-4 as traceless linkers in solid phase synthesis.162 
 59
Scheme 2 
Si
OMe
OMe
N HO
HO
+
O
O
Si
O
O
NH
CH3CN
III-4III-3  
The formation of silicate III-4 entails a carbon-silicon bond cleavage (phenyl) in 
order to form the silicate III-4.  A similar carbon-silicon bond cleavage was observed by 
Frye when he attempted to synthesize dialkyl hexacoordinate silicates III-6 from 
diphenylmethoxysilane (III-5) (Scheme 3).  Instead, the observed product was 
pentacoordinate silicate III-7.  The facile Si-C bond cleavage in these reactions is 
attributed to the relief of steric strain in the formation of the pentacoordinate species.152    
Scheme 3 
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 Reaction Of Bis(catechol) Silicates with Strong Nucleophiles 
 The reactivity of pentacoordinate silicates with strong nucleophiles has been 
studied extensively by Corriu.163-166 When silicate III-7 is treated with an excess of 
phenyl magnesium bromide, tetraphenyl silane is rapidly formed.  If the number of 
equivalents of Grignard reagent are reduced, tri-organosilanes can be formed after 
reduction with a metal hydride (Scheme 4).  Mechanistically, these reactions proceed via 
attack of an anionic nucleophile upon an anionic electrophile; however, the exact 
mechanistic details have yet to be elucidated. 
Scheme 4 
O
O
Si
O
O
Me4N
III-7
1. 2 equiv EtMgBr
2. LiAlH4
PhEt2SiH
 
 Use of Bis(catechol) Silicates for the Allylation of Aldehydes 
 Hosomi has reported that allyl bis(catechol) silicates III-8 are effective aldehyde 
allylation reagents.167-169  These allylation reactions allow for the generation of 
homoallylic alcohols III-9 in high yield and without the use of a Lewis acid catalyst 
(Scheme 5).  The addition of chiral additives allows the reaction to proceed with 
moderate enantiomeric excess (54%).  Kira and Sakurai were able to effect a similar 
allylation using pentacoordinate allyl silicates generated in situ from allyl trichlorosilane 
and dilithiocatecholate.170  
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Scheme 5 
O
O
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O
O
Et3NH
III-8
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R
R
III-9  
 Use of Bis(catechol) Silicates in Palladium-Catalyzed Coupling Reactions 
In an example of the use of bis(catechol) silicates in a palladium-catalyzed cross-
coupling reaction, Hosomi171,172 has shown that pentacoordinate alkenylsiliconates III-8 
will couple in good yields with electron deficient aryl iodides (60-84%) and in poor to 
moderate yields with aryl bromides, triflates, and electron-rich aryl iodides (21-57%) 
(Scheme 6).  In addition to low yields and poor functional group tolerance, these 
reactions suffered from long reaction times (30-110 hours). 
Scheme 6 
X
+
R
21-84%
 PdCl2(PhCN)2
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 Palladium-Catalyzed Cross-Coupling Methodologies 
Palladium-catalyzed cross-coupling reactions of aryl halides or triflates to form 
unsymmetrical biaryls are one of the most useful tools in synthetic organic chemistry.3  
Several of the most common methods for performing these transformations are the Stille 
(organostannane),6-10 Suzuki-Miyaura (organoboron),15-19 and  the Hiyama 
(organosilicon)30-36 reactions (Scheme 7). The more established Suzuki-Miyaura and 
Stille reactions have benefited from high yields and wide functional group tolerances.  
Despite these advantages, organosilicon reagents have emerged as a viable alternative for 
the synthesis of unsymmetrical biaryls, due in part to the inherent drawbacks in the Stille 
and Suzuki-Miyaura methodologies.  For example, Stille couplings require the use of 
toxic organotin reagents; while the boronic acid derivatives utilized in Suzuki couplings 
can be difficult to synthesize and purify.  
Scheme 7 
X
X = I
    = Br
    = Cl
    = OTf
Pd (0)
Y
Y = SnBu3 
    = B(OH)2
    = Si(OEt)3
+
R1
R2
R2
R1
 
 Work in the DeShong group has focused on the use of aryl trialkoxysilanes as 
alternatives to the organotin and organoboron compounds.  These siloxanes can be 
readily synthesized via metalation (Li or Mg) of the corresponding aryl halide followed 
by nucleophilic attack upon readily available tetraalkylorthosilicates,56 or through 
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palladium58,59 or rhodium60 catalyzed silylation (Scheme 8).  In the presence of a fluoride 
activator, aryl siloxanes undergo Pd(0)-catalyzed cross-coupling with aryl iodides,45 
bromides,45,46 and chlorides.46   In addition, Fu has recently extended this methodology to 
include couplings with alkyl bromides and iodides.52   
Scheme 8 
CH3
Br/I
1.  Mg or Li
2.  Si(OEt)4
CH3
Si(OEt)3
Pd(0) or Rh(I)
HSi(OEt)3
CH3
Si(OEt)3
 
One limitation of the siloxane-based methodology is that aryl siloxanes do not 
couple efficiently to aryl triflates due to competing hydrolysis of the triflate under the 
basic reaction conditions.  However, the use of aryl triflates is advantageous because they 
can easily be synthesized from the corresponding phenol and are often more accessible 
than the analogous aryl halide.173  Recent studies in our laboratory have demonstrated 
that siloxane derivatives can be employed for the coupling of aryl triflates under strictly 
controlled conditions.51  Nonetheless, we sought to develop new silicon-based reagents 
that would give better yields and show greater functional group tolerance and synthetic 
utility than the siloxane based approach.  It is within this context we sought to develop a 
methodology for the efficient cross-coupling of (bis)catechol silicates with aryl triflates. 
Additionally, we sought to extend the scope of the coupling to electron-rich aryl iodides,  
substrates that had proven problematic in previous studies by Hosomi.171  
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RESULTS AND DISCUSSION 
Aryl (bis)catechol silicates were readily prepared in excellent yields by the 
reaction of their siloxane counterparts with two equivalents of catechol in the presence of 
triethylamine (see Table 1).  The silicates are white, air stable, crystalline solids that can 
be recrystallized from methanol-ether or acetonitrile.  The salts are freely soluble in warm 
ethereal solvents (THF, dioxane) and DMF. 
Table 1.  Synthesis of Triethlyammonium Aryl Bis(catechol) Silicates from Aryl 
Siloxanes 
Si(OEt)3
HO
HO
NEt3
MeOH O
O
Si
O
O
Et3NH
R
R yield (%)
3,4-methylenedioxy
H 88
82
94
86
83
90
88
82
4-CO2Et 89
+
entry
1
2
3
4
5
6
7
8
9
R
2-OCH3
3-OCH3
4-OCH3
2-CH3
3-CH3
4-CH3
 
Employing the protocol established in our lab for siloxane couplings, the 
(bis)catechol silicates did not cross-couple efficiently with aryl bromides (Table 2, entries 
 65
1-4) or chlorides (data not shown).  With bromides, the yields of coupled product were 
generally less than 40% and chlorides provided no coupled product.  For comparison, the 
analogous reaction with the aryl trialkoxysilane afforded 90% of the respective 
unsymmetrical biaryl.45   
The (bis)catechol silicates coupled successfully with aryl iodides (Table 2, entries 
5 and 6).  However, the best coupling substrates for the (bis)catechol silicates were aryl 
triflates (Table 2, entries 7-16).  As summarized in Table 2 (entries 9, 14-16), the best 
conditions for the cross- coupling with anisoyl triflate were 5 mol % palladium catalyst 
and 5 mol % dicyclohexylphosphinobiphenyl (III-10) in refluxing dioxane, although 
satisfactory yields can be obtained at lower temperatures in refluxing THF.   
The success of the biphenyl phosphine III-10 is attributed to a combination of 
two factors.  The electron-rich nature of the phospine, due to the cyclohexyl substituents, 
facilitates rapid oxidative addition into the aryl triflate, while at the same time its steric 
bulk allows it to readily disassociate and facilitate transmetallation with the 
hypercoordinate silicate species.  Employing a similar ligand to III-10, di-tert-
butylphosphinobiphenyl III-11,149 provided only a 23% yield of the cross-coupled 
product (Table 3, entry 12), providing further evidence that phosphine III-10 combines 
the optimal combination of steric and electronic effects to promote the coupling reaction.        
PCy2 P(t-Bu)2
III-10 III-11  
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Table 2.  Optimization of the Palladium-Catalyzed Cross-Coupling Reaction of 
Triethylammonium Bis(catechol) Phenyl Silicate with Aryl Triflates. 
+
Si
O
OO
O
HNEt3
Pd (0)
Phosphine
Solvent
TBAF
OCH3
R
OCH3
R silicate complex
      (equiv)a
PdLn phosphine solvent yield (%)
2.0 Pd(OAc)2 (10) PPh3 (20) DMF (90) 40Br
2.0 Pd(OAc)2 (10) PPh3 (20) DMF (150) 40Br
2.0 Pd(dba)2 (10) III-10 (10) DMF (90) 38Br
2.0 Pd(dba)2 (10) III-10 (10) THF (65) 7Br
2.0 Pd(OAc)2 (10) DMF (90) 87I
2.0 Pd(dba)2 (10) III-10 (10) THF (65) 9I
a For each equivalent of the catechol complex, 1.0 equivalent of TBAF was added.
2.0 Pd(OAc)2 (10) PPh3 (20) DMF (90) 75OTf
PPh3 (20)
2.0 Pd(dba)2 (10) III-10 (10) THF (65) 96OTf
2.0 Pd(dba)2 (10) none THF (65) 11OTf
2.0 Pd(dba)2 (10) THF (65) 0OTf
2.0 Pd(dba)2 (10) III-11 (10) THF (65) 23OTf
PPh3 (10)
1.0 Pd(dba)2 (10) III-10 (10) THF (65) 49OTf
1.5 Pd(dba)2 (10) III-10 (10) THF (65) 95OTf
1.5 Pd(dba)2 (5) III-10 (5) THF (65) 93OTf
1.5 Pd(dba)2 (5) III-10 (5) Dioxane (101) 97OTf
entry
1
2
3
4
5
6
7
9
10
11
12
13
14
15
16
(temp., oC)
8 2.0 Pd(OAc)2 (10) PPh3 (20) THF (65) 0OTf
(mol %)(mol %)
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The poor yields of coupled product obtained in DMF versus THF or dioxane 
indicate that increasing the polarity of the reaction solvent has an adverse effect upon the 
reaction.  This result can be attributed to the ability of the solvent to coordinate to the 
palladium and occupy an otherwise vacant coordination site that would be utilized to 
catalyze the coupling reaction. 
Two notable features of this reaction were discovered during the course of the 
optimization studies.  It was found that catechol could be quantitatively recovered from 
the crude cross-coupling reaction mixture by extraction with aqueous base (1M NaOH), 
followed by acidification and re-extraction of the aqueous layer.  Also, approximately 
50% of the phosphine III-10 could be recovered during chromatographic separation of 
the reaction products. 
Having established that iodides and triflates are effective coupling substrates with 
aryl (bis)catechol silicates, a systematic investigation of the scope and limitations of the 
reaction was undertaken.  The results summarized in Table 3 indicate that ortho, meta, 
and para-substituted electron-rich aryl iodides (entries 1-3) couple with phenyl 
(bis)catechol silicate with almost equal efficiency.  In addition, meta and para-substituted 
(bis)catechol silicates were successfully coupled with iodobenzene (Table 3, entries 5 and 
6).  However, the ortho substituted silicate coupled in poor yield. (entry 4).  This is most 
likely due to steric crowding around the silicon atom, which hinders transmetalation of 
the aryl ring to the palladium.  This drastic reduction in yield that occurs with ortho-
substituted bis(catechol) silicates is not observed with aryl siloxanes.  For example, the 
coupling of ortho-methyl siloxane proceeds in 85% yield.138 
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Table 3.  Palladium-Catalyzed Cross-Couplings of Aryl Triethylammonium 
Bis(catechol) Silicates with Aryl Iodides. 
+ Si
O
OO
O
Ar
HNEt3
10% Pd(OAc)2
20% PPh3
TBAF
Biaryl
Ar
I
biaryl product
OCH3 814-methoxyphenyl
I
OCH3
phenyl
OCH3
74
I
H3CO
phenyl
H3CO
82
IH3CO phenyl H3CO 86
yield (%)
I 2-methoxyphenyl
H3CO
29
I 3-methoxyphenyl 84
OCH3
entry
1
2
3
4
5
6
Product
Ar-I
Ar-I
DMF
 
Efficient cross-coupling reactions with aryl triflates is gratifying because 
previously we had previously found that siloxanes failed to undergo cross-coupling with 
triflates due to facile hydrolysis of the triflate under the coupling conditions.45,46 
Subsequently, we had reported a revised protocol using silatrane analogues that allows 
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for cross coupling with electron-rich aryl triflates in fair to good overall yields.51  The 
silicate methodology discussed above, however, is more general and consistently gives 
higher yields of product than the silatrane method. 
The analogous study was performed with aryl triflates to evaluate the functional 
group and steric tolerances of the reaction.  The results are summarized in Table 4.  The 
data indicates that this new methodology is applicable to a wide range of aryl triflates.  
Attempted coupling of very strongly electron-deficient triflates (Table 4, entry 12) 
proceeded in only moderate yield, with the remainder of the mass balance being 4-
nitrophenol (hydrolysis product).  Coupling of unprotected 4-aniline triflate was not 
successful (Table 4, entry 9); however, when the amine was acylated, cross-coupling 
proceeded in excellent yield (Table 4, entry 7).  The inability of the cross-coupling 
reaction to proceed in the presence of a free amino group is attributed to coordination of 
the amine to the palladium and poisoning of the catalyst. 
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Table 4. Coupling of Triethylammonium (Bis)catechol Phenyl Silicate with Aryl 
Triflates.a 
92 777
+
Si
O
OO
O
HNEt3
5% Pd(dba)2
5% III-10
TBAF
THF or Dioxane
yield (%)b
96
98
96
93
94
95
91
OTf
R
R
4-tert-butyl
0
89
46d
1-naphthyl 86
95
2,6-dimethoxy 0e (0)f
92
2,6-dimethyl
88
86
93
90
24
58
96e (0)f
2-methoxy-6-formyl 86e (64)f
Rentry
1
2
3
4
5
6
8
9
10
11
12
13
14
15
16
17
a Reactions were perfomed for 6 hours. b Reaction was performed in refluxing THF as solvent
 unless otherwise noted. c Yields are obtained using the corresponding aryl bromide in place 
of the triflate, coupling to phenyltrimethoxysilane. d Remainder of mass balance was 
hydrolyzed triflate. e Yield in refluxing dioxane. f Yield in refluxing THF.
bromidec
4-NHAc
4-OCH3
4-CHO
4-COCH3
2-COCH3
4-CO2CH3
4-NH2
4-CN
2-CN
4-NO2
2-OCH3
2-CH3
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Entries 16 and 17 are of particular interest.  These di-ortho substituted aryl 
triflates coupled in only moderate yield (Table 4, entry 17), or not at all (entry 16) when 
the reaction was performed in THF.  However, when the reaction was run at a higher 
temperature (refluxing dioxane), these substrates coupled in excellent yields.  This result 
indicates that it is possible to couple more stericly demanding substrates by switching the 
solvent to dioxane and performing the reaction at a higher temperature.  It is thought that 
the higher reaction temperature achieved in refluxing dioxane facilitates oxidative 
addition of the palladium into these hindered systems.  This assertion is supported by the 
fact that at lower temperatures (THF), the triflate is recovered quantitatively (Table 4, 
entries 14 and 16).  However, 2,6-dimethoxyphenyl trifluoromethanesulfonate (Table 4, 
entry 14) would not couple with the silicate, even in refluxing dioxane.  The triflate was 
recovered quantitatively.   
The coupling of (bis)catechol silicates with heteroaryl triflates was also 
investigated.  Palladium-catalyzed cross-coupling reactions of heteroaryl halides with 
aryl siloxanes proceed in only moderate yields and we were therefore interested to see if 
we could improve on the yield by employing a coupling between heteroaryl triflates and 
aryl (bis)catechol silicates.47,138  The results are presented in Table 5. 
The coupling of pyridyl triflates with triethylammonium (bis)catechol phenyl 
silicate in refluxing dioxane gave the desired cross-coupled products in yields that were 
comparable to the equivalent heteroaryl bromide/siloxane reactions (Table 5, entries 1 
and 2).46  However, the coupling of unprotected 5-indole trifluoromethanesulfonate 
(Table 5, entry 3) proceeded in a significantly higher yield than that observed in the 
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corresponding siloxane reaction.47  In addition, the coupling of 2-quinoline 
trifluoromethanesulfonate (Table 5, entry 4), proceeded in excellent yield.   
 The scope and limitations of triflate coupling was extended to the highly 
functionalized triflates shown in Table 6.  The first coupling was 2-tropolone 
trifluoromethanesulfonate (III-12) with (bis)catechol phenyl silicate (Table 6, entry 1).  
The tropolone ring system is present in the colchicine family of alkaloids and these 
compounds have shown promise as anti-cancer agents by binding to cellular tubulin.174  
Thus, there is interest in developing novel analogues.  Tropolone III-12 cross coupled in 
excellent yield with triethylammonium (bis)catechol phenyl silicate to produce the 
functionalized tropone III-13, thus demonstrating the ability to add aryl functionality to 
the tropolone system. 
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Table 5.  Palladium-Catalyzed Cross-Couplings of Triethylammonium (Bis)catechol 
Phenyl Silicate with Heteroaryl Triflates.a 
yieldb
73 (51)
78 (53)
69 (51)
91d
entry
1
2
3
4
a Reactions were run using 1.5 eq. of triethylammonium (bis)catechol phenyl silicate, 1.5 eq. of 
TBAF,  5 mol % Pd(dba)2, 5 mol % III-10 in refluxing dioxane for 6 h. b Value in parenthesis is 
the yield obtained in refluxing THF. c Bromide yield refers to the coupling of phenyl 
trimethoxysilane with the corresponding heteroaryl bromide. d Reaction run in refluxing THF.
N OTf
N
biaryl product
N
H
TfO
OTf
N OTf
N
N
N
H
N
bromide
76
62
40
75
yieldc
O
O
Si
O
O
Et3NH +
5% Pd(dba)2
5 % III-10
TBAF
Dioxane
Product
Biaryl
Ar-OTf
Ar-OTf
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Table 6.  Palladium-Catalyzed Cross-Coupling of Triethylammonium (Bis)catechol 
Phenyl Silicate with Functionalized Triflates. 
+
Si
O
OO
O HNEt3
5% Pd(dba)2
5% III-10
TBAF
Ar-Ph
entry Ar-OTf Ar-Ph yield (%)
O
OTf
O
III-12 III-13
89a
a Solvent was THF. b Solvent was dioxane. c Triflate was hydrolyzed under all 
conditions investigated.
1
2
3
TfO
O C16H33 O C16H33
90b
III-14 III-15
O O
OTf
O O
III-16 III-17
0c
Ar-OTf
 
Similarly, the triflate of α-tocopherol III-14 (vitamin E) was chosen to evaluate 
the ability of the (bis)catechol silicates to cross couple with highly hindered systems 
(Table 6, entry 2).   When triflate III-14 was allowed to couple with (bis)catechol phenyl 
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silicate in refluxing dioxane, the desired cross coupled product III-15 was obtained in 
excellent yield.  Attempts to couple 5-coumarin trifluoromethanesulfonate (III-16) 
yielded none of the desired cross-coupled product III-17 (Table 6, entry 3).  Instead, the 
triflate was quantitatively hydrolyzed.   
 Having demonstrated the scope and limitations of the reaction with various triflate 
substrates, attention was turned to a systematic investigation of substituent effects on the 
aryl (bis)catechol silicates.  These results are presented in Table 7.  In summary, the 
presence of either electron-rich (Table 7, entries 5 and 6) or electron-deficient (entry 7) 
substituents on the silicate was well tolerated.  The presence of functional groups in the 
meta and para positions of the aryl ring did not adversely affect the yields of cross-
coupled product.  However, when a substituent was present in the ortho position, the 
yield droped dramatically (Table 7, entries 1 and 4).  The yield can be improved slightly 
by performing the reaction at a higher temperature (refluxing dioxane).  This outcome is 
not entirely unexpected as a similar result was obtained in the coupling of the aryl iodides 
(Table 3, entry 4).   
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Table 7.  Palladium-Catalyzed Cross-Couplings of Aryl Triethylammonium 
(Bis)catechol Silicates with Aryl Triflates. 
+ Si
O
OO
O
Ar
HNEt3
5% Pd(dba)2
5% III-10
TBAF
THF
Biaryl
Ar biaryl product yield (%)
40a (20)bo-toluene
97m-toluene H3CO
92p-toluene H3CO CH3
H3C
41a (21)bo-anisole
H3CO
87m-anisole
OCH3
91p-anisole OCH3
94p-ethyl benzoate H3CO
O
OEt
3,4-methylenedioxybenzene
H3CO
O
O 89
CH3
OTf
OTfH3CO
OTfH3CO
OTf
OTf
OTf
OTfH3CO
OTfH3CO
entry
1
2
3
4
5
6
7
8
 a Yield obtained in refluxing dioxane. b Yield obtained in refluxing THF.
Product
H3CO
Ar-OTf
Ar-OTf
 
Another interesting system that would further define the scope of the (bis)catechol 
silicate coupling technology was the coupling of a heteroaromatic triflate with a 
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heteroaromatic (bis)catechol silicate.  Quinoline-pyridyl moieties are found in multiple 
natural products such as streptonigrin175 and camptothecin.176  We, therefore, designed a 
template that would probe the feasibility of applying the (bis)catechol silicate coupling 
technology to these systems.  Pyridyl derivative III-19 is readily available in excellent 
yield from the respective pyridyl siloxane III-18 (Scheme 9).59 Having obtained the 
desired heteroaromatic (bis)catechol silicate III-19, a simple triflate was chosen to probe 
the feasibility of the coupling reaction.  Accordingly, heteroaromatic (bis)catechol silicate 
III-19 was coupled with 4-methoxyphenyl trifluromethanesulfonate III-20 to yield the 
heteroaromatic biaryl III-21 in 96% yield (Scheme 5). 
 Encouraged by the high yield obtained in this reaction, the coupling of 2-
quinoline trifluoromethanesulfonate III-22 with heteroaromatic (bis)catechol silicate III-
19 was attempted  (Scheme 5) and we were pleased to find that this coupling proceeded 
smoothly to produce the quinolopyridine III-23 in 97% yield.  It is anticipated that an 
analogous coupling reaction will be applicable to the total synthesis of streptonigrin and 
related substances. 
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Scheme 9 
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N
OTf N
N
OCH3
III-18 III-21
III-23
III-22
III-10
97 %
NEt3
94%
III-20
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   A final feature of the cross-coupling reaction that was investigated was the source 
of the fluoride activator.  For aryl halide substrates, the typical fluoride source in siloxane 
couplings was tetrabutylammonium fluoride (TBAF) in THF solution (Acros) containing 
5% water.  However, this reagent induced extensive hydrolysis of triflates derived from 
phenols bearing strong electron-withdrawing groups (Table 4, entry 12).  Accordingly, a 
variety of alternative fluoride sources was investigated and the results are summarized in 
Table 8. 
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Table 8.  Effect of Varying the Fluoride Source on Cross-Coupling Efficiency  
+
Si
O
OO
O
HNEt3
5% Pd(dba)2
5% III-10
OCH3
OTf
THF
"F- source"
"F- Source" yield (%)
none 0a
KF 29a
TBAF    3H2O 94
TBAF (1.0M in THF) 95
NaF 0
a
CsF 3
a
LiF 0
a
NaBF4 30
a
NaOSiMe3 33
a
TMAF (anhydrous)b 74c
entry
1
2
3
5
6
7
8
9
10
11
4
96
OCH3
a Remainder of triflate was unreacted. b Commercially available "anhydrous" TMAF
contains less than 3 % water. c Remainder of triflate was hydrolyzed.
TMAF    3H2O
 
In the absence of a fluoride source, the cross coupling reaction does not occur 
(entry 1).  Alkali fluoride salts were ineffective as fluoride sources for the coupling 
reactions, most likely caused by their poor solubilities in THF (entries 2-6).  TBAF 
trihydrate, available as a crystalline solid, was as effective as the 1.0 M solution of TBAF 
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in THF in promoting the cross-coupling reaction (entries 7 and 8).  
Tetramethylammonium fluoride trihydrate (TMAF) was also found to have similar 
activity (entry 9).  It is interesting to note that the use of anhydrous TMAF actually 
lowered the yield of the cross-coupling reaction, with the remainder of the triflate 
undergoing hydrolysis (entry 10). It is plausible that the water present in the hydrated 
TMAF is serving to moderate the bacicity of the fluoride ion in solution and slow the rate 
of hydrolysis of the triflate.  A similar effect was noticed in the coupling of aryl triflates 
and nonaflates with silanols,177 and with phenyl silatrane.51 
 Denmark had previously reported that silanolates were effective promoters in the 
cross-coupling of organosilanols.178  However, this reagent was not effective when 
extended to the coupling of (bis)catechol silicates with aryl triflates (Table 8, entry 11). 
CONCLUSION 
 Aryl siloxanes efficiently couple to aryl iodides, bromides, and chlorides to 
provide unsymmetrical biaryl derivatives.  However, the cross-coupling of aryl triflates to 
aryl siloxanes has been largely unsuccessful due to hydrolysis of the triflate under the 
reaction conditions.  This study demonstrated that crystalline pentacoordinate aryl 
(bis)catechol silicates effectively serve as siloxane surrogates and couple to a wide range 
of aryl and heteroaryl triflates in excellent yields.   
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Part 2: Palladium-Catalyzed Cross-Coupling of Aryl 
Triethylammonium Bis(catechol) Silicates with Aryl Bromides Using 
Microwave Irradiation 
INTRODUCTION 
Since the first reported use of microwave irradiation to promote a chemical 
reaction by Gedye in 1986,179 the use of microwave irradiation has emerged as a valuable 
method for inducing or accelerating chemical reactions.180,181 The microwave reactor has 
evolved from a simple domestic microwave oven, which was prone to explosions and 
irreproducible results, to complex multimode microwave reactors replete with internal 
stirring and cooling capabilities.  These new reactors allow for the processing of 
kilograms of material by microwave technology.181  
Microwave Effects in Chemical Reactions 
Microwave assisted reactions are known for their fast reaction times, suppression 
of side reactions, and higher yields.  These effects have been attributed to two different 
features of microwave reactions: rapid and uniform heating, and specific “microwave 
effects.”  These “microwave effects” have been proposed to be due to changes in 
theromodynamic paramaters under microwave irradiation.   For example, it has been 
proposed that there is a change in the activation energy of a reaction, possibly due to a 
change in the entropy of the system.182 Today, the existence of specific microwave 
effects has been largely discounted.   Strauss and coworkers have demonstrated that 
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reactions conducted under microwave and conventional heating have similar kinetics and 
the increase in yields and faster reaction times are due to rapid, uniform heating.182-184 
Choice of solvent plays a key role in microwave reactions.  Polar solvents (DMF, 
DMSO) absorb microwaves efficiently, which in turn leads to rapid heating of the 
solvent.  This thermal energy is then transferred to the reactants.  On the other hand, non-
polar solvents are transparent to microwaves.  When a reaction is carried out in a non-
polar solvent (toluene, hydrocarbon), the majority of the microwave energy goes to the 
reactants.  This allows for a more direct flow of energy to the reactants, and may be 
responsible for the decreased reaction times and higher chemical yields.185   
Synthetic Applications 
Microwave technology has been extended to many different types and classes of 
reactions.  Two of the most popular research areas to employ microwave reactors are 
solid supported reactions,186-188 and homogeneous catalysis.  Solid supported reactions 
can suffer from long reaction times, which can be dramatically shortened by using 
microwave heating.187  Homogenous catalysis can also suffer from long reaction times 
and side reactions that reduce overall product yield.189  
Of the different areas of homogenous catalysis, by far the most well studied using 
microwave irradiation is the Suzuki cross-coupling reaction.  This reaction is of wide 
scope and conditions have been developed to allow for the coupling of almost any 
boronic acid with any aryl halide or triflate.19 The use of microwave irradiation has 
expanded the scope of the Suzuki reaction by permitting more cost-effective and 
environmentally friendly reaction conditions. 
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Recently, Leadbeater and coworkers have developed conditions for the coupling 
of aryl bornic acids with aryl chlorides in water using microwave irradiation (Scheme 
10).190   Aryl chlorides are typically difficult substrates for palladium-catalyzed cross-
coupling reactions due to their low reativity.191  In addition, water is usually a poor 
solvent for these reactions because of the low solubility of the reactants.  In this case, the 
solubility problem was overcome by addition of tetrabutylammonium bromide (TBAB) 
as a phase transfer reagent.  Leadbeater was able to couple a variety of aryl chlorides in 
moderate to excellent yield using this reaction.  For comparison, under thermal 
conditions, no reaction occurred.190 
Scheme 10 
B(OH)2 Cl
R
+
Pd/C
TBAB, H2O
48-90% R
μw
 
 The use of a microwave promoted Suzuki coupling reaction in total synthesis has 
recently been reported.  Zhu has recently completed the total synthesis of the cyclic 
tripeptide biphenomycin B (III-24) using a microwave promoted Suzuki-Miyaura 
coupling reaction as the key macrolactonization step (Scheme 11).192  The key couping 
reaction was conducted intra-molecularly between an aryl iodide and an aryl pinacol 
boronate ester present in compound III-25 to form the biaryl linkage of intermediate III-
26.  This approach allowed for the formation of the biaryl linkage with concomitant 
macrolactonization of the 15-membered macrocycle.  In addition, the reaction conditions 
were tolerant of the protecting groups present in the molecule.  
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Cross-Coupling of Aryl Bromides with Aryl Bis(catechol) Silicates 
Using conventional heating, aryl bis(catechol) silicates III-27 undergo coupling 
with aryl iodides and triflates to provide unsymmetrical biaryl derivatives (Scheme 12).  
However, under these reaction conditions, it is not possible to couple aryl bromides in 
greater than 40% yield.  In order to circumvent this limitation, we explored the 
application of microwave irradiation to the coupling of aryl bromides and aryl 
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bis(catechol) silicates.  It was hoped that microwave irradiation would provide the 
additional energy required to couple the silicates with the less reactive aryl bromides.     
Scheme 12. Cross-Coupling of Aryl Iodides and Triflates  
Si
O
OO
O
HNEt3 X
R2
R2
R1
+
Pd (0)
74-98 %
X=I or OTfIII-27
R1
conventional heating
 
 
RESULTS AND DISCUSSION 
The coupling of silicate III-28 with bromobenzene under idealized thermal 
conditions  had resulted in the formation of biphenyl in a yield of only 38%.  However, 
under the influence of microwave irradiation, rapid and efficient cross-coupling of aryl 
bromides was realized (Scheme 13).   
Scheme 13 
Si
O
OO
O
HNEt3 Br
+
III-28
THF
TBAF
5 mol % Pd(dba)2
50 W / 10 min / 120 oC
5 mol % III-10
89%  
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Reaction conditions for this coupling were found to be analogous to the thermal 
reaction and entailed 5 mol % Pd(dba)2 as the Pd(0) source, 5 mol % dicyclohexyl 
phosphinobiphenyl (III-10) and 1.5 equiv of tetrabutylammonium fluoride (TBAF) in 
THF (Scheme 13).  Exposure of the reaction mixture to microwave irradiation (50 W / 10 
min / 120 °C) led to efficient cross-coupling of bromobenzene with triethylammonium 
phenyl bis(catechol) silicate (III-28).  In the absence of irradiation, the yield of coupling 
product under identical conditions was <40%.   
Having demonstrated the effectiveness of microwave irradiation for the coupling 
reaction, the functional group tolerance of substituted aryl bromides was investigated and 
the results are summarized in Table 9.  The data indicates that the reaction is tolerant of 
both electron-donating (entries 1-5) and electron-withdrawing (entries 8 and 9) functional 
groups.   
In addition, it was possible to couple di-ortho substituted aryl bromides 
demonstrating that even highly hindered biaryls could be realized under these conditions 
(entry 6). The only functional group that was found to fail in the coupling study was the 
amino group which gave starting materials back in high yield (entry 10).  We attribute the 
failure of this coupling reaction to poisoning of the catalyst by the amino function.  The 
analogous triflate coupling under thermal conditions had also failed in the presence of 
free amino groups. 
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Table 9.  Probing the Functional Group Tolerance of the Microwave Assisted 
Coupling Reaction  
81
84
86
88
89
80
THF
TBAF
Br
entry yield (%)R
4-t-Bu
2,6-dimethyl
1
2
3
4
5
6
7
+
5 mol % Pd(dba)2
50 W / 10 min / 120 oC
5 mol % III-10
III-28
R
R
H 89
1-naphthyl 84
8
9
10
93
0
4-OCH3
2-OCH3
2-CH3
4-COCH3
4-NO2
4-NH2
 
Once the feasibility of the coupling of simple aryl bromides had been 
demonstrated, attention turned to the cross-coupling of more complex substrates bearing 
multiple functional groups.  In the less idealized world of natural product synthesis, one 
can only determine the full scope of the new coupling protocol by investigating these 
more complex substrates.   The results of these investigations are shown in Table 10.   As 
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was observed in the simpler substrates, electron-rich aryl bromides (entries 1-3) couple in 
good to excellent yields.  Particularly noteworthy are the couplings shown in entries 2 
and 3 which involved substrates with di-ortho substitution.  Even though the silicate is 
bulky, coupling at highly hindered centers occurred.  
 Table 10.  Coupling of Complex Aryl Bromides 
Br
OMeMeO
MeO
OMeMeO
BrMeO
+
5 mol % Pd(dba)2
THF
TBAF
50 W / 10 min / 120 oC
5 mol % III-10
Aryl Bromide Biaryl Product
OMeMeO
MeO
OMeMeO
MeO
O
MeO
Br
O
MeO
OMeMeO
BrMeO
OMeMeO
MeO
CO2Me
III-28
84
74
entry aryl bromide biaryl product yield (%)
1
2
4
3 79
76
CHO CHO
CO2Me
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Another important achievement of the microwave methodology was the coupling 
of 5-bromo tropolone with silicate III-28 (entry 4).  Previous studies in our group had 
found that siloxane and silicate derivatives underwent coupling with this tropolone to 
provide low yields of biaryl product.  The excellent yield of coupling with silicate III-28, 
on the other hand, bodes well for an approach to the natural products colchicine (III-29) 
and allocolchicine (III-30) based on this methodology.  
O
OCH3
OMe
MeO
MeO
NHAc
(-)-(aR, 7S)-colchicine (III-29)
OMe
MeO
MeO
NHAc
CO2Me
(-)-(aR, 7S)-allocolchicine (III-30)  
To fully explore the scope and limitations of the coupling reaction, the coupling 
of a select number of substituted aryl bis(catechol) silicates with aryl bromides was also 
studied (Table 11).  Substituents in the para- and meta-positions were well tolerated and 
gave adducts in yields comparable to their unsubstituted counterpart  (entries 1, 2, and 5).  
In addition, electronic effects associated with the substituent did not manifest themselves 
in either the yields of adduct obtained nor the conditions required to achieve the coupling.  
However, coupling efficiency was significantly altered when ortho-substituents were 
present on the bis(catechol) silicate (entries 3 and 4).  This effect on the yield by ortho-
substituents was also observed in the thermal coupling of aryl triflates with silicates. 
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Table 11.  Coupling of Substituted Bis(catechol) Silicate Complexes 
O
O
Si
O
O
Et3NH
R2
Br
R2
OMe
MeO
Me
CO2Et
+
entry coupled product yield (%)
1 4-OMe
2
2-OMe3
2-Me4
4-CO2Et
88
82
3-OMe 84
OMe
5
R1
R1
H
H
H
H
4-OMe MeO
49
47
R1
R25 % Pd(dba)2
5 % III-10
THF
50 W / 120 oC
10 min
TBAF
 
 
CONCLUSIONS AND OUTLOOK 
Using microwave irradiation, we have extended the palladium-catalyzed cross-
coupling methodology of aryl bis(catechol) silicates to aryl bromides to form 
unsymmetrical biaryls.  Aryl bis(catechol) silicates are particularly attractive reagents for 
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coupling reactions due to their ease of formation, crystallinity, and stability.  These 
results, combined with our previous coupling studies, provide a valuable resource for the 
cross-coupling of aryl bromides, iodides, and triflates with aryl bis(catechol) silicates. 
Future work with aryl (bis)catechol silicates will entail the use of solid supported 
reagents such as silicate III-31 (Scheme 14).  This would allow for the possibility of 
recycling reagents thereby reducing waste.  In addition, this technique could allow for the 
elimination of costly and time consuming chromatographic purification of the biaryl 
products. 
Scheme 14 
Si
O
OO
O
HNEt3
X
R2
R2
R1
+
Pd (0)
X=Br, I, OTfIII-31
R1
= solid support resin
 
   
PART 3: Experimental Section 
General Experimental 
 Thin-layer chromatography (TLC) was performed on 0.25 mm Merck silica gel 
coated plates treated with a UV-active binder with compounds being identified by UV 
(254 nm).  Flash chromatography was performed using thick walled columns and 
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medium pressure silica gel (Whatman 200-425 mesh), with column length and diameter 
being determined by the method of Still.142 
 Melting points were taken in Kimax soft glass capillary tubes using a Thomas-
Hoover Uni-Melt capillary melting point apparatus (Model 6406K) equipped with a 
calibrated thermometer.  Melting points above 200 ºC were taken with a Mel-Temp 
apparatus using a calibrated thermometer.  Melting points are corrected. 
 Samples used for obtaining infrared spectra were either dissolved in carbon 
tetrachloride or prepared as a potassium bromide pellet.  Band positions are reported in 
reciprocal centimeters (cm-1) and relative intensities are listed as br (broad), s (strong), m 
(medium), or w (weak). 
 Nuclear magnetic resonance (1H, 13C NMR) spectra were recorded at 400 and 200 
MHz respectively. Chemical shifts are reported in parts per million (δ) relative to 
tetramethylsilane (TMS).  Coupling constants (J values) are reported in hertz (Hz), and 
spin multiplicities are indicated by the following symbols: s (singlet), d (doublet), t 
(triplet), q (quartet), m (multiplet), br s (broad singlet).   
 Low resolution mass spectrometry (LRMS) and high resolution mass 
spectrometry (HRMS) data are reported in the form of m/z (intensity relative to base peak 
= 100).  The matrix used for fast atom bombardment (FAB) was ethylene glycol. 
 Tetrahydrofuran, diethyl ether, and dioxane were distilled from 
sodium/benzophenone ketyl.  Methylene chloride and pyridine were distilled from 
calcium hydride.  Dimethylformamide and triethylamine were distilled from calcium 
sulfate.  Methanol was fractionally distilled from calcium chloride.  
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   2-(Dicyclohexylphosphino)biphenyl and 2-(di-tert-butylphosphino)biphenyl 
were recrystallized from ethanol prior to use  Catechol and triphenylphosphine were each 
recrystallized from hexanes prior to use.  
 All glassware used in these reactions was either oven dried at 120 ºC for 12 hours 
or flame dried prior to use.  All reactions were conducted under an atmosphere of argon.   
 Microwave reactions were conducted in a CEM Discover microwave reactor with 
a circular, single mode, self tuning, microwave applicator operating at 2450 MHz.  The 
reaction vessel was purged with argon prior to use.  
All compounds were determined to be >95% pure by 1H NMR or GC analysis, 
unless otherwise noted.  Previously reported compounds were characterized via 1H and 
13C NMR and IR and compared to literature values.  All new compounds were 
characterized using 1H NMR, 13C NMR, IR, low resolution and high resolution mass 
spectrometry. 
 
Synthesis and Characterization of Aryl Bis(catechol) Silicates. 
Triethylammonium bis(1,2-benzenediolato)phenylsilicate  (Table 1 Entry 1).  To a 
maroon colored solution of catechol (13.1 g, 120 mmol) in EtOH (30 mL) was added 
PhSi(OMe)3  (11.2 mL, 60.0 mmol) and NEt3  (8.36 mL, 60.0 mmol).  The reddish-brown 
solution was stirred for 15 minutes during which time a white precipitate formed.  The 
silicate complex was further precipitated by the addition of 10 mL of ether.  The reaction 
mixture was then filtered and the filter cake was washed with ether to yield a white 
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powder which was dried under vacuum at 60 °C for two days to give 22.4 g (88 %) of the 
title compound as a white powder  mp 218-220 °C (lit. 220-230 ºC).152  IR (KBr) 3421 
(m), 3064 (w), 3040 (m), 2943 (s), 2802 (m), 2722 (m), 2360 (s), 2329 (s), 1597 (s), 1493 
(s), 1359 (s), 1241 (s), 1110 (s), 1014 (s); LRMS (FAB-) m/z 321 (M- - HNEt3, 56), 319 
(12), 239 (30), 118 (16), 102 (100), 85 (9); HRMS (FAB-, M- - NHEt3) m/z calcd for 
C18H13O4Si 321.0564, found 321.0563. The spectral data (1H, 13C NMR) were identical to 
those previously reported by Woolins.193  
 
General Procedure for the Synthesis and Characterization of 
Triethylammonium (Bis)catechol Arylsilicates.  To a maroon solution of catechol (1.71 
g, 15.5 mmol) in MeOH (10 mL) was added the aryl siloxane (7.40 mmol) and NEt3 
(1.13 mL, 8.10 mmol).  The reaction was stirred overnight at room temperature, during 
which time some precipitation of the arylsilicate occurred.  The arylsilicate was further 
precipitated with 20 mL of ether.  The solid was filtered and the filter cake washed with 
50 mL of ether.  The arylsilicate was dried under vacuum at 60 ºC overnight. 
 
Triethylammonium bis(1,2-benzenediolato)-(2-methoxyphenyl)silicate (Table 1 Entry 
2).  White crystals 2.75 g (82%) mp 195-199 ºC;  IR (KBr) 3426 (m), 3064 (m), 3036 
(m), 1487 (s), 1242 (s), 1013 (m), 831 (s); 1H NMR (DMSO-d6) δ 1.15 (t, J=7.6, 9H), 
3.07 (q, J= 7.6, 6H), 3.27 (s, 3H), 6.44-6.53 (m, 8H), 6.66-6.69 (m, 2H), 7.03-7.08 (m, 
2H), 8.8 (br s, 1H); 13C NMR (DMSO-d6) δ 10.7, 47.6, 56.8, 111.2, 112.0, 118.9, 121.3, 
130.2,  134.0, 134.6, 152.8, 163.4; LRMS (FAB-) m/z 351 (M- - NHEt3, 100), 339 (30), 
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325 (20), 323 (9);  HRMS (FAB-, M- - HNEt3) m/z calcd for C19H15O5Si 351.0689, found 
351.0688. 
 
Triethylammonium bis(1,2-benzenediolato)-(3-methoxyphenyl)silicate (Table 1, 
Entry 3).  Precipitation from ether produced a white powder which was recrystallized 
from methanol to yield colorless needles 3.16 g (94%) mp 219-220 ºC;  IR (KBr) 3423 
(m), 3095 (s), 3057 (m), 3002 (m), 2936 (m), 2878 (m), 2836 (m), 2733 (w), 1566 (s), 
1483 (s), 1407 (s), 1355 (s), 1252 (s), 1107 (m), 1048 (m), 1014 (s), 827 (s); 1H NMR 
(DMSO-d6) δ 1.15 (t, J=7.2, 9H), 3.06 (t, J=7.2, 6H), 3.62 (s, 3H), 6.48 (m, 4H), 6.59-
6.62 (m, 4H), 6.71-6.74 (m, 1H), 7.06-7.08 (m, 3H), 8.70 (br s, 1H); 13C NMR (DMSO-
d6) δ 9.0, 46.1, 54.9, 110.1, 113.0, 117.9, 121.0, 127.4, 128.2, 143.7, 150.7, 158.4; LRMS 
(FAB-) m/z 351 (M- - NHEt3, 100), 259 (9); HRMS (FAB-, M- - HNEt3) m/z calcd for 
C19H15O5Si 351.0689, found 351.0679. 
 
Triethylammonium bis(1,2-benzenediolato)-(4-methoxyphenyl)silicate (Table 1, 
Entry 4).  White crystals 2.89 g (86%) mp 184-185 °C;  IR (KBr) 3430 (m), 3040 (w), 
2943 (s), 2831 (s), 2900 (s), 2831 (w), 2730 (s), 2077 (s), 2046 (s), 1910 (s), 1860 (s), 
1751 (s), 1596 (s), 1487 (s), 1363 (s), 1246 (s), 1180 (s), 1114 (s), 1017 (s);  1H NMR 
(DMSO-d6) δ 1.24 (t, J=7.3, 9H), 3.22 (q, J=7.3, 6H), 3.69 (s, 3H), 6.66-6.74 (m, 10H), 
7.54 (d, J=3.2, 2H), 9.51 (br s, 1H); 13C NMR (DMSO-d6) δ 8.4, 46.2, 54.8, 110.7, 112.8, 
118.8, 130.8, 136.6, 149.6, 160.1;  LRMS (FAB-) m/z 351 (M- - NHEt3, 40), 251 (100), 
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138 (30), 122 (26), 46 (22); HRMS (FAB+) (M- - HNEt3 + Li) m/z calcd for 
C12H15O5SiLi 358.0849, found 358.0841. 
 
Triethylammonium bis(1,2-benzenediolato)-(2-methylphenyl)silicate (Table 1, Entry 
5).  White crystals 2.69 g (83%) mp 194-196 ºC;  IR (KBr) 3429 (m), 3029 (s), 3002 (s), 
2702 (s), 2536 (m), 2494 (m), 1590 (m), 1486 (s), 1355 (m), 1241 (s), 834 (s); 1H NMR 
(DMSO-d6) δ 1.15 (t, J=8.0, 9H), 2.32 (s, 3H), 3.06 (q, J=8.0, 6H), 6.61-6.72 (m, 8H), 
6.92-6.95 (m, 2H), 7.00-7.02 (m, 1H), 7.43-7.45 (m, 1H), 9.45 (br s, 1H); 13C NMR 
(DMSO-d6) δ 8.2, 22.9, 46.1, 110.8, 118.7, 124.0, 128.0, 129.3, 133.8, 140.1, 142.2, 
149.5; LRMS (FAB-) m/z 335 (M- - NHEt3, 100)  153 (10); HRMS (FAB-) (M- - NHEt3) 
m/z calcd for C19H15O4Si 335.0740, found 335.0750. 
 
Triethylammonium bis(1,2-benzenediolato)-(3-methylphenyl)silicate (Table 1, Entry 
6).  White powder 2.91 g (90%) mp 177-179 ºC; IR (KBr) 3432 (m), 3064 (m), 1490 (s), 
1355 (m), 1245 (s), 824 (s); 1H NMR (DMSO-d6) δ 1.14 (t, J=7.2, 9H), 2.17 (s, 3H), 3.05 
(q, J=7.2, 6H), 6.24-6.25 (m, 1H), 6.45-6.50 (m, 4H), 6.58-6.62 (m, 4H), 6.95-7.03 (m, 
2H), 7.30-7.33 (m, 2H), 8.95 (br s, 1H); 13C NMR (DMSO-d6) δ 8.7, 21.3, 45.8, 109.8, 
117.5, 126.7, 128.4, 131.9, 135.1, 135.3, 141.7, 150.4; LRMS (FAB-) m/z 335 (M- - 
NHEt3, 100), 297 (23), 148 (69), 146 (10); HRMS (FAB-, M- - NHEt3) m/z calcd for 
C19H15O4Si 335.0740, found 335.0742. 
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Triethylammonium bis(1,2-benzenediolato)-(4-methylphenyl)silicate (Table 1, Entry 
7).  The product was contaminated with a small amount of catechol which could not be 
separated despite repeated recrystallizations from THF.  White crystals 2.85 g (88%) mp 
190-194 ºC; IR (KBr) 3431 (m), 3040 (s), 2971 (s), 2809 (m), 2777 (m), 2746 (m), 1600 
(m), 1493 (s), 1359 (s), 1238 (s), 1103 (s), 1017 (s), 831 (s); 1H NMR (DMSO-d6) δ 1.14 
(t, J=7.2, 9H), 2.18 (s, 3H), 3.05 (q, J=7.2, 6H),  6.22-6.28 (m, 4H), 6.47-6.50 (m, 2H), 
6.58-6.61 (m, 2H), 6.94 (d, J=7.6, 2H), 7.41 (d, J=7.6, 2H), 8.87 (br s, 1H); 13C NMR 
(DMSO-d6) δ 8.7, 21.0, 45.7, 109.0, 109.7, 115.4, 117.4, 127.4, 135.1, 150.5; LRMS 
(FAB-) m/z 335 (M- - NHEt3, 100), 243 (9); HRMS (FAB-, M- - NHEt3) m/z calcd for 
C19H15O4Si 335.0740, found 335.0738. 
 
Triethylammonium bis(1,2-benzenediolato)-(3,4-benzodioxole)silicate (Table 1, Entry 
8).  Precipitation from ether produced a light red solid which was recrystallized from 
methanol to yield light brown plates 2.84 g (82%) mp 219.0-219.5ºC; IR (KBr) 3430 (m), 
3052 (m), 2994 (m), 2877 (m), 2772 (m), 2726 (w), 1479 (s), 1411 (m), 1352 (m), 1246 
(s), 1034 (s), 1014 (m), 893 (s), 827 (s); 1H NMR (DMSO-d6) δ 1.14 (t, J=7.2, 9H), 3.05 
(t, J=7.2, 6H), 5.85 (s, 2H), 6.48-6.52 (m, 4H), 6.60-6.62 (m, 4H), 6.72 (d, J=7.6, 1H), 
6.99 (s, 1H), 7.07 (d, J=7.6, 2H), 8.70 (br s, 1H); 13C NMR (DMSO-d6) δ 9.1, 46.1, 
100.2, 107.9, 110.1, 114.9, 117.9, 129.4, 135.3, 146.5, 147.4, 150.7; LRMS (FAB-) m/z 
365 (M- - NHEt3, 100), 298 (9), 148 (45); HRMS (FAB-, M- - NHEt3) m/z calcd for 
C19H13O6Si 365.0481, found 365.0480. 
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Triethylammonium bis(1,2-benzenediolato)-(4-carboethoxyphenyl)silicate (Table 1, 
Entry 9).  White crystals 3.26 g (89%) mp 230-240 ºC (decomp.); IR (KBr) 3433 (m), 
3043 (m), 2981 (m), 2736 (w), 1721 (s), 1486 (s), 1279 (s), 1245 (s), 1089 (m), 1020 (m), 
824 (s); 1H NMR (DMSO-d6) δ 1.13 (t, J=7.2, 9H), 1.26 (t, J=6.8, 3H), 2.99-3.00 (m, 6), 
4.24 (q, J=6.8, 2H), 6.47-6.50 (m, 4H), 6.59-6.62 (m, 4H), 7.68 (d, J=8.0, 2H), 7.71 (d, 
J=8.0, 2H), 8.70 (br, 1H); 13C NMR (DMSO-d6) δ 9.1, 14.2, 45.7, 60.4, 109.9, 115.7, 
117.7, 127.3, 129.1, 134.5, 150.1; LRMS (FAB-) m/z 393 (M- - NHEt3, 100), 320 (11); 
HRMS (FAB-, M- - NHEt3) m/z calcd for C21H17O6Si 393.0794, found 393.0791. 
 
Triethylammonium bis(1,2-benzenediolato)-3-(4-methoxy)pyridylsilicate (III-19).  
White powder,  recrystallization from methanol yielded white flakes 3.16 g (94%); mp 
173-174 ºC; IR (KBr) 3405 (w), 3056 (s), 3013 (s), 2932 (m), 2833 (m), 2730 (m), 1583 
(s), 1491 (s), 1355 (s), 1234 (s), 1110 (s), 1020 (s), 819 (s); 1H NMR (DMSO-d6) δ 1.15 
(t, J=7.1, 9H), 3.10 (q, J=7.1, 6H), 3.73 (s, 3H), 6.19-6.25 (m, 4H), 6.48-6.50 (m, 2H), 
6.58-6.63 (m, 2H), 7.71-7.74 (m, 2H), 8.22 (s, 1H), 8.89 (br s, 1H); 13C NMR (DMSO-d6) 
δ 10.1, 47.2, 54.2, 111.4, 116.7, 119.2, 147.5, 151.7, 153.5, 155.1, 165.1; LRMS (FAB-) 
m/z 352 (M- - NHEt3, 100), 169 (60); HRMS (FAB-, M- - NHEt3) m/z calcd for 
C18H14O5NSi 352.0641, found 352.0648. 
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General Procedures for the Synthesis and Characterization of Aryl Triflates. 
Method A.  In a modified procedure of Ritter,173 triflic anhydride (3.10 g, 11.0 
mmol) was added dropwise to the corresponding phenol (10.0 mmol) in pyridine (10.0 
mL) at 0 °C and stirred for 10 minutes at 0 ºC.  The reaction was then allowed to stir at 
room temperature for 12 h.  The solution was diluted with 25 mL of ether and extracted 
with a 1M solution of CuSO4 (25 mL x3).  The organic layer was then washed with water 
(25 mL), dried (MgSO4), and concentrated in vacuo.  The aryl triflate was then purified 
via silica gel chromatography. 
Method B.  Triflate was prepared according to a modified procedure of Barf.194  
Phenyl trifluromethanesulfonamide (3.09 g, 11.0 mmol), triethylamine (1.57 mL, 11.0 
mmol) and the corresponding phenol (10.0 mmol) were combined in 20 mL of CH2Cl2 
and stirred at room temperature for 12 h.  The solution was then poured into 50 mL of 
water and extracted twice with 50 mL of CH2Cl2.  The organic layer was dried (MgSO4), 
and concentrated in vacuo.  The aryl triflate was then purified via silica gel 
chromatography. 
Method C.  The following is a modified procedure of Genet.195  4-aminophenol 
(545 mg, 5.00 mmol) and triethylamine (0.715 mL, 5.00 mmol) were added to CH2Cl2 
(20 mL) and stirred at room temperature for 30 minutes.  The solution was cooled to -40 
ºC and trifluoromethanesulfonyl chloride (840 mg, 5.00 mmol) in 3 mL of CH2Cl2 was 
added over 10 minutes.  The resulting solution was stirred at -40 ºC for 30 min, followed 
by 1 hour at room temperature.  Diethyl ether was added (50 mL) and the mixture was 
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filtered.  The filtrate was washed with brine (50 mL), dried (MgSO4), and evaporated.  
The triflate was then purified via silica gel chromatography. 
 
4-Methoxyphenyl trifluoromethanesulfonate (Table 4, Entry 1).  Triflate was prepared 
according to method A.  Column chromatography (4:1 hexane/EtOAc, TLC Rf = 0.49) 
yielded 2.26 g of a pale yellow oil (94%); 13C NMR (CDCl3) δ 55.4, 114.0, 119.0 (q, JCF 
= 322), 122.2, 143.0, 159.1. The spectral data (IR, 1H NMR) were identical to those 
previously reported by Stille.196 
 
2-Methoxyphenyl trifluoromethanesulfonate (Table 4, Entry 2).  Triflate was prepared 
according to method A.  Column chromatography (4:1 hexane/EtOAc, TLC Rf = 0.46) 
yielded 1.99 g of a colorless oil (83%); 13C NMR (CDCl3) δ 56.2, 113.36, 119.0 (q, JCF = 
321), 121.0, 122.6, 129.5, 139.0, 151.6. The spectral data (IR, 1H NMR) were identical to 
those previously reported by Cabri.197 
 
4-Phenylcarbaldehyde trifluoromethanesulfonate (Table 4, Entry 3).  Triflate was 
prepared according to method A.  Column chromatography (4:1 hexane/EtOAc, TLC Rf 
= 0.46) yielded 2.05 g of a white solid mp 140-142 ºC (86%); IR (CCl4) 2826 (m), 2791 
(w), 2729 (m), 1714 (s), 1593 (s), 1500 (m), 1438 (s), 1210 (s), 1141 (s), 886 (s); 1H 
NMR (CDCl3) δ 7.51 (m, 2H), 8.01-8.04 (m, 2H), 10.06 (s, 1H); 13C NMR (CDCl3) δ 
118.7 (q, JCF = 320), 123.3, 131.6, 135.8, 153.0, 190.1; LRMS (EI+) m/z 254 (M+, 80), 
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253 (12), 189 (100), 161 (10), 95 (18), 69 (10), 65 (25); HRMS (EI+) m/z for C8H4O4F3S 
calcd 252.9782, found 252.9790.  
 
4-Acetylphenyl trifluoromethanesulfonate (Table 4, Entry 4) is commercially available 
from Aldrich.  
 
2-Acetylphenyl trifluoromethanesulfonate (Table 4, Entry 5).  Triflate was prepared 
according to method A.  Column chromatography (4:1 hexane/EtOAc, TLC Rf = 0.33) 
yielded 2.30 g of a pale yellow oil (91%); 13C NMR (CDCl3) δ 29.3, 118.2 (q, JCF = 319), 
122.9, 128.9, 131.1, 132.0, 134.0, 146.9, 196.9; LRMS (EI+) m/z 268 (M+, 35), 253 
(100), 189 (10), 120 (75), 107 (17), 92 (39), 77 (28), 69 (39), 63 (23), 43 (19); HRMS 
(EI+) m/z calcd for C9H7O4F3S 268.0017, found 268.0027. The spectral data (IR, 1H 
NMR) were identical to those previously reported by Cabri.197 
 
4-Carbomethoxyphenyl trifluoromethanesulfonate (Table 4, Entry 6).  Triflate was 
prepared according to method A.  Column chromatography (4:1 hexane/EtOAc, TLC Rf 
= 0.51) yielded 2.55 g of a colorless oil (95%);  The spectral data (IR, 1H and 13C NMR) 
were identical to those previously reported by DeShong.198 
 
4-Acetamidophenyl trifluoromethanesulfonate (Table 4, Entry 7).  Triflate was 
prepared according to method A.  Crude compound was isolated as a red solid.  
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Recrystallization from toluene yielded 2.46 g of colorless needles (92%) mp 125.5-126.0 
ºC (lit. 120-124 ºC);199  IR (KBr) 3306 (s), 3202 (w), 3130 (w), 3081 (w), 3040 (w), 2795 
(w), 1673 (s), 1535 (s), 1428 (s), 1221 (s), 1138 (s) 896 (s); 1H NMR (DMSO) δ 2.06 (s, 
3H), 7.41 (d,  J=8.1, 2H), 7.72 (d, J=8.1, 2H). 10.23 (s, 1H); 13C NMR (DMSO) δ 24.0, 
118.3 (q, JCF = 322), 120.3, 121.8, 139.7, 144.0, 168.7; LRMS (EI+) m/z 283 (M+, 51), 
150 (33), 108 (100), 43 (34); HRMS (EI+) m/z for C9H9O4NF3S calcd 284.0204, found 
284.0202. 
 
4-tert-Butyl phenyl trifluoromethanesulfonate (Table 4, Entry 8).  Triflate was 
prepared according to method A.   Column chromatography (19:1 hexane/EtOAc, TLC Rf 
= 0.52) yielded 2.32 g of a colorless oil (87%);  IR (CCl4) 3064 (w), 2967 (s), 2905 (m), 
2867 (m), 1504 (s), 1424 (s), 1214 (s), 1145 (s), 889 (s); 13C NMR (CDCl3) δ 31.3, 34.8, 
118.7 (q, JCF = 319), 120.9, 123.8, 127.3, 147.7, 151.8;  LRMS (EI+) m/z 282 (M+, 15), 
267 (100), 175 (20), 134 (11), 91 (17); HRMS (EI+) m/z for C11H13O3F3S calcd 
282.0538, found 282.0534. The spectral data (1H NMR) was identical to that previously 
reported by Zhu.200 
 
4-Aminophenyl trifluoromethanesulfonate (Table 4, Entry 9).  Triflate was prepared 
according to method C.  Column chromatography (1:1 hexane/EtOAc, TLC Rf = 0.52) 
yielded 1.04 g of a light brown oil (92%); IR (CCl4) 3496 (m), 3402 (m), 3054 (w), 3023 
(w), 1618 (m), 1545 (m), 1504 (s), 1421 (s), 1252 (m), 1214 (s), 1145 (s), 889 (s); 1H 
NMR (CDCl3) δ 3.58 (br s, 2H), 6.56 (d, J=8.8, 2H), 7.99 (d, J=8.8, 2H); 13C NMR 
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(CDCl3) δ 115.6, 118.6 (q, JCF = 320), 122.3, 141.6, 147.2; LRMS (EI+) m/z 241 (M+, 
40), 108 (100), 80 (15); HRMS m/z calcd for C7H6O3NF3S 241.0020 found 241.0018.  
 
4-Cyanophenyl trifluoromethanesulfonate (Table 4, Entry 10).  Triflate was prepared 
according to method A.  Column chromatography (4:1 hexane/EtOAc, TLC Rf = 0.43) 
yielded 1.98 g of a colorless oil (84%);  IR (CCl4) 3105 (w), 3074 (w), 2236 (s), 1600 (s), 
1504 (s), 1421 (s), 1245 (s), 1210 (s), 1155 (s), 882 (s); 13C NMR (CDCl3) δ 113.2, 
117.3, 118.5 (q, JCF = 320), 122.9, 134.9, 152.3. The spectral data (1H NMR) was 
identical to that previously reported by Cabri.197 
 
2-Cyanophenyl trifluoromethanesulfonate (Table 4, Entry 11).  Triflate was prepared 
according to method A.  Column chromatography (4:1 hexane/EtOAc, TLC Rf = 0.40) 
yielded 2.35 g of a colorless oil (77%);  13C NMR (CDCl3) δ 107.4, 113.8, 118.7 (q, JCF = 
319), 122.8, 123.6, 129.2, 134.6, 135.2, 149.8; LRMS (EI+) m/z 251 (M+, 55), 187 (35), 
159 (100), 139 (11), 90 (45), 69 (85), 63 (15); HRMS (EI+) m/z for C8H4O3NF3S calcd 
250.9864, found 250.9869. The spectral data (IR, 1H NMR) were identical to those 
previously reported by Cabri. 197 
 
4-Nitrophenyl trifluoromethanesulfonate (Table 4, Entry 12).  Triflate was prepared 
according to method A.  Column chromatography (4:1 hexane/EtOAc, TLC Rf = 0.56) 
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yielded 2.45 g of a white solid (96%) mp 51.0-51.9 ºC (lit. 50.5-52 ºC).198 The spectral 
data (IR, 1H and 13C NMR) were identical to those previously reported by DeShong.198 
 
1-Naphthyl trifluoromethanesulfonate (Table 4, Entry 13).  Triflate was prepared 
according to method A.  Column chromatography (19:1 hexane/EtOAc, TLC Rf = 0.36) 
yielded 2.11 g of a colorless oil (81%). The spectral data (IR, 1H and 13C NMR) were 
identical to those previously reported by DeShong.198 
 
2,6-Dimethoxyphenyl trifluoromethanesulfonate (Table 4, Entry 14).  Triflate was 
prepared according to method A. Column chromatography (4:1 hexane/EtOAc, TLC Rf = 
0.39) yielded 2.54 g of a colorless oil (94%). The spectral data (IR, 1H and 13C NMR) 
were identical to those previously reported by Saa.201 
 
2-Methylphenyl trifluoromethanesulfonate (Table 4, Entry 15).  Triflate was prepared 
according to method A.  Column chromatography (19:1 hexane/EtOAc, TLC Rf = 0.49) 
yielded 1.86 g of a colorless oil (83%); 13C NMR (CDCl3) δ 118.9 (q, JCF = 318), 121.4, 
123.7, 128.5, 131.1, 132.4, 148.8. The spectral data (IR, 1H NMR) were identical to those 
previously reported by Cabri.197 
 
2,6-Dimethylphenyl trifluoromethanesulfonate (Table 4, Entry 16).  Triflate was 
prepared according to method A.  Column chromatography (4:1 hexane/EtOAc, TLC Rf 
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= 0.66) yielded 2.07 g of a colorless oil (87%).  The spectral data (IR, 1H and 13C NMR) 
were identical to those previously reported by Saa.202 
 
2-Formyl-6-methoxyphenyl trifluoromethanesulfonate (Table 4, Entry 17).  Triflate 
was prepared according to method A.  Column chromatography (4:1 hexane/EtOAc, TLC 
Rf = 0.26) yielded 2.36 g of white crystals (88%) mp 37.9-38.5 ºC (lit. 36-38 ºC);202  IR 
(CCl4) 3023 (w), 2964 (w), 2947 (m), 2888 (w), 2843 (m), 2757 (w), 1704 (s), 1583 (s), 
1486 (s), 1431 (s), 1221 (s), 1148 (s), 1076 (s), 882 (s). The spectral data (1H and 13C 
NMR) were identical to those previously reported by Saa.202 
 
2-Pyridyl trifluoromethanesulfonate (Table 5, Entry 1).  Triflate was prepared 
according to method A.  Triflate was isolated in 96% yield (2.03 g) and 97% purity (GC) 
without purification as a colorless oil; 13C NMR (CDCl3) δ 118.9 (q, JCF = 320), 115.4, 
124.6, 141.4, 148.9, 156.2. The spectral data (IR, 1H NMR) were identical to those 
previously reported by Umemoto.203 
 
3-Pyridyl trifluoromethanesulfonate (Table 5, Entry 2).  Triflate was prepared 
according to method A.  Column chromatography (4:1 hexane/EtOAc, TLC Rf = 0.30) 
yielded 1.88 g of  a colorless oil (89%); IR (CCl4) 3064 (w), 1593 (s), 1569 (s), 1466 (s), 
1428 (s), 1228 (s), 1165 (s), 1141 (s), 893 (s); 1H NMR (CDCl3) δ 7.43-7.46 (m, 1H), 
7.66-7.69 (m, 1H), 8.64-8.67 (m, 2H); 13C NMR (CDCl3) δ 118.9 (q, JCF = 319), 124.9, 
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129.2, 143.1, 147.1, 149.8; LRMS (EI+) m/z 228 (M+, 10), 227 (100), 163 (32), 94 (18), 
66 (44), 39 (31); HRMS (EI+) m/z for C6H5O3NF3S calcd 227.9942, found 227.9939. 
 
5-Indole trifluoromethanesulfonate (Table 5, Entry 3).  Triflate was prepared according 
to method B.  Column chromatography (4:1 hexane/EtOAc, TLC Rf = 0.24) yielded 1.89 
g of a colorless oil (76%);  IR (CCl4) 3489 (s), 1428 (s), 1221 (s), 1145 (s), 1100 (s), 941 
(s), 879 (s); 1H NMR (CDCl3) δ 6.49 (s, 1H), 6.98-7.01 (m, 1H), 7.15-7.21 (m, 2H), 7.49 
(s, 1H), 8.26 (br s, 1H); 13C NMR (CDCl3) δ 103.1, 112.1, 112.8, 114.8, 118.6 (q, JCF = 
318), 126.9, 128.0, 129.5, 134.6, 143.6; LRMS (EI+) m/z 265 (M+, 67), 132 (100), 104 
(64); HRMS (EI+) m/z for C9H6O3NF3S calcd 265.0020, found 265.0019. 
 
2-Quinolyl trifluoromethanesulfonate (III-22).  Triflate was prepared according to 
method A.  Triflate was isolated in 97% yield (2.53 g) and 98% purity (GC) without 
purification as a pale yellow oil; 13C NMR (CDCl3) δ 113.1, 118.8 (q, JCF = 320), 127.8, 
128.8, 131.3, 142.1, 145.9, 153.8  The spectral data (IR, 1H NMR) were identical to those 
previously reported by Stille.196 
 
Phenyl trifluoromethanesulfonate (Table 7 Entries 1,4-6).  Triflate was prepared 
according to method A.  Column chromatography (4:1 hexane/EtOAc, TLC Rf = 0.63) 
yielded 1.79 g of a colorless oil (85%). The spectral data (IR, 1H and 13C NMR) were 
identical to those previously reported by DeShong.198 
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2-[(Trifluoromethyl)sulfonyl)oxy]-2,4,6-cycloheptatrienone (III-12).  Triflate was 
prepared according to method A.  Column chromatography (1:1 hexane/EtOAc, TLC Rf 
= 0.34) yielded 1.52 g of a yellow oil (64%). The spectral data (IR, 1H and 13C NMR) 
were identical to those previously reported by Stille.204 
 
α-Tocopherol trifluoromethanesulfonate (III-14).  Triflate was prepared according to 
method A. Column chromatography (pentane, TLC Rf = 0.44) yielded 4.78 g of a viscous 
colorless oil (85%);  IR (CCl4) 2957 (s), 2929 (s), 2867 (m), 1466 (m), 1421 (m), 1404 
(s), 1380 (m), 1221 (s), 1145 (s), 1111 (w), 1035 (w), 879 (m); 1H NMR (CDCl3) δ 0.84-
0.87 (m, 13H), 1.07-1.54 (m, 23H), 1.72-1.80 (m, 2H), 2.10 (s, 3H), 2.19 (s, 3H), 2.22 (s, 
3H), 2.57-2.59 (m, 2H); 13C NMR (CDCl3) δ 12.0, 13.2, 14.0, 19.7, 19.8, 20.7, 21.0, 22.7, 
22.8, 23.9, 24.5, 24.9, 28.0, 32.8, 32.9, 37.3, 37.4, 37.5, 39.4, 75.7, 77.4, 118.5, 119.0 (q, 
JCF = 321), 124.4, 126.7, 128.1, 139.7, 151.0;  LRMS (FAB+) m/z 562 (M+, 6), 429 (60), 
428 (15), 337 (16), 297 (64), 203 (22), 165 (100), 149 (44), 55 (34), 43 (33); HRMS 
(FAB+) m/z calcd for C30H49O4F3S 562.3304, found 562.3303. 
 
4-Trifluoromethanesulfonyloxy coumarin (III-16).  Triflate was prepared according to 
method A.  Filtration through a short pad of silica gel yielded 2.59 g of pale yellow 
crystals (88%) mp 59.5-60.9 ºC (lit. 59-60 ºC);205 13C NMR (CDCl3) δ 105.9, 113.9, 
117.4, 118.6 (q, JCF = 320), 122.6, 125.3, 134.2, 153.5, 157.2, 159.6; LRMS (EI+) m/z 
294 (M+, 76) 202 (100), 133  (98), 116 (11), 105 (70), 92 (31), 69 (92), 63 (24), 51 (18); 
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HRMS (EI+) m/z calcd for C10H5O4F3S 293.9807, found 293.9798.  The spectral data (IR, 
1H NMR) were identical to those previously reported by Wattanasin.205 
 
General Procedure for the Palladium-Catalyzed Cross-Coupling of 
Pentacoordinate Aryl (Bis)catechol Silicates.  Aryl triflate (1.00 mmol), catechol 
complex (1.50 mmol), Pd(dba)2 (0.0500 mmol), and dicyclohexyl phosphinobiphenyl 
(0.0500 mmol) were combined in a 50 mL round bottom flask equipped with a magnetic 
stir bar and placed under argon.  THF was added via syringe (10 mL), followed by 1.50 
mmol of TBAF (1.0 M solution in THF).  The deep red-brown solution was subjected to 
one freeze-pump-thaw cycle followed by heating at reflux for 6 h.  The crude reaction 
mixture was diluted with ether (50 mL), and poured into 50 mL of an aqueous 1.0 M 
NaOH solution.  The aqueous layer was then washed twice with 50 mL of ether.  The 
combined ethereal extracts were dried (MgSO4), and evaporated in vacuo.  The coupled 
products were purified via column chromatography. 
  
4-Methoxybiphenyl (Table 4, Entry 1).  Column chromatography (19:1 hexanes/EtOAc, 
TLC Rf = 0.32) yielded 175 mg of a white solid (95%) mp 87.0-87.5 °C (lit. 87.5 °C).198 
The spectral data (IR, 1H and 13C NMR) were identical to those previously reported by 
DeShong.198 
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2-Methoxybiphenyl (Table 4, Entry 2).  Column chromatography (19:1 hexanes/EtOAc, 
TLC Rf = 0.37) yielded 175 mg of a colorless oil (95%). The spectral data (IR, 1H and 
13C NMR) were identical to those previously reported by Buchwald.149 
 
4-Phenylbenzaldehyde (Table 4, Entry 3).  Column chromatography (4:1 
hexanes/EtOAc, TLC Rf = 0.49) yielded of a yellow solid.  Recrystallization from 
petroleum ether yielded 179 mg of a white powder (98%) mp 60.5-61.0 ºC (lit. 60-
61°C);206  IR (CCl4) 3064 (w), 3029 (w), 2822 (w), 2726 (w), 1707 (s), 1604 (m), 1549 
(m), 1210 (w), 1165 (w). The spectral data (IR, 1H and 13C NMR) were identical to those 
previously reported by Leadbeater.206 
 
4-Acetylbiphenyl (Table 4, Entry 4).  Column chromatography (9:1 hexanes/EtOAc, 
TLC Rf = 0.31) yielded 188 mg of a white solid (96%) mp 119.0-119.4 °C (lit. 119.0-
119.5 °C).198 The spectral data (IR, 1H and 13C NMR) were identical to those previously 
reported by DeShong.198 
 
2-Acetylbiphenyl (Table 4, Entry 5).  Column chromatography (9:1 hexanes/EtOAc, 
TLC Rf = 0.43) yielded 183 mg of a slight yellow oil (93%). The spectral data (IR, 1H 
and 13C NMR) were identical to those previously reported by Clive.207 
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4-Carbomethoxybiphenyl (Table 4, Entry 6).  Column chromatography (19:1 
hexanes/EtOAc, TLC Rf = 0.32) yielded 197 mg of a white solid (93%) mp 115-116 ºC 
(lit. 116-117 °C);198 13C NMR (CDCl3) δ 52.1, 127.1, 127.3, 128.1, 128.8, 128.9, 130.1, 
140.0, 145.6, 167.0. The spectral data (IR, 1H NMR) were identical to those previously 
reported by DeShong.198 
 
N-Acetyl-4-aminobiphenyl (Table 4, Entry 7).  Column chromatography (1:1 
hexanes/EtOAc, TLC Rf = 0.27) yielded 195 mg of a white solid (92%) mp 152-153 ºC 
(lit. 150-153 °C).149 The spectral data (IR, 1H and 13C NMR) were identical to those 
previously reported by Buchwald.149 
 
4-tert-Butylbiphenyl (Table 4, Entry 8).  Column chromatography (pentane, TLC Rf = 
0.36) yielded 200 mg of a white solid (95%) mp 49-50 ºC (lit. 47-49 ºC).149 The spectral 
data (IR, 1H and 13C NMR) were identical to those previously reported by Buchwald.149 
 
4-Cyanobiphenyl (Table 4, Entry 10).  Column chromatography (1:1 hexanes/EtOAc, 
TLC Rf = 0.40) yielded 163 mg of a white solid (91%) mp 85.6-86.2 ºC (lit. 86-87 ºC);149  
IR (CCl4) 3064 (w), 3033 (w), 2232 (m), 1545 (m). The spectral data (1H and 13C NMR) 
were identical to those previously reported by Buchwald.149 
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2-Cyanobiphenyl (Table 4, Entry 11).  Column chromatography (9:1 hexanes/EtOAc, 
TLC Rf = 0.32) yielded 160 mg of a pale yellow oil (89%); IR (CCl4) 3067 (w), 3036 
(w), 2933 (w), 2853 (w), 2229 (m), 1480 (m). The spectral data (1H and 13C NMR) were 
identical to those previously reported by Lemaire.208 
 
4-Nitrobiphenyl (Table 4, Entry 12).  Column chromatography (4:1 hexanes/EtOAc, 
TLC Rf = 0.20) yielded 97.6 mg of a white solid (49%) mp 114-115 ºC (lit. 113-115 
°C);209  IR (CCl4) 3064 (w), 3036 (w), 1600 (m), 1552 (m), 1521 (s), 1476 (w), 1341 (s). 
The spectral data (1H and 13C NMR) were identical to those previously reported by 
Novak.209 
 
1-Phenylnapthalene (Table 4, Entry 13).  Column chromatography (pentane, TLC Rf = 
0.42) yielded 176 mg of a colorless oil (86%); LRMS (EI+) m/z 204 (M+, 100), 203 (74), 
188 (20), 29 (50), 18 (90); HRMS (EI+) m/z calcd for C16H12 204.0939, found 204.0948. 
The IR and 1H NMR were identical to those reported by DeShong.198  The 13C NMR was 
identical to that reported by Bergbreiter.210 
 
2-Methylbiphenyl (Table 4, Entry 15).  Column chromatography (pentane, TLC Rf = 
0.57) yielded 155 mg of a colorless oil (92%).  The spectral data (IR, 1H and 13C NMR) 
were identical to those previously reported by DeShong.198 
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2,6-Dimethylbiphenyl (Table 4, Entry 16).  Reaction was run in refluxing dioxane.  
Column chromatography (pentane, TLC Rf = 0.47) yielded 175 mg of a colorless oil 
(96%); IR (CCl4) 3029, (w), 2992 (w), 2950 (w), 2916 (w), 2829 (w), 1611 (m), 1500 
(m), 1241 (m), 1176 (w), 1045 (w). The spectral data (1H and 13C NMR) were identical to 
those previously reported by Buchwald.149 
 
2-Methoxy-6-formyl-biphenyl (Table 4, Entry 17).  Reaction was run in refluxing 
dioxane.  Column chromatography (19:1 hexanes/EtOAc, TLC Rf = 0.23) yielded 183 mg 
of a pale yellow oil (86%);  IR (CCl4) 3064 (w), 3033 (w), 3005 (w), 2960 (w), 2933 (w), 
2864 (w), 2833 (w), 2746 (w), 1694 (s), 1593 (m), 1576 (m), 1469 (m), 1259 (s), 1065 
(m), 910 (m); 1H NMR (CDCl3) δ 3.77 (s, 3H), 7.18 (d, J=8.4, 1H), 7.31-7.33 (m, 2H), 
7.42-7.46 (m, 4H), 7.62 (d, J=7.6, 1H), 9.73 (s, 1H); 13C NMR (CDCl3) δ 56.0, 115.8, 
119.0, 127.9, 128.0, 128.7, 131.0, 133.1, 134.9, 135.4, 157.0, 192.5; LRMS (EI+) m/z 212 
(M+, 100), 211 (50), 197 (19), 180 (25), 169 (27), 152 (26), 139 (28), 115 (18); HRMS 
(EI+) m/z calcd for C14H12O2 212.0837, found 212.0831. 
 
2-Phenylpyridine (Table 5, Entry 1).  Column chromatography (4:1 hexanes/EtOAc, 
TLC Rf = 0.39) yielded 77.6 mg of a pale yellow oil (50%); IR (CCl4) 3088 (w), 3067 
(m), 3037 (w), 3009 (w), 1580 (s), 1566 (s), 1466 (s), 1445 (s), 1424 (m). The spectral 
data (1H and 13C NMR) were identical to those previously reported by Furukawa.211 
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3-Phenylpyridine (Table 5, Entry 2).  Column chromatography (4:1 hexanes/EtOAc, 
TLC Rf = 0.24) yielded 82.2 mg of a yellow oil (53%); IR (CCl4) 3095 (w), 3061 (w), 
3029 (w), 2929 (w), 2853 (w), 1476 (m), 1455 (m), 1411 (s), 1007 (m); 13C NMR 
(CDCl3) δ 123.5, 127.1, 128.1, 129.1, 134.3, 136.6, 137.8, 148.3, 148.4; LRMS m/z (EI+) 
155 (M+, 100), 154 (39), 127 (11), 76 (15), 63 (9), 43 (23); HRMS (EI+) m/z for C11H9N 
calcd 155.0735, found 155.0725. The spectral data (1H NMR) was identical to that 
previously reported by Sakamoto.212 
 
5-Phenylindole (Table 5, Entry 3).  Column chromatography (4:1 hexanes/EtOAc, TLC 
Rf = 0.24) yielded 147 mg of a light brown oil (76%); IR (CCl4) 3485 (m), 3067 (w), 
3029 (w), 907 (m); 1H NMR (CDCl3) δ 6.56 (s, 1H), 7.10-7.12 (m, 1H), 7.27-7.44 (m, 
5H), 7.64 (d, J=7.6, 2H), 7.85 (s, 1H), 7.99 (br s, 1H); 13C NMR (CDCl3) δ 102.8, 111.3, 
119.2, 121.8, 124.9, 126.3, 127.3, 128.3, 128.6, 133.3, 135.2, 142.5; LRMS (FAB+) m/z 
194 (M+, 100), 193 (70), 165 (10); HRMS (FAB+) m/z calcd for C14H11N 193.0891, 
found 193.0900. 
 
2-Phenylquinoline (Table 5, Entry 4).  Column chromatography (9:1 hexanes/EtOAc, 
TLC Rf = 0.36) yielded 187 mg of a white solid (91%) mp 82.0-83.0 °C (lit. 82.0-82.5 
°C);213  IR (CCl4) 3061 (m), 3033 (m), 1604 (m), 1552 (s). The spectral data (1H and 13C 
NMR) were identical to those previously reported by Miyaura.213 
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2′-Methyl-4-methoxybiphenyl (Table 7, Entry 1).  Column chromatography (4:1 
hexanes/CH2Cl2, TLC Rf = 0.27) yielded 39.7 mg of a colorless oil (20%);   IR (CCl4) 
3064 (w), 3002 (w), 2954 (w), 2933 (w), 2909 (w), 2840 (w), 1614 (w), 1545 (s), 1248 
(m); LRMS (FAB+) m/z 198 (M+, 24), 133 (22), 89 (35), 73 (35), 45 (35); HRMS (FAB+) 
m/z calcd for C14H14O 198.1045, found 198.1052. The spectral data (1H and 13C NMR) 
were identical to those previously reported by Lipshutz.214 
 
3′-Methyl-4-methoxybiphenyl (Table 7, Entry 2).  Column chromatography (4:1 
hexanes/EtOAc, TLC Rf = 0.47) yielded 192 mg of a white solid (97%) mp 52.0-53.2 ºC 
(lit. 54 ºC);215 IR (CCl4) 3057 (w), 3033 (w), 2995 (w), 2957 (w), 2936 (w), 2840 (w), 
1614 (s), 1514 (s), 1252 (s), 1170 (m), 1038 (m); 13C NMR (CDCl3) δ 21.6, 55.3, 114.1, 
123.8, 127.4, 127.6, 128.2, 128.6, 133.9, 138.3, 140.8, 159.0; LRMS (FAB+) m/z 198 
(M+, 100), 184 (5), 183 (5); HRMS (FAB+) m/z calcd for C14H14O 198.1045, found 
198.1036. The spectral data (1H NMR) was identical to that previously reported by 
Rao.215 
 
4′-Methyl-4-methoxybiphenyl (Table 7, Entry 3).  Column chromatography (19:1 
hexanes/EtOAc, TLC Rf = 0.40) yielded 182 mg of a white solid (92%) mp 107.4-108.1 
ºC (lit. 105-107 ºC);216  IR (CCl4) 3064 (w), 3019 (w), 2957 (w), 2919 (w), 2857 (w), 
1462 (w), 1448 (w); 13C NMR (CDCl3) δ 21.1, 55.3, 114.1, 126.6, 128.0, 129.4, 133.7, 
136.3, 138.0, 158.9. The spectral data (1H NMR) was identical to that previously reported 
by Roth.216 
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3-Methoxybiphenyl (Table 7, Entry 5).  Column chromatography (19:1 hexanes/EtOAc, 
TLC Rf = 0.21) yielded 160 mg of a colorless oil (87%);  IR (CCl4) 3064 (m), 3033 (m), 
3005 (w), 2957 (m), 2940 (m), 2833 (m), 1604, (s), 1569 (s), 1480 (s), 1424 (m), 1293 
(m), 1214 (s), 1176 (m), 1058 (m); 13C NMR (CDCl3) δ 55.1, 112.6, 112.6, 112.9, 119.6, 
127.2, 127.4, 128.7, 129.7, 141.1, 142.7, 159.9; LRMS (EI+) m/z 184 (M+, 100), 154 
(22), 141 (46), 139 (18), 115 (42); HRMS (EI+) m/z calcd for C13H12O 184.0888, found 
184.0884. The spectral data (1H NMR) was identical to that previously reported by 
Nielson. 217 
 
2′-Methoxy-biphenyl-4-carboxylic acid ethyl ester (Table 7, Entry 7).  Column 
chromatography (4:1 hexanes/EtOAc, TLC Rf = 0.53) yielded 241 mg of a white solid 
(94%) mp 104.5-105.0 °C (lit. 105 °C);218  IR (CCl4) 3040 (w), 2985 (w), 2957 (w), 2933 
(w), 2874 (w), 2833 (w), 1718 (s), 1604 (m), 1500 (m), 1462 (w), 1276 (s), 1245 (m), 
1183 (m), 1107 (m), 1045 (m). The spectral data (1H and 13C NMR) were identical to 
those previously reported by Gosmimi.219 
 
5-(4-Methoxy-phenyl)-1,3-benzodioxole (Table 7, Entry 8).  Column chromatography 
(19:1 hexanes/EtOAc, TLC Rf = 0.24) yielded a sticky white solid.  The solid was 
recrystallized from Et2O/hexanes to yield 176 mg of colorless plates (89%) mp 95.6-96.2 
ºC (lit 95-96 ºC);220  IR (CCl4) 3071 (w), 3040 (w), 3006 (w), 2961 (m), 2930 (m), 2888 
(w), 2833 (w), 2775 (w), 1611 (m), 1480 (s), 1256 (s), 1218 (s), 1183 (m), 1045 (s), 945 
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(m).  The spectral data (1H and 13C NMR) were identical to those previously reported by 
Bannwarth.220 
 
2-Phenylcyclohepta-2,4,6-triene-1-one (III-13).  Column chromatography (4:1 
hexanes/EtOAc, TLC Rf = 0.27) yielded 162 mg of a slightly yellow solid (89%) mp 
83.5-84.2 ºC (lit. 84.5-85.5 ºC);221  IR (CCl4) 3065 (w), 3030 (w), 2930 (w), 2850 (w), 
1632 (m), 1595 (s); 13C NMR (CDCl3) δ 128.1, 128.4, 129.1, 133.3, 133.7, 135.3,  136.5, 
139.9, 142.4, 152.6, 186.6; LRMS (EI+) m/z 182 (M+, 25), 181 (100), 154 (56), 153 (38), 
76 (15); HRMS (EI+) m/z calcd for C13H10O 183.0732, found 182.0727.  The spectral 
data (1H NMR) was identical to that previously reported by Mann.222 
 
Phenyl-α-tocopherol (III-15).  Column chromatography (pentane, TLC Rf = 0.35) 
yielded 442 mg of a viscous, colorless oil (90%);  IR (CCl4) 3085 (w), 3057 (w), 3026 
(w), 2957 (s), 2926 (s), 2864 (s), 1562 (m), 1459 (m) 1155 (m), 1103 (s); 1H NMR 
(CDCl3) δ 0.84-0.87 (m, 14H), 1.07-1.60 (m, 21H), 1.80 (m, 3H), 1.86 (s, 3H), 1.90 (s, 
3H), 2.15 (m, 1H), 2.19 (s, 3H), 2.61-2.65 (m, 2H), 7.12 (m, 2H), 7.30 (t, J=8.0, 1H), 
7.38 (t, J=8.0, 2H); 13C NMR (CDCl3) δ 11.9, 16.7, 17.7, 19.7, 20.8, 22.6, 22.7, 24.0, 
24.5, 24.8, 27.9, 32.7, 37.4, 37.5, 39.4, 75.0, 116.6, 121.7, 126.1, 128.1, 130.1, 130.2, 
131.6, 133.1, 133.4, 142.7, 150.7; LRMS (FAB+) m/z 490 (M+, 19), 265 (11), 225 (100), 
223 (18), 55 (16); HRMS (FAB+) m/z calcd for C35H54O 490.4175, found 490.4176. 
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5-(4-Methoxybenzene)-2-methoxypyridine (III-21).  Column chromatography (19:1 
hexanes/EtOAc, TLC Rf = 0.26) yielded 207 mg of a white solid (96%) mp 75.0-75.9 ºC;  
IR (CCl4) 3043 (m), 3016 (m), 2981 (m), 2847 (m), 2902 (m), 2840 (m), 1604 (s), 1486 
(s), 1373 (m), 1290 (s), 1279 (s), 1245 (s), 1172 (m), 1055 (m), 1020 (m); 1H NMR 
(CDCl3) δ 3.85 (s, 3H), 3.97 (s, 3H), 6.79 (d, J=12.0, 1H), 6.98 (d, J=8.0, 2H), 7.45 (d, 
J=8.0, 2H), 7.73-7.76 (m, 1H), 8.34 (s, 1H); 13C NMR (CDCl3) δ 53.5, 55.4, 110.7, 
114.4, 127.7, 129.8, 130.4, 137.2, 144.5, 159.1, 163.2; LRMS (FAB+) m/z 216 (M+, 100), 
215 (30); HRMS (FAB+) m/z calcd for C13H14O2N 216.1025, found 216.1033. 
 
5-(2-Quinoyl)-2-methoxypyridine (III-23).  Column chromatography (9:1 
hexanes/EtOAc, TLC Rf = 0.31) yielded 229 mg of a white solid (97%) mp 78.5-79.0 ºC;  
IR (CCl4) 3067 (w), 3040 (w), 3016 (w), 2981 (w), 2947 (w), 2905 (w), 2850 (w), 1604 
(s), 1490 (s), 1390 (m), 1286 (m), 1020 (m); 1H NMR (CDCl3) δ 4.03 (s, 3H), 6.90 (d, 
J=8.4, 1H), 7.53 (m, 1H), 7.73 (m, 1H), 7.82 (d, J=8.4, 2H), 8.13 (d, J=8.8, 1H), 8.21 (d, 
J=8.8, 1H), 8.47-8.50 (m, 1H), 8.91 (s, 1H);  13C NMR (CDCl3) δ 54.3, 111.6, 118.7, 
126.8, 127.6, 128.0, 129.4, 130.1, 130.4, 137.5, 138.5, 146.7, 148.8, 155.3, 165.4; LRMS 
(EI+) m/z 236 (M+, 100), 235 (79), 207 (33), 192 (22); HRMS (EI+) m/z calcd for 
C15H12ON2 236.0950, found 236.0940. 
 
General Procedure for the Palladium-Catalyzed Cross-Coupling Reaction of 
Aryl Bromides with Aryl (Bis)catechol Silicates Using Microwave Irradiation: Aryl 
bromide (1.00 mmol), aryl bis(catechol) silicate (1.50 mmol), Pd(dba)2 (0.0500 mmol) 
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and dicyclohexylphosphinobiphenyl (0.0500 mmol) were combined in a microwave tube 
with a magnetic stir bar.  The microwave tube was sealed with a septum and 5 mL of 
THF was added, followed by TBAF (1.0 M in THF, 1.50 mmol).  The reaction was 
stirred briefly to dissolve the reagents and placed into the microwave reactor.  The 
reaction was then heated to a set temperature of 120 °C (100 W) for 10 min.  The tube 
was removed from the reactor and the contents filtered through a short plug (2 cm) of 
silica gel (CH2Cl2 elutant).  The solvent was removed in vacuo and the biaryl product 
purified via column chromatography. 
 
Biphenyl (Table 9, Entry 1).  Column chromatography (TLC Rf = 0.54, pentane) yielded 
137 mg of a white solid (89%) mp 69-71 °C (lit. 69-70°C). The 1H and 13C NMR and IR 
match that reported by Koza.223 
 
4-Methoxybiphenyl (Table 9, Entry 2).  Column chromatography (19:1 hexanes/EtOAc, 
TLC Rf = 0.32) yielded 149 mg of a white solid (81%) mp 87.0-87.5 °C (lit. 87.5 °C).198 
The spectral data (IR, 1H and 13C NMR) were identical to those previously reported by 
DeShong.198 
 
2-Methoxybiphenyl (Table 9, Entry 3).  Column chromatography (19:1 hexanes/EtOAc, 
TLC Rf = 0.37) yielded 154 mg of a colorless oil (84%). The spectral data (IR, 1H and 
13C NMR) were identical to those previously reported by Buchwald.149 
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4-tert-Butylbiphenyl (Table 9, Entry 4).  Column chromatography (pentane, TLC Rf = 
0.36) yielded 185 mg of a white solid (88%) mp 49-50 ºC (lit. 47-49 ºC).149 The spectral 
data (IR, 1H and 13C NMR) were identical to those previously reported by Buchwald.149 
 
2-Methylbiphenyl (Table 9, Entry 5).  Column chromatography (19:1 hexanes/EtOAc, 
TLC Rf = 0.32) yielded 145 mg of a white solid (86%) mp 87.0-87.5 °C (lit. 87.5 °C).198 
The spectral data (IR, 1H and 13C NMR) were identical to those previously reported by 
DeShong.198 
 
2,6-Dimethylbiphenyl (Table 9, Entry 6).  Column chromatography (pentane, TLC Rf = 
0.47) yielded 146 mg of a colorless oil (80%); IR (CCl4) 3029, (w), 2992 (w), 2950 (w), 
2916 (w), 2829 (w), 1611 (m), 1500 (m), 1241 (m), 1176 (w), 1045 (w). The spectral data 
(1H and 13C NMR) were identical to those previously reported by Buchwald.149 
 
1-Phenylnapthalene (Table 9, Entry 7).  Column chromatography (pentane, TLC Rf = 
0.42) yielded 172 mg of a colorless oil (84%); LRMS (EI+) m/z 204 (M+, 100), 203 (74), 
188 (20), 29 (50), 18 (90); HRMS (EI+) m/z calcd for C16H12 204.0939, found 204.0948. 
The IR and 1H NMR were identical to those reported by DeShong.198  The 13C NMR was 
identical to that reported by Bergbreiter.210 
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4-Acetylbiphenyl (Table 9, Entry 8).  Column chromatography (9:1 hexanes/EtOAc, 
TLC Rf = 0.31) yielded 175 mg of a white solid (89%) mp 119.0-119.4 °C (lit. 119.0-
119.5 °C).198 The spectral data (IR, 1H and 13C NMR) were identical to those previously 
reported by DeShong.198 
 
4-Nitrobiphenyl (Table 9, Entry 9).  Column chromatography (4:1 hexanes/EtOAc, TLC 
Rf = 0.20) yielded 185  mg of a white solid (93%) mp 114-115 ºC (lit. 113-115 °C);209  IR 
(CCl4) 3064 (w), 3036 (w), 1600 (m), 1552 (m), 1521 (s), 1476 (w), 1341 (s). The 
spectral data (1H and 13C NMR) were identical to those previously reported by Novak.209 
 
3-Methoxybiphenyl (Table 11, Entry 2).  Column chromatography (19:1 
hexanes/EtOAc, TLC Rf = 0.21) yielded 155 mg of a colorless oil (84%);  IR (CCl4) 3064 
(m), 3033 (m), 3005 (w), 2957 (m), 2940 (m), 2833 (m), 1604, (s), 1569 (s), 1480 (s), 
1424 (m), 1293 (m), 1214 (s), 1176 (m), 1058 (m); 13C NMR (CDCl3) δ 55.1, 112.6, 
112.6, 112.9, 119.6, 127.2, 127.4, 128.7, 129.7, 141.1, 142.7, 159.9; LRMS (EI+) m/z 184 
(M+, 100), 154 (22), 141 (46), 139 (18), 115 (42); HRMS (EI+) m/z calcd for C13H12O 
184.0888, found 184.0884. The spectral data (1H NMR) was identical to that previously 
reported by Nielson. 217 
 
4′-Methoxy-biphenyl-4-carboxylic acid ethyl ester (Table 11, Entry 5).  Column 
chromatography (4:1 hexanes/EtOAc, TLC Rf = 0.53) yielded 210 mg of a white solid 
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(82%) mp 104.5-105.0 °C (lit. 105 °C);218  IR (CCl4) 3040 (w), 2985 (w), 2957 (w), 2933 
(w), 2874 (w), 2833 (w), 1718 (s), 1604 (m), 1500 (m), 1462 (w), 1276 (s), 1245 (m), 
1183 (m), 1107 (m), 1045 (m). The spectral data (1H and 13C NMR) were identical to 
those previously reported by Gosmimi.219 
 
2,3,4-Trimethoxybiphenyl (Table 10, Entry 1). Column chromatography (TLC Rf = 
0.31, 9:1 Hexanes/EtOAc) yielded a yellow oil which was recrystallized (hexane) to give 
205 mg of a white solid (84%) mp 47.2-47.9 °C (lit. 46-47 °C). The 1H, and 13C NMR, 
and IR match that reported by Banwell.224 
 
2,3,4-Trimethoxy-6-carbaldehyde-biphenyl (Table 10, Entry 2). Column 
chromatography (TLC Rf = 0.24, 9:1 hexanes/EtOAc) yielded 202 mg of a white solid 
(74%) mp 91.2-92.4 °C.  IR (CCl4) 3085 (w) 3067 (w), 3009 (w), 2960 (m), 2933 (m), 
2857 (m), 1683 (s), 1587 (m), 1328 (s), 1193(m), 1141 (s), 1096 (s); 1H NMR (CDCl3) δ 
3.59 (s, 3H), 3.94 (s, 3H), 3.99 (s, 3H), 7.30-7.35 (m, 3H), 7.42-7.43 (m, 2H), 9.63 (s, 
1H); 13C NMR (CDCl3) δ 56.6, 61.4, 61.5, 105.6, 110.2, 127.5, 128.1, 123.3, 128.4, 
129.9, 130.1, 131.4, 133.2, 191.8; LRMS (FAB+) m/z 273 (M+ + H, 100), 272 (80), 255 
(42), 230 (24), 214 (19), 151 (18), 135 (24), 119 (25), 85 (29), 55 (34), 43 (25); HRMS 
(FAB+, M+) m/z calcd for C16H16O4 272.1049, found 272.1045. 
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2,3,4-Trimethoxy-6-carbomethoxy-biphenyl (Table 10, Entry 3).  Column 
chromatography (TLC Rf = 0.31, 4:1 hexanes/EtOAc) yielded 239 mg of a white solid 
(79%) mp 67.2-67.8 °C.  IR (CCl4) 3065 (w), 3002 (w), 2940 (m), 2836 (w), 1718 (s), 
1593 (m), 1486 (m), 1435 (m), 1397 (m), 1335 (s), 1224 (m), 1134 (m), 1100 (s), 1045 
(m), 1007 (m); 1H NMR (CDCl3) δ 3.54 (s, 3H), 3.57 (s, 3H), 3.94 (s, 3H), 3.96 (s, 3H), 
7.22-7.26 (m, 3H), 7.37-7.38 (m, 3H); 13C NMR (CDCl3) δ 51.9, 56.1, 59.9, 60.0, 108.9, 
126.4, 126.9, 127.6, 129.3, 130.7, 136.7, 145.3, 151.5, 152.3, 168.1; LRMS (FAB+) m/z 
302 (M+, 100), 271  (79), 256 (20); HRMS (FAB+, M+) m/z calcd for C17H20O5 302.1154, 
found 302.1148. 
 
2-Methoxy-5-phenylcyclohepta-2,4,6-trien-1-one (Table 10, Entry 4).  5-
Bromotropolone was prepared according to a literature procedure.225  Column 
chromatography (TLC Rf = 0.38, EtOAc) yielded 161 mg of a light tan solid (76%) mp 
139.2-140.4 °C (lit. 140-141 °C).226  The IR, 1H NMR, and 13C NMR matched that 
reported by Banwell.226 
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Chapter 4 - Application of Aryl Siloxane Cross-Coupling 
Technology to the Synthesis of Colchicine and Allocolchicine 
 
PART 1:  Efforts Directed Toward the Synthesis of Colchicine 
INTRODUCTION 
Biological Activity of the Colchicinoids 
 Colchicine (IV-1) was first isolated from the meadow saffron Colchicum 
autumnale over one hundred years ago and is commonly used in the treatment of gout.227 
More recently, the activity of colchicine as a spindle poison has been reported.228,229  Its 
mechanism of action involves binding to tubulin monomers and prevention of the 
formation of microtubules, which are essential to cellular mitosis.230-234   
O
OMe
OMe
MeO
MeO
NHAc
colchicine (IV-1)  
Tubulin consists of α and β protein subunits which combine to form a heterodimer.  
These heterodimers polymerize in a helical fashion to form long tubes, called 
microtubules.  Microtubules are responsible for a multitude of cellular functions 
including: formation of the cytoskeleton to maintain the cellular shape, transport systems 
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for moving material around inside the cell, and most importantly, microtubules are 
required for the formation of the mitotic spindle during cell division.  Colchicine disrupts 
these activities by binding to the tubulin heterodimer and preventing polymerization to 
form microtubules.234  This leads to a halt to cellular mitosis and subsequent cell death. 
Despite this promising activity, attempts to develop colchicine as an antitumor 
compound have been ineffective due to its potent broad spectrum cytotoxicity.  The 
mitigation of the cytotoxicity of colchicinoids has been extensively investigated in an 
effort to find new antitumor agents with improved therapeutic properties. 231-238   This has 
led to the development of colchicine derivatives that display lower toxicity, and these 
compounds have seen limited therapeutic activity.235 
Due to the success of taxol in the treatment of certain types of cancer, there has 
been renewed interest in the development of the colchicinoids for therapeutic use.239 
Currently, the obstacle to accessing new and potentially useful derivatives of colchicine 
is the availability of synthetically useful pathways.  The majority of the syntheses of 
colchicine are long, tedious, or suffer from very poor yields.  In recent years there has 
been an effort to develop new and more efficient synthetic procedures for the production 
of colchicine, and more importantly, colchicine derivatives.240  
Biosynthesis and Previous Total Syntheses of Colchicine 
The biosynthesis of colchicine was unknown until the early 1970’s when 
Battersby241-245 and others246 performed extensive isotope labeling and feeding studies to 
determine the biosynthetic pathway of colchicine.  Preliminary studies demonstrated that 
colchicine was a modified isoquinoline alkaloid, derived from autumnaline (IV-2) 
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(Scheme 1).245  Autumnaline is ultimately derived from tyrosine and phenylalanine.  
Methylation of autumnaline, followed by oxidative coupling generates O-
methylandrocymbine (IV-3).241,246  At this point an interesting, and not completely 
understood fragmentation of the ethaneamine bridge occurs to give the ring expanded 7-
membered tropolone ring of  N-formyldemecolcine (IV-4), which is directly converted to 
colchicine.  This ring expansion step is thought to occur via a P-450 radical mediated 
process, however, no intermediates have been isolated to conclusively prove this 
theory.242,243 
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Colchicine has attracted the attention of the synthetic community over the 
years.240,247,248 Its deceptively simple structure poses several significant challenges, most 
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notably the synthesis of the tropolone ring system,249,250  and the construction of the 6-7-7 
fused ring system. 
The majority of the total syntheses of colchicine have been linear, and suffer from 
one or more steps that proceed in poor yields.  Recently, several synthetic approaches 
have been developed facilitating a more efficient construction of the carbocyclic 
framework.240   
Cha developed a novel approach to the tropolone ring based upon an oxyallyl 
cycloaddition as the key step (Scheme 2).251  Accordingly, treatment of advanced 
intermediate IV-5 with an in situ generated oxallyl cation IV-7, formed in situ from TMS 
enol ether IV-6 (see Scheme 3), generated the cycloaddition product IV-8 in good yield.  
Base-induced ring opening of ether IV-8 led to the generation of the tropolone ring in 
colchicinoid IV-9.  Deprotection and acylation provided to colchicine (IV-1).   
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Scheme 3 
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Another recent approach to the colchicine skeleton entailed a rhodium-catalyzed 
cyclization/cycloaddition cascade performed by Schmalz and coworkers (Scheme 4).252 
Cyclization precursor IV-10 (readily obtained in 7 steps from commercially available 
starting materials) was treated with a rhodium catalyst to generate carbonyl ylide IV-11 
as an intermediate, which cyclized with the alkyne moiety to form advanced colchicinoid 
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intermediate IV-12.   Fragmentation and aromatization led to colchicinoid IV-13, which 
was converted to colchicine in moderate overall yield.253   
Scheme 4  
OMe
MeO
MeO
IV-10
O
O
N2
TMS
OTBS
Rh2(OAc)4
PhH
62% OMe
MeO
MeO TMS
OTBS
O
O
IV-11
O
MeO
MeO
MeO
O
OTBS
TMS
IV-12
OH
MeO
MeO
MeO
OTBS
IV-13
O
colchicine (IV-1)  
Aryl Siloxane Cross-Coupling Approach 
Despite the recent advances in the synthesis of colchicine, no methods exist that 
permit the facile production of analogues, which may prove to be therapeutically more 
useful than colchicine itself.  Our approach to the synthesis of colchicine and its 
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derivatives employed a palladium-catalyzed siloxane cross-coupling reaction to form the 
carbon-carbon bond between the aryl ring siloxane IV-15 and the tropolone ring IV-16 
(Scheme 5).  This coupling would allow facile access to functionalized derivatives of 
Fitzgerald’s compound (IV-14, R=H), which has been shown to possess the same 
biological activity as colchicine.230   
Formation of the aryl-tropolone bond by a cross-coupling reaction has been 
investigated previously in model systems using Stille couplings254 and Fitzgerald’s 
compound (IV-14) has been prepared using a Suzuki coupling.255,256 We chose to 
investigate a siloxane coupling reaction for the synthesis of the colchicine carbocyclic 
framework.  This study would yield a direct comparison of the siloxane reaction to other 
cross-coupling strategies. 
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 Palladium-catalyzed coupling reactions play an ever increasing role in organic 
synthesis since the ability to efficiently form carbon-carbon bonds in molecules with 
complex chemical architecture remains a challenging task.5    Work in our laboratory has 
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focused on the formation of aryl-aryl bonds using hypercoordinate siloxane derivatives,45-
51,56,57,59 a variant of the Hiyama cross-coupling reaction.30-36 This reaction has 
advantages over traditional cross-coupling protocols3 such as the Suzuki-Miyaura15-19 
(organoboron) or Stille6-10 (organostannane) coupling reactions (Scheme 6) because the 
siloxane methodology eliminates the purification difficulties associated with organoboron 
reagents,20 and the toxic by-products associated with the use of organotin compounds.10  
The goal of this study was to demonstrate that siloxane-based couplings could be 
employed effectively in complex natural product synthesis.  In addition, the use of 
colchicine (IV-1) as a target would also allow for the direct comparison of the siloxane 
and boronic acid based strategies.   
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RESULTS AND DISCUSSION  
  The aryl bromide coupling partner for the key siloxane coupling reaction is 5-
bromotropolone (IV-16).  Banwell and coworkers have developed an efficient synthesis 
of this compound and we adopted a modified sequence of the Banwell procedure for this 
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study (Scheme 7).225  Treatment of 1,4 cyclohexadiene (IV-17) with in situ generated 
dibromocarbene provided dibromide IV-18.  Formation of dibromo ester IV-19 
proceeded uneventfully.  Oxidation of the hydroxyl moiety of IV-19 using PCC led to 
ketone IV-20 that underwent base-induced ring expansion to give unprotected 
bromotropolone IV-21 in excellent yield.  Methylation with dimethyl sulfate provided the 
desired methoxybromotropolone IV-16.  
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With bromotropolone (IV-16) in hand, an investigation of the cross-coupling with 
phenyltrimethoxysilane was undertaken. The results are summarized in Table 1.  A 
variety of catalyst and phosphine combinations were tested and palladium acetate and 
triphenyl phosphine in a 1:5 ratio was found to be the optimum catalyst for the cross-
coupling reaction (entries 4 and 5).  
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Table 1.  Optimization of 5-Bromotropolone Coupling with Phenyl 
Trimethoxysilane 
O
OMe
Br
Pd source
TBAF
PhSi(OMe)3
Solvent
O
OMe
entry Pd source
 (mol %) (mol %)
solventb yield (%)c
7 Pd(PPh3)4 (10) - DMF 0
20 [Pd(allyl)Cl]2 (10) PPh3 (20) DMF 0
21 [Pd(allyl)Cl]2 (10) P(cy)2(o-biphenyl) (10) DMF 0
8 Pd(PPh3)4 (10) - THF 24
12 Pd(PPh3)4 (10) - dioxane 0
17 Pd(dba)2 (10) P(cy)2(o-biphenyl) (10) DMF 0
19 [Pd(allyl)Cl]2 (10) PPh3 (20) THF 0
18 Pd(dba)2 (10) P(t-Bu)2(o-biphenyl) (10) DMF 0
13 Pd(dba)2 (10) - DMF 0
9 Pd(PPh3)4 (10) PPh3 (10) THF 84
10 Pd(PPh3)4 (10) PPh3 (20) THF 88
2 Pd(OAc)2 (10) PPh3 (20) DMF 15
3 Pd(OAc)2 (10) PPh3 (40) THF 51
 4 Pd(OAc)2 (10) PPh3 (50) THF 86
5 Pd(OAc)2 (5) PPh3 (25) THF 84
1 Pd(OAc)2 (10) P(o-tol)3 (20) DMF 0
6 Pd(OAc)2 (1) PPh3 (5) THF 52
11 Pd(PPh3)4 (5) PPh3 (10) THF 23
14 Pd(dba)2 (10) - THF 0
15 Pd(dba)2 (10) PPh3 (50) THF 46
16 Pd(dba)2 (10) PPh3 (100) THF 54
IV-16 IV-22
PR3
PR3
a Reactions were stirred for 10 h unless otherwise noted.  b Reactions conducted in THF or 
dioxane were performed at the reflux temperature of the solvent.  Reactions in DMF were 
heated to 90  oC. c Isolated yields.  
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The reaction could be conducted with no appreciable loss in yield with as little as 
5 mol % catalyst (entry 5).  Similar results could be obtained using 
tetrakis(triphenylphosphine) palladium(0) with the addition of 10 to 20 mol % of excess 
phosphine (entries 9 and 10).  However, it was interesting to note that without the 
additional phosphine, Pd(PPh3)4 was a poor catalyst for the reaction (entry 8).   
Clearly, the optimum catalyst for the reaction requires a high degree of 
triphenylphosphine ligation to palladium.  This observation is particularly evident when 
the palladium source is changed to Pd(dba)2.  No cross-coupling occurred (entries 13 and 
14) unless a large excess (5 equiv) of triphenylphosphine was added (entry 15).  The 
addition of further equivalents of phosphine did not improve the yield (entry 16).  More 
importantly, the yield of coupled product was poor compared to the palladium acetate and 
Pd(PPh3)4 systems.     
These results indicate that even though the active catalyst in each case is a 
palladium(0) triphenylphosphine complex, the original ligands on the palladium source 
(OAc, PPh3, dba) play important roles in determining the activity of the catalyst.  
Particularly in the case of Pd(dba)2, the original ligand (dba) may be effectively 
competing with triphenylphosphine for ligation to the metal, thus decreasing the activity 
of the catalyst.  The detrimental effect of dba on palladium(0) catalyst efficiency was 
observed by Amatore and Jutand, and is attributed to the strong binding affinity of the 
dba ligand to the palladium metal.257 In addition, other studies have shown that dba slows 
the oxidative addition of Pd(0) and aryl halides.258 
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After optimizing the conditions for the palladium-catalyzed coupling of 5-
bromotropolone with phenyltrimethoxysilane, attention turned to the preparation of 
functionalized aryl siloxanes that would be more typical tropolone coupling partners for 
colchicine analogue synthesis.  The preparation of functionalized siloxanes is presented 
in Table 2.  All of the selected siloxanes contain highly electron-rich aryl rings, which 
can prove to be difficult substrates for palladium-catalyzed coupling reactions.  
Using (triethoxysilyl)-2,3,4-trimethoxybenzene (Table 2, entry 1) as the coupling 
partner with 5-bromotropolone (IV-16) would give Fitzgerald’s compound (IV-14).  
Entries 2 through 7 would define the scope and limitations of the siloxane coupling 
technology by demonstrating the ability to couple highly substituted electron-rich aryl 
rings.  The siloxanes shown in Table 2 were readily prepared in high yields using either 
ortho-metallation (entries 1,2),57 Grignard (entries 3-6),56 or hydrosilylation (entry 7)58-60  
reactions.  These three methods are complementary, and taken together allow for the 
synthesis of virtually any aryl siloxane (Scheme 8).   
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Table 2.  Synthesis of Siloxanes as Substrates for the Palladium-Catalyzed Coupling 
with Bromotropolone.a 
starting material siloxane yield (%)b
MeO
MeO OMe
MeO
MeO OMe
Si(OEt)3 77
entry
1
3
MeO
MeO
Br MeO
MeO
Si(OEt)3 61
O
O
Br
7
O
O
Si(OEt)3
5
6
MeO
MeO
Br MeO
MeO
Si(OEt)3 66
MeO MeO
BrMeO Si(OEt)3MeO 82
59
a See Experimental Section for details. b Isolated yields of purified product.
methoda
ortho-metallation
Grignard
hydrosilylation
Grignard
Grignard
2
OMe
Br
Me
4
OMe
Si(OEt)3
Me
Si(OEt)3 ortho-metallation
Grignard
62
81
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The next aspect of the study was to investigate the cross-coupling reaction 
between functionalized siloxane substrates and 5-bromotropolone (IV-16).  In addition to 
coupling reactions using aryl siloxanes, we were presented with an opportunity to directly 
compare the coupling efficiency of aryl stannanes and boronic acids with aryl siloxanes.  
Banwell has reported the coupling of a variety of aryl stannanes with bromotropolone,254 
and Nair256 has reported the synthesis of Fitzgerald’s compound (IV-14) using a boronic 
acid coupling.  Using the aryl stannane coupling results of Banwell, and the aryl boronic 
acid and siloxane couplings from our laboratory, a side-by-side comparison of the 
coupling methodologies could be made.  The results of this comparison study are 
presented in Table 3.  In the case of aryl siloxanes, the coupling reaction is tolerant of 
both meta- and para-substituents (entries 1, 2, 4-7).  The coupling of o-methoxy-
substituted siloxanes (entries 3 and 8) failed, however, and no coupling product was 
observed under standard coupling conditions (vide infra). On the other hand, the coupling 
of o-methyl siloxane (entry 4) proceeded smoothly under standard conditions.    
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In general, when the three methodologies are compared, the aryl siloxanes 
provide similar yields to the corresponding boronic acids, while both the siloxanes and 
boronic acids provide superior yields to organostannane reagents.  All three 
methodologies efficiently coupled a simple phenyl group (entry 1), however, the coupling 
of electron-rich substrates proved more problematic for the Stille couplings (entries 2,3, 
5-8).  Notable is the fact that only the boronic acid was able to efficiently provide 
coupled product for the 2,3,4-trimethoxy moiety (Table 3, entry 8), while the Stille 
reaction failed to provide any product,254 and the siloxane coupling required a 
stoichiometric amount of palladium to yield the desired biaryl.    
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Table 3.  Coupling of Aryl Siloxanes with 5-Bromotropolonea 
O
OMe
Br
Ar-M
O
OMe
Ar
entry yield (%)b
1
M
OMeMeO
MeO
2
M
OMe
M
MMeO
MMeO
MeO
3
4
6
7
MO
O
5
MMeO
MeO
MeO
IV-16
M
CH3
Pd (0)
Ar-M
8
M = SnBu3c B(OH)2 Si(OEt)3
98 89 84
53 87 81
31 80 0
- 96 81
60 92 87
57 89 88
59 87 89
0 94d 92e(0)f
a All coupling reactions performed with 5 mol % catalyst unless otherwise noted.  See 
Experimental Section (boronic acid, siloxane) or ref xx (organostannane) for details.  
b Isolated yield of purified product. c Data from ref 254. d ref 255. e Bromotropolone 
premixed with a stoichiometric amount of palladium before addition of the siloxane.  
See experimental section for details.  f Reaction performed with 5 mol % catalyst.  
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The failure of the o-methoxy siloxane to undergo coupling was not unexpected as it had 
been previously observed that siloxanes containing an ortho-methoxy substituent were 
rapidly protodesilylated under the cross-coupling conditions, yielding poor yields of 
coupled product.57  This propensity for protodesilylation could be overcome, to a degree, 
by increasing the catalyst loading to 50 mol % (Scheme 9).57 However, in the case of the 
tropolone ring system, increasing the catalyst loading to 50 mol % failed to provide any 
coupled product and the siloxane underwent quantitative protodesilylation.  In contrast to 
the tropolone coupling, when siloxane IV-23 was coupled with bromobenzene to 
generate biaryl IV-24, good yields of coupled product could be isolated with high catalyst 
loading (see Scheme 9). 
 
 
 
 
 
 
 
 
 
 
 140
Scheme 9 
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The failure of the bromotropolone ring system to couple with o-methoxy 
containing siloxanes is attributed to a slower oxidative addition step for the tropolone 
coupling, thus permitting protodesilylation to consume the siloxane before coupling can 
occur.  In support of this hypothesis, treatment of 5-bromotropolone with a stoichiometric 
amount of the palladium catalyst, followed by the addition of siloxane IV-23 and TBAF, 
gave a 92% yield of the coupled product (Scheme 10).  There are several notable features 
of the coupling reaction under these conditions: the oxidative addition product IV-25 was 
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formed, and upon addition of the siloxane and TBAF, transmetallation occured faster 
than protodesilylation to give Fitzgerald’s compound IV-14.  The isolation and 
characterization of a palladium(0)-aryl halide oxidative addition product has been 
accomplished previously.259-261 In their study, however, Hartwig and coworkers used 
haloarenes as substrates and were able to isolate and fully characterize the product.  No 
studies exist that report the synthesis and characterization of a bromotropolone oxidative 
insertion product such as IV-25.  Thus, we were disappointed when all attempts at 
isolation and characterization of IV-25 were unsuccessful.262  
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 It is plausible that the pre-mixing of the palladium, phosphine, and 5-
bromotropolone is actually allowing time for the formation of Pd(0), and not necessarily 
the formation of the oxidative addition product. In their study of the rates and mechanism 
of formation of zerovalent palladium from Pd(OAc)2 and PPh3, Amatore and Jutand have 
indicated that the reduction of Pd(II) to Pd(0) requires approximately 10-15 min at 60 ˚C 
in THF.263,264 Consequently, if protodesilylation is complete after 10 minutes, then it 
would be expected that no coupled product would be observed.   
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In view of the Amatore results, pre-mixing palladium acetate and 
triphenylphosphine, followed by the simultaneous addition of 5-bromotropolone, aryl 
siloxane IV-22, and TBAF should yield coupled product.  When this experiment was 
conducted, however, the yield of coupled product was low (43%).  This result indicated 
that the slow formation of Pd(0) is indeed allowing significant protodesilylation to occur; 
however, since the yield of coupled product is still low after allowing the formation of 
Pd(0), a slow oxidative addition is also hindering the coupling reaction.    
 Based on our initial observations, we can propose relative rates of reaction for 
several key steps in the catalytic cycle for the coupling of siloxane IV-22 with 
bromotropolone IV-15 (Scheme 11).  The oxidative addition reaction for the catalytic 
cycle (Koa) is the slowest step.  The high yield of coupled product obtained (92%) after 
allowing the Pd catalyst and bromotropolone IV-15 to be pre-mixed (Scheme 10) 
demonstrated that the rate of transmetalation (Ktrans) is much faster than the rate of 
protodesilylation (Kdemet).  Without the pre-mixing of the Pd(0) catalyst and 
bromotropolone IV-15, no coupled product was observed, with the only product being 
protodesilylated siloxane.  Because Ktrans> Kdemet, the lack of coupled product is the result 
of a slow oxidative addition that permits time for all of the siloxane to be protodesilylated 
before any oxidative insertion product is generated.  Therefore, the relative rates for the 
reaction are: Ktrans> Kdemet >> Koa.   
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 An alternative approach to the coupling reaction would be to employ a siloxane 
derived from 5-bromotropolone and 2,3,4-trimethoxybromobenzene as the coupling 
partners (Scheme 12).  However, attempts to prepare the tropolone siloxane IV-26 via 
metallation,56 rhodium-,58,60 or palladium-catalyzed59 silylation were unsuccessful.  
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Additionally, attempts to form the corresponding boronate ester IV-27 using established 
protocols were unsuccessful.265-270  
Scheme 12 
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 CONCLUSION 
In conclusion, these studies of the synthesis of aryl tropolone derivatives have 
allowed for a side-by-side comparison between tin, boron, and silicon cross-coupling 
reagents.  The organoboron and organosilicon reagents were found to couple in 
comparable yields, with the exception of ortho-methoxy containing siloxanes.  Both 
methods produced higher yields of coupled product than the organotin reagents.  Using a 
stoichiometric amount of palladium to overcome a slow oxidative addition step, the 
siloxane coupling to form Fitzgerald’s compound (IV-13) could be realized.  
 
PART 2: Synthesis of the Carbocyclic Framework of Allocolchicine 
 INTRODUCTION 
 Allocolchicine (IV-28) and N-acetyl colchinol-O-methyl ether (NCME) (IV-29) 
possess a 6-7-6 carbocyclic framework, related to the 6-7-7 tricylic system present in 
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colchicine (IV-1).  Like colchicine, allocolchicine (IV-28) displays potent antitumor 
activity.271-278  Importantly, allocolchicine displays diminished cytotoxicity compared to 
colchicine.  This reduced toxicity of the allocolchicinoids has led to an interest in the 
development of synthetic protocols to provide allocolchicine and  its derivatives for 
biological evaluation.271 
OMe
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 Previous Synthetic Work 
 The majority of the synthetic work on allocolchicine has relied on chemical 
degradation of colchicine to provide allocolchicine and its analogues.  This has therefore 
severely limited access to novel derivatives.  Several approaches have been reported for 
the partial synthesis of allocolchicine, or for derivatives.279-283 Additionally, a racemic 
total synthesis has been achieved by Sawyer and Macdonald.284  All of these approaches 
do not facilitate the production of B ring analogues.  It has been demonstrated that the A 
and B rings are required to maintain full biological activity.285-287 However, the B ring 
can be manipulated to generate different analogues that may still retain the antitumor 
activity, while at the same time moderate the toxicity of these compounds.  Accordingly, 
a synthetic approach that would allow for the facile construction of the A, B and C rings, 
while also permitting functionalization of all of the rings, would have great synthetic 
value. 
 146
 Recently, Seitz and coworkers have developed a synthetic approach to seven-
membered heterocylic B ring allocolchicine analogues (Scheme 13).287  The key biaryl 
formation reaction was conducting using a Ziegler-Ullmann reaction between the aryl-
copper reagent IV-30 and aryl iodide IV-31 to generate biaryl IV-32.  This biaryl was 
transformed to a variety of allocolchicinoids IV-33 bearing B ring heteroatom 
substitutions.  These compounds displayed similar biological activity to natural 
allocolchicine.287 
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 Another synthetic approach to allocolchicinoids was developed by Wulff and 
coworkers.288  The key step of this synthesis involved a Diels-Alder/aromatization 
reaction (Scheme 14) in which reaction of diene IV-34 with methyl propiolate (IV-35) 
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followed by aromatication with DDQ provided the allocolchicinoid carbocyclic 
framework in tricycle IV-36.  The protected alcohol is converted asymmetrically through 
a series of steps to the N-acetyl moiety, generating the natural product. 
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 Fagnou and coworkers have developed a formal total synthesis of allocolchicine 
based upon a direct arylation reaction to form the A-C biaryl linkage (Scheme 15).289-291  
The synthesis began with a Sonagashira coupling of alkyne IV-37 with aryl chloride IV-
38 to provide ketone IV-39 in 92% yield.  Ketone IV-39 was subsequently converted 
through a series of steps to MOM-protected alcohol IV-40.  Direct arylation of this 
compound using Pd(OAc)2 and biphenyl phosphine IV-41 gave allocolchicinoid IV-42.  
Deprotection of the TBS ether completed the formal total synthesis of the natural product.  
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 Aryl Siloxane Approach to Allocolchicine 
 We envisioned an approach to allocolchicine that would entail the connection of 
ring A and ring C using an aryl siloxane coupling reaction, followed by either a ring 
expansion of a fluoreneone (IV-43) or phenanthrene (IV-44) intermediate to give the 7-
membered B ring (Scheme 16).  Alternatively, the B ring could be formed via an 
intramolecular nitrile coupling using substrate IV-45.  In all three approaches, the key A-
C ring coupling would be achieved using bromide IV-46 and siloxane IV-47.  These 
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approaches are advantageous because altering the substitution of either the aryl bromide 
or the aryl siloxane coupling partner would generate a wide range of colchicinoid 
derivatives.  Additionally, using the phenanthrene (IV-44) or nitrile (IV-45) pathways 
would allow for the generation of B ring analogues (vide infra).      
Scheme 16 
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 RESULTS AND DISCUSSION 
 Fluorenone Ring Expansion Pathway 
 The first synthetic route that was explored was the two-carbon homologation of 
fluorenone.  The impetus for this study was the report of a two-carbon ring expansion by 
Liao and coworkers.292-294  Tertiary allylic alcohol IV-48 was deprotonated and the 
resulting anion heated, inducing an anionic [1,3] rearrangement to ketone IV-49 (Scheme 
 150
17).  This reaction involved the incorporation of the two ethylene carbons into the 
macrocycle, resulting in a two-carbon ring expansion.      
Scheme 17 
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In an attempt to employ a similar ring expansion in our synthesis of 
allocolchicine, the first task was the synthesis of the fluorenone substrate (Scheme 18).  
Accordingly, bromination of ester IV-50 smoothly generated aryl bromide IV-51.  Under 
palladium (0) cross-coupling conditions, aryl bromide IV-51 was coupled in excellent 
yield with phenyl trimethoxysilane to generate the biaryl IV-52.  Hydrolysis of the ester 
to the acid, followed by conversion to the acid chloride with SOCl2, provided a substrate 
for intramolecular Friedal-Crafts ring closure to generate fluorenone IV-53 in 92% yield.  
Treatment of fluorenone IV-53 with vinylmagnesium bromide led to the formation of 
allylic alcohol IV-54.  When this alcohol was treated under the anionic fragmentation 
conditions developed by Liao,294 only unreacted starting material was recovered.  A wide 
range of solvents, bases, and temperatures were employed to induce 
fragmentation/rearrangement with no success.  It may be that the substrate used by Liao 
possessed sufficient ring strain to promote the fragmentation whereas the alcohol IV-54 
was unstrained.   
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 At this time, we sought other conditions that would facilitate a two-carbon ring 
expansion of the allylic alcohol substrate IV-54.  However, instead of an anionic 
fragmentation, a radical fragmentation was investigated.295-297  Pattenden and Ellwood 
had reported the allylic radical fragmentation of tertiary alcohol IV-55 using 
diacetoxyiodosylbenzene (DIB) to give β-iodoketone IV-56 (Scheme 19).295 DIB 
generated the oxygen radical IV-57, which then fragmented to form carbon radical IV-58 
with concomitant formation of the enone.  The carbon radical attacked the alkene to 
generate the primary radical IV-59.  This radical was captured using iodine to generate 
the β-iodoketone IV-58.   
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 In the fluorenone system, DIB would generate oxygen radical IV-60 (Scheme 20).  
It was then envisioned that fragmentation could occur to generate enone IV-61.  The 
carbon radical could then added via conjugate addition to the enone to provide the seven-
membered ring product IV-62, which would be quenched with iodine to give the α-
iodoketone IV-63.  Treatment of allylic alcohol IV-54 with DIB in refluxing cyclohexane 
provided none of the desired α-iodoketone IV-63.  Instead, an excellent yield of 
fluorenone IV-53 was obtained (Scheme 21).  This product was unexpected as it would 
necessitate the loss of an ethylene radical to generate the ketone.      
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 In an attempt to circumvent the ethylene loss, it was thought that if the alkene was 
changed to an alkyne, the loss of the alkynyl radical should be more disfavored, thus 
favoring the desired reaction pathway.  The preparation of the required alkyne is shown 
in Scheme 22.  Treatment of fluorenone IV-53 with alkynyl magnesium bromide led to 
the formation of propargylic alcohol IV-64 in excellent yield.  Exposure of propargylic 
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alcohol to the radical fragmentation conditions led to the recovery of equimolar amounts 
of starting material IV-64 and fluorenone IV-53, with decomposition of the remainder of 
the starting material. Like the allylic alcohol, the propargyl alcohol fragmented to provide 
fluorenone IV-53.  In the case of the propargyl alcohol, the reaction did not go to 
completion, and it is likely that the generation of a reactive alkynyl radical led to the 
decomposition of the remainder of the starting material, which would explain the poor 
mass balance.   
Scheme 22 
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 Having been unsuccessful in performing a two-carbon ring expansion of 
fluorenone, attention turned to an alternative pathway that would allow for the formation 
of the allocolchicine B ring in a single step.  In order to carry out this transformation, we 
studied the C-H activation/nitrile coupling reaction developed by Larock and 
coworkers.298 
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 Nitrile Coupling 
 The activation of C-H bonds for chemical functionalization is an active area of 
ongoing research.299-301 The ability to directly install chemical groups onto hydrocarbon 
substrates has the potential to provide economical and clean pathways for the synthesis of 
complex molecules.  This transformation is difficult due to the high strength of the C-H 
bond (105-110 kcal/mol).  The use of highly electron-deficient palladium(II) catalysts 
have permitted the functionalization of a wide range of substrates.299 The electron-poor 
palladium, under specific condition, is able to oxidatively insert into the C-H bond and 
thus permit the installation of various functional groups.   
 Recently, Larock and Zhou reported a methodology for the synthesis of aryl 
ketones by a palladium-catalyzed C-H activation followed by carbopalladation of a nitrile 
(Scheme 23).298 This reaction was utilized to generate a range of aryl ketones, both 
intramolecularly (as in Scheme 23) and intermolecularly.  The proposed mechanism for 
this reaction is presented in Scheme 24.  The active catalyst is the palladium(II) 
trifluoroacetate adduct IV-67 that undergoes C-H insertion with the arene to form the aryl 
palladium adduct IV-68.  Following ligand exchange, IV-69 undergoes aryl group 
transfer to the nitrile, forming an imine, which is then lost from the catalyst to regenerate 
IV-67.  The imine can then be hydrolyzed to form the ketone.    
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 Our initial task was to develop of a model system to probe whether intramolecular 
reaction in a biaryl system could be achieved.  Synthesis of the model system is presented 
in Scheme 25.  Alkylation of 2-phenylbenzyl bromide (IV-71) with the lithium salt of 2-
propylnitrile provided gem-dimethyl nitrile IV-72.  Treatment of this nitrile with a 
palladium (II) catalyst in refluxing TFA cleanly provided the intramolecular ring closure 
product IV-73.  During the course of optimization studies, it was discovered that the 
presence of molecular oxygen was vital for the reaction to occur.  If the reaction was 
performed under Ar, or using degassed solvents, no product was obtained.  It is 
hypothesized that oxygen is serving to maintain palladium (II) during the course of the 
reaction. 
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 Having shown that the ring closure was successful in the model, the next task was 
to apply this reaction to the synthesis of the allocolchicine carbocyclic skeleton.  The 
synthesis began with bromination of benzaldehyde IV-74 to provide aryl bromide IV-75.  
Palladium-catalyzed siloxane cross-coupling gave biaryls IV-76 (R = H), and IV-77 (R = 
OMe) in excellent yields.  Reduction of the aldehyde, followed by conversion of the 
resulting alcohol to the bromide and subsequent alkylation generated the cyclization 
precursors IV-82 and IV-83.  Gratifyingly, these compounds cyclized in good yields to 
generate gem-dimethyl allocolchicinoids  IV-84 and IV-85 (Scheme 26).   
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 While this approach allowed facile access to gem-dimethyl allocolchicinoids, our 
goal was to establish the parent allocolchicine framework, which is devoid of gem-
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dimethyl substituents.  We, therefore, sought to perform the nitrile coupling in the 
absence of these groups.  In his studies, Larock was unable to successfully react nitriles 
that did not possess gem-dimethyl groups (vide infra).  However, because our substrate 
was different from those previously studied, it was deemed important to perform the 
cyclization without the gem-dimethyls present.  Starting with biaryl IV-76, Wittig 
olefination gave α-β unsaturated nitile IV-86 in 86% yield.  Selective reduction of the 
alkene with sodium borohydride in methanolic pyridine provided the saturated nitrile IV-
87 in excellent yield.  Disappointingly, all attempts to cyclize nitrile IV-87 led to 
decomposition. 
Scheme 27 
OMe
MeO
MeO
O
H Ph3P
CN
NaOH
CH2Cl2, H2O OMe
MeO
MeO
CN
NaBH4
MeOH, py
OMe
MeO
MeO
CN
Pd(OAc)2
DMSO, TFA
decomposition
IV-76 IV-86
IV-87
86%
94%
 
 The role of the gem-dimethyl groups had been studied by Larock and Pletnev.302 
It was proposed that the gem-dimethyl groups control the orientation of the nitrile 
(Scheme 28).  Without the presence of these groups, the nitrile is not oriented toward the 
palladium, and no productive reaction occurs.  However, when these groups are present, 
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the nitrile, as it is the smallest of the substituents, is oriented directly toward the 
palladium, allowing for the cyclization to proceed.  An alternative reason for the presence 
of the methyl groups is that they prevent the enolization of the nitrile.  Coordination of 
the nitrile (see IV-88 below) would make the α-protons more acidic, potentially leading 
to enolization and competitive side reactions.  However, using deuterium-labeled 
substrates,302 Larock demonstrated that these protons are not abstracted under the reaction 
conditions, and the most likely role for the methyl groups is to control conformation.   
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Carbene Annulation 
 Our final approach to the synthesis of the carbocyclic skeleton of allocolchicine 
was centered upon a one-carbon ring expansion of a functionalized phenanthrene ring 
system.  Joshi and coworkers developed a procedure whereby the 9-10 double bond of 
phenanthrene IV-89 can be selectively reacted with dichlorocarbene to generate 
dichlorocyclopropyl adduct IV-90 (Scheme 29).303  If compound IV-90 is heated neat, 
followed by an aqueous quench, the ring expanded allyic alcohol IV-91 is obtained 
quantitatively.304-306   Oxidation provides the α-chloroenone IV-92.  This compound 
possesses the 6-7-6 ring system of allocolchicine.  We, therefore, sought to develop this 
methodology beyond the simple phenanthrene system, and use it to synthesize the 
unsymmetrical allocolchicine skeleton. 
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 The initial target was allocolchicinoid IV-93.  This compound, lacking the C ring 
ester of natural allocolchicine, has been shown to possess potent antitumor activity.283 
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Retrosynthetically, this compound would be obtained from a ring expansion of 
phenanthrol IV-94, which in turn would be obtained from a siloxane coupling of 
functionalized aryl bromide IV-75 and phenyl trimethoxysilane (Scheme 30).  However, 
as the ring expansion of phenanthrols has received little attention, a model system 
utilizing 9-phenanthrol (IV-95) as substrate was examined.   
Scheme 30 
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 Protection of the hydroxyl of 9-phenanthrol (IV-95) as a MOM group proceeded 
smoothly to provide ether IV-96 (Scheme 31).  Reaction of this compound under 
optimized conditions (CHCl3, 50% NaOH, BnEt3NCl, r. t., 5h), led to the formation of 
the dichlorocyclopropyl adduct IV-97 in excellent yield.  Treatment of compound IV-97 
with dilute acid removed the MOM ether and induced cyclopropane ring cleavage 
providing the ring expanded α-chloroenone IV-92.  Hydrogenation of the chloroenone, 
using conditions developed by Jones and Coburn,304 smoothly generated aryl ketone IV-
98.  
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 The final task remaining was to construct the unsymmetrical allocolchicine 
framework.  Up to now, the ring expansion had been conducted on a simple phenanthrol 
derivative and a synthesis of the full A-B-C ring system of allocolchicine was necessary.  
Accordingly, biaryl IV-76 (obtained via siloxane coupling, see Scheme 26 above), was 
homologated by Wittig reaction, followed by oxidation to acid IV-99 (Scheme 32).  
Friedal-Crafts ring closure generated air sensitive phenanthrol IV-100.  Phenanthrol IV-
100 was oxidized by atmospheric oxygen to generate the 9,10-diketone.307  This 
oxidation was circumvented by immediately protecting the free hydroxyl to provide 
MOM ether IV-94.       
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 Cyclopropanation of MOM ether IV-94 provided dichlorocyclopropyl adduct IV-
101 (Scheme 33).  Ring expansion, presumably occurring via deprotected alcohol IV-
102, proceeded uneventfully to provide α-chloroenone IV-103.  Hydrogenation of enone 
IV-103 gave saturated ketone IV-104.  Reductive amination followed by acylation 
provided the known291 allocolchicinoid IV-93.   
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Having successfully generated the allocolchicine carbocyclic framework, 
attention focused onto functionalization of α-chloroenone IV-92 (Scheme 34).  This 
compound possesses a high degree of functionalization, which could be utilized to 
generate allocolchicine B ring analogues, which have proven difficult to obtain.273,277 
Analogues of allocolchicine are desirable for medicinal studies; however, the generation 
of analogues derived from the natural product are difficult to obtain.  Accordingly, enone 
IV-92 can be hydrogenated to the benzyl alcohol IV-105.  Alternatively, by switching the 
hydrogenation solvent from EtOH to EtOAc,304 hydrogenation can be stopped at the α-
chloroketone, which can be eliminated to generate the Michael acceptor IV-106.    
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The palladium-catalyzed cross-coupling of the chloride moiety of α-chloroenone 
IV-92 was also investigated.  Gratifyingly, when α-chloroenone IV-92 was subjected to 
basic Suzuki coupling conditions,19 a good yield of the coupled product IV-107 was 
obtained.  This result is particularly noteworthy because it constitutes the first example of 
the coupling of an α-chloroenone.  The coupling of iodides and bromides has been 
reported previously,308-316 but there are no examples of the coupling of chlorides.  The 
corresponding aryl siloxane coupling reaction proceeded in a moderate (35%) yield; 
therefore, in this instance the use of an aryl boronic acid is advantageous. 
 The phenanthrene-carbene ring expansion pathway has facilitated the synthesis of 
the full carbocyclic skeleton of allocolchine and its derivatives.  This pathway is based 
upon two key steps.  First, the siloxane coupling reaction to generate the A-C ring biaryl 
bond.  Using a variety of aryl siloxanes as shown in Table 4, allows for the generation of 
a variety of allocolchicine derivatives in excellent yields, including allocolchicine itself 
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(Table 4, entry 4).  Additionally, the generation of an α-chloroenone upon ring expansion 
of the phenanthrol intermediate allowed for extensive modification of the B ring, 
including a novel Suzuki cross-coupling. 
Table 4. Coupling of Substituted Siloxanesa 
CHO
OMe
MeO
MeO
Br
94
entry yieldb
1
2
3
4
a Conditions: 5 % Pd(OAc)2, 25 % PPh3, 1.5 equiv aryl 
siloxane, 1.5 equiv TBAF, THF.  b Isolated yield of purified 
product.
CHO
OMe
MeO
MeO
R
R
H
OMe
Me
CO2Et
93
87
94
 
 
 CONCLUSION 
 Several pathways were explored for the synthesis of allocolchicine and its 
analogues.  Attempts to develop a novel two-carbon ring expansion of a fluorenone 
derivative were unsuccessful.  However, the application of Larock’s nitrile coupling 
reaction has allowed for the synthesis of gem-dimethyl allocolchicinoids.  This 
methodology has the potential to be modified to allow for the synthesis of 
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allocolchicinoids without the gem-dimethyl groups present by utilizing a removable alkyl 
protecting group.   The phenanthrene-carbene ring expansion pathway holds the most 
promise as a useful synthetic route to allocolchicinoids.  When the synthetic utility of the 
α-chloroenone is combined with the flexibility of the aryl siloxane coupling reaction, it is 
possible to selectively functionalize and modify every carbon present in allocolchine; 
thus making it possible to access derivatives that may prove therapeutically useful. 
     
PART 3: Experimental Section 
  
COLCHICINE EXPERIMENTAL SECTION 
 Synthesis of 5-Bromotroplone (IV-16) 
7,7-Dibromo-bicyclo[4.1.0]hept-3-ene (IV-18).  The dibromide was prepared using a 
modified procedure of Hofmann.317  To 300 mL of tert-butyl alcohol was added 10.0 g of 
potassium.  Upon dissolution of all of the potassium, excess alcohol was removed in 
vacuo.  The resulting white potassium tert-butoxide was dried in vacuo for 12 h.  The dry 
potassium tert-butoxide (14.6 g, 130 mmol) was added to 250 mL of pentane.  The 
suspension was cooled to 0 °C and 25.0 mL (260 mmol) of 1,4-cyclohexadiene was 
added.  With stirring, 11.0 mL (130 mmol) of bromoform was added over 30 min at a rate 
to maintain an internal temperature between 0 °C and 5 °C.  The reaction was stirred for 
an additional 30 min at 0 °C followed by the addition of 200 mL of water.  The organic 
layer was separated, and the aqueous fraction extracted with pentane (100 mL x2).  The 
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combined organic extracts were dried (MgSO4) and concentrated in vacuo to give a pale 
yellow oil.  Column chromatography (pentane, TLC Rf = 0.59) yielded colorless crystals 
(60%) mp 36-37 °C (lit. 36.8-37 °C).318 The IR matched that reported by Coates.318  The 
1H NMR and 13C NMR match that reported by Rigby.319 
 
(1α, 3β, 4β, 6α)-4-Acetoxy-7,7-dibromobicyclo[4.1.0]heptan-3-ol (IV-19).  The 
hydroxyacetate was prepared using a modified procedure of Banwell.320 Iodine (4.47 g, 
17.6 mmol) was added over a 30 min period to a stirred mixture of 7,7-Dibromo-
bicyclo[4.1.0]hept-3-ene (4.00 g, 16.0 mmol), and silver acetate (5.34 g, 32.0 mmol) in 
acetic acid (70 mL).  Upon completion of the addition of the iodine, water was added 
(0.288 mL, 16.0 mmol).  The reaction was stirred in the dark for 3 days.  The mixture 
was then filtered through celite and diluted with 100 mL of CH2Cl2.  Water (100 mL) was 
added, followed by solid Na2CO3 until all of the acetic acid had been consumed.  The 
layers were separated and the aqueous layer was washed with 75 mL of CH2Cl2 twice.  
The combined organic layers were washed with successively with saturated NaHCO3 
(100 mL), 20% NaHSO3 (100 mL), water (100 mL), and brine (100 mL), dried with 
MgSO4, and concentrated in vacuo.  Column chromatography (1:1 hexanes/EtOAc, TLC 
Rf = 0.39) yielded a white solid (81%) mp 82.6-83.8 °C (lit. 82-83 °C).320  The IR, 1H 
NMR, and 13C NMR matched that reported by Banwell.320  
 
(1α, 4β, 6α)-4-Acetoxy-7,7-dibromobicyclo[4.1.0]heptan-3-one (IV-20).  The α-
acetoxy ketone was prepared according to a modified procedure of Banwell.320  (1α, 3β, 
4β, 6α)-4-Acetoxy-7,7-dibromobicyclo[4.1.0]heptan-3-ol (3.91 g, 9.50 mmol) was added 
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to 100 mL of CH2Cl2.  Pyridinium chlorochromate (5.11 g, 24.0 mmol) was then added in 
one portion.  The reaction was stirred at room temperature until TLC indicated the all of 
the starting alcohol had been consumed (2 h).  The reaction was concentrated to 1/5 of 
the original volume and 100 mL of ether was added.  The mixture was then filtered 
through  a short pad of silica gel using 500 mL of 1:1 ether/CH2Cl2.  The solvents were 
removed in vacuo to produce a light brown solid.  Column chromatography (3:1 
hexanes/EtOAc, TLC Rf = 0.39) yielded a white solid (90%) mp 119.6-120.3 °C (lit. 118-
120 °C).320  The IR, 1H NMR, and 13C NMR matched that reported by Banwell.320 
 
5-Bromo-2-hydroxycyclohepta-2,4,6-triene-1-one (IV-21).  5-Bromotropolone was 
prepared according to a literature procedure.320    
 
5-Bromo-2-methoxy-cyclohepat-2,4,6-trien-1-one (IV-16).  Dimethyl sulfate (0.283 
mL, 2.99 mmol) was added to a stirred solution of K2CO3 (1.03 g, 7.47 mmol) and 5-
Bromo-2-hydroxycyclohepta-2,4,6-triene-1-one (500 mg, 2.49 mmol) in 10 mL of 90:10 
acetone/water.  The bright yellow suspension was refluxed for 4 h to produce a cloudy 
white mixture.  The acetone was then removed in vacuo and the remaining mixture 
extracted with CH2Cl2 (30 mL x3).  The combined organic extracts were dried (MgSO4) 
and concentrated in vacuo to produce pale yellow needles (89%) mp 136.2-137.0 °C (lit. 
135-137 °C).320  The IR, 1H NMR, and 13C NMR matched that reported by Banwell.320 
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 Synthesis of Aryl Siloxanes for Bromotropolone Couplings 
4-(Triethoxysilyl)-1,2,3-trimethoxybenzene (Table 2, entry 1).  Siloxane was prepared 
according to the ortho-lithiation procedure of DeShong57 and purified by column 
chromatography (TLC Rf = 0.41 4:1 hexanes/EtOAc) to yield a colorless oil (77%).  IR 
(CCl4) 3071 (w), 2978 (s), 2940 (s), 2895 (s), 2836 (m), 1587 (s), 1493 (s), 1455 (s), 
1400 (s), 1293 (s), 1234 (s), 1089 (vs), 958 (s); 1H NMR (CDCl3) δ 1.23 (t, J=7.0, 9H), 
3.87 (q, J=7.0, 6H), 3.83 (s, 3H), 3.85 (s, 3H), 3.91 (s, 3H), 6.65 (d, J=8.4, 1H), 7.27 (d, 
J=8.4, 1H); 13C NMR (CDCl3) δ 18.3, 55.9, 58.6, 60.6, 60.8, 107.4, 116.7, 131.7, 141.5, 
156.2, 158.7; LRMS (FAB+) m/z 331 (M+ +H, 95), 330 (92), 285 (100), 241 (40), 163 
(40); HRMS (EI+) m/z calcd for C18H26O6Si 330.1499, found 330.1513. 
 
2-(Triethoxysilyl)anisole (Table 2, entry 2).  The title compound was synthesized 
according to a published procedure.57 The spectral data match those reported 
previously.57  
 
4-(Triethoxysilyl)-1,2-dimethoxybenzene (Table 2, entry 3).  Siloxane was prepared 
according to the metallation procedure of DeShong.56 Kugelrohr distillation (130 °C, 0.1 
mm Hg) yielded a colorless oil (61%).  IR (CCl4) 3054 (w), 2971 (s), 2936 (s), 2898 (s), 
2833 (m), 1590 (s), 1507 (s), 1466 (m), 1390 (m), 1259 (s), 1114 (vs), 962 (s); 1H NMR 
(CDCl3) δ 1.25 (t, J=7.0, 9H), 3.86 (q, J=7.0, 6H), 3.90 (s, 3H), 3.91 (s, 3H), 6.90 (d, 
J=8.4, 1H), 7.15 (m, 1H), 7.26 (m, 1H); 13C NMR (CDCl3) δ 18.3, 55.7, 55.8, 58.7, 
 172
110.9, 116.8, 122.2, 128.4, 148.6, 150.9; LRMS (FAB+) m/z 300 (M+, 100), 299 (15), 
255 (48), 163 (38); HRMS (EI+) m/z calcd for C14H24O5Si 300.1393, found 300.1385. 
 
2-(Triethoxysilyl)toluene (Table 2, entry 4).  The title compound was synthesized 
according to a published procedure.56 The spectral data match those reported 
previously.56  
 
1-(Triethoxysilyl)-3,4-methylenedioxybenzene (Table 2, entry 5).  The title compound 
was synthesized according to a published procedure.56 The spectral data match those 
reported previously.50 
 
4-(Triethoxysilyl)anisole (Table 2, entry 6).  The title compound was synthesized 
according to a published procedure.56 The spectral data match those reported 
previously.56 
 
5-(Triethoxysilyl)-1,2,3-trimethoxybenzene (Table 2, entry 7).  Siloxane was prepared 
according to the hydrosilylation procedure of Masuda60 using 1-bromo-2,3,4-
trimethoxybenzene, which was prepared according to a literature procedure.254  Title 
compound was isolated as a colorless oil (66%) using column chromatography (TLC Rf = 
0.21, 9:1 hexane/EtOAc). IR (CCl4) 3078 (w), 2974 (s), 2926 (s), 2881 (m), 2836 (w), 
1576 (s), 1500 (m), 1459 (m), 1400 (s), 1307 (s), 1110 (vs), 969 (m); 1H NMR (CDCl3) δ 
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1.27(t, J=7.0, 9H), 3.86 (q, J=7.0, 6H), 3.87s, 3H), 3.89 (s, 6H), 6.88 (s, 2H); 13C NMR 
(CDCl3) δ 18.3, 56.1, 58.8, 60.8, 111.3, 125.8, 140.1, 153.1; LRMS (FAB+) m/z 330 (M+, 
100), 329 (15), 285 (23), 162 (37); HRMS (EI+) m/z calcd for C15H26O6Si 330.1499, 
found 330.1493. 
 
Representative procedure for the palladium-catalyzed cross-coupling of 5-
bromotropolone (IV-16) with aryl siloxanes: 2-Methoxy-5-phenylcyclohepta-2,4,6-
trien-1-one (Table 3, entry 1).  To a 25 mL round bottom flask was added 5-bromo-2-
methoxy-cyclohepat-2,4,6-trien-1-one (104 mg, 0.480 mmol), 10.8 mg Pd(OAc)2 (0.0480 
mmol), 63.0 mg PPh3 (0.240 mmol) and phenyl trimethoxysilane (180 μL, 0.970 mmol).  
The flask was placed under argon and 5 mL of THF was added, followed by 0.970 mL of 
a 1.0 M solution of TBAF in THF (0.970 mmol).  The reaction was refluxed for 12 h.  
Following this time, the reaction mixture was poured into 20 mL of water and extracted 
three times with CH2Cl2  (50 mL).  The organic extracts were combined and dried 
(Na2SO4) and evaporated to produce a dark brown oil.  Column chromatography (TLC Rf 
= 0.38, EtOAc) yielded 86.0 mg of  a light tan solid (84%) mp 139.2-140.4 °C (lit. 140-
141 °C).226  The IR, 1H NMR, and 13C NMR matched that reported by Banwell.226 
 
2-Methoxy-5-(4′-methoxyphenyl)cyclohepta-2,4,6-trien-1-one (Table 3, entry 2).  
Title compound was prepared in a similar manner as described above and was purified 
via column chromatography (TLC Rf = 0.30, EtOAc) to provide 94.0 mg of a light tan 
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solid (81%) mp 148.5-148.9 °C (lit. 151.5-152.0 °C).254 The IR, 1H NMR, and 13C NMR 
matched that reported by Banwell.254 
 
2-Methoxy-5-(2′-methylphenyl)cyclohepta-2,4,6-trien-1-one (Table 3, entry 4).  Title 
compound was prepared in a similar manner as described above and was purified via 
column chromatography (TLC Rf = 0.30, EtOAc) to provide 88.3 mg of a light tan solid 
(81%) mp 110.0-110.5 °C.  IR (CCl4) 3080 (w), 3057 (w), 3020 (w), 2957 (w), 2933 (w), 
2863 (w), 2840 (w), 1632 (m), 1596 (s), 1483 (m), 1248 (s), 1204 (m), 1117(s); 1H NMR 
(CDCl3) δ 2.26 (s, 3H), 3.99 (s, 3H), 6.80 (d, J=10.4, 1H), 7.03 (d, J=10.4, 1H); 7.18 (m, 
1H), 7.26-7.29 (m, 2H), 7.46-7.55 (m, 2H), 7.65-7.70 (m, 1H); 13C NMR (CDCl3) δ 20.2, 
56.3, 112.4, 128.4, 129.1, 130.6, 130.8, 131.9, 132.6, 133.6, 139.3, 142.0, 142.3, 164.5, 
180.1; LRMS (FAB+) m/z 227 (M+, 100), 226 (10), 164 (10); HRMS (EI+) m/z calcd for 
C15H15O2 227.1072, found 227.1081. 
 
2-Methoxy-5-(3′,4′-methylenedioxyphenyl)cyclohepta-2,4,6-trien-1-one (Table 3, 
entry 5).  Title compound was prepared in a similar manner as described above and was 
purified via column chromatography (TLC Rf = 0.30, 4:1 EtOAc/hexanes) to provide 107 
mg of a light tan solid (87%) mp 150-151°C. IR (CCl4) 3081 (w), 3061 (w), 3009 (w), 
2964 (w), 2926 (w), 2850 (w), 1635 (m), 1587 (m), 1507 (m), 1486 (m), 1245 (s), 1121 
(m); 1H NMR (CDCl3) δ 3.98 (s, 3H), 6.02 (s, 2H), 6.81-6.94 (m, 1H), 6.95-6.96 (m, 1H), 
7.19-7.22 (m, 1H), 7.29-7.32 (m, 1H), 7.47-7.50 (m, 2H), 7.68-7.69 (m, 1H); 13C NMR 
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(CDCl3) δ 56.3, 101.5, 107.7, 108.7, 112.8, 121.2, 128.4, 128.6, 130.6, 137.0, 137.9, 
141.4, 148.3, 164.1, 179.8; LRMS (FAB+) m/z 257 (M+, 20), 245 (100), 243 (30), 239 
(20); HRMS (EI+) m/z calcd for C15H13O4 257.0814, found 257.0822. 
 
2-Methoxy-5-(3′,4′-dimethoxyphenyl)cyclohepta-2,4,6-trien-1-one (Table 3, entry 6).  
Title compound was prepared in a similar manner as described above and was purified 
via column chromatography (TLC Rf = 0.30, EtOAc) to provide 115 mg of a light tan 
solid (88%) mp 168.1-168.3 °C (lit. 168-168.5 °C).254 The IR, 1H NMR, and 13C NMR 
matched that reported by Banwell.254 
 
2-Methoxy-5-(3′,4′,5′-trimethoxyphenyl)cyclohepta-2,4,6-trien-1-one (Table 3, entry 
7).  Title compound was prepared in a similar manner as described above and was 
purified via column chromatography (TLC Rf = 0.40, EtOAc) to provide 129 mg of a 
light tan solid (89%) mp 137-138 °C (lit. 138-139 °C).254 The IR, 1H NMR, and 13C 
NMR matched that reported by Banwell.254 
 
2-Methoxy-5-(2′,3′,4′-trimethoxyphenyl)cyclohepta-2,4,6-trien-1-one (IV-14).   To a 
25 mL roundbottom flask was added 50.0 mg (0.233 mmol) of 5-bromotropolone, 225 
mg (0.253 mmol) Pd(OAc)2, and 336 mg (1.28 mmol) PPh3.  The contents of the flask 
were placed under argon and THF (5 mL) was added.  The reaction was refluxed for 15 
min, and 154 mg (0.466 mmol) of 4-(triethoxysilyl)-1,2,3-trimethoxybenzene (IV-23) in 
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2.0 mL of THF was added via syringe, followed by 0.466 mL of TBAF (1.0 M in THF, 
0.466 mmol).  The reaction was maintained at reflux for a further 30 min, poured into 
water (50 mL) and extracted three times with 50 mL of CH2Cl2.  The organic extracts 
were dried (MgSO4) and evaporated.  Column chromatography (TLC Rf = 0.21 EtOAc) 
yielded 70.4 mg of a light tan powder (92%) mp 116-117 °C (lit. 112-117°C).254 The IR, 
1H NMR, and 13C NMR matched that reported by Banwell.254 
 
2,3,4-Trimethoxybiphenyl (IV-24).  4-(Triethoxysilyl)-1,2,3-trimethoxybenzene (IV-
23) (496 mg, 1.50 mmole), bromobenzene (157 mg, 1.00 mmol), Pd(OAc)2 (112 mg, 
0.500 mmol), and PPh3 (262 mg, 1.00 mmol) were combined in a 25 mL round bottom 
flask and placed under argon.  THF (10 mL) was added, followed by 1.50 mL (1.50 
mmol) of TBAF (1.0 M in THF).  The reaction was heated to reflux for 1 h.  The reaction 
mixture was cooled to room temperature and diluted with ether (20 mL).  The organic 
layer was washed with water (20 x2), dried (MgSO4), and evaporated to yield a brown 
oil.  Column chromatography (TLC Rf = 0.31, 9:1 Hexanes/EtOAc) yielded a yellow oil 
which was recrystallized (hexane) to give 171 mg of a white solid (70%) mp 47.2-47.9 °C 
(lit. 46-47 °C).224 The 1H, and 13C NMR, and IR match that reported by Banwell.224 
 
Representative procedure for the palladium-catalyzed cross-coupling of 5-
bromotropolone (IV-16) with aryl boronic acids: 2-Methoxy-5-(2′-
methoxyphenyl)cyclohepta-2,4,6-trien-1-one (Table 3, entry 3).  2-Bromoanisole (748 
mg, 4.00 mmol) was added to a suspension of Mg (107 mg, 4.40 mmol) in 10 mL of 
 177
THF.  The reaction mixture was heated to reflux until all of the aryl bromide had been 
consumed (3 h).  After cooling to -78 °C, the aryl Grignard reagent was transferred via 
cannula to a -78 °C solution of trimethyl borate (538 μL, 4.80 mmol) in 15 mL of THF.  
The reaction mixture was allowed to warm to room temperature overnight, at which time 
the yellow solution was poured into 50 mL of 1M HCl.  The aqueous layer was extracted 
three times with 40 mL of ether.  The combined ether extracts were washed with three 50 
mL portions of 1M NaOH.  The combined basic extracts were acidified with 2 M HCl.  
The boronic acid was then extracted into CH2Cl2, dried (MgSO4) and the solvent 
evaporated to provide the boronic acid as a white solid which was used without further 
purification in the coupling reaction   
   The palladium-catalyzed cross-coupling reaction is a modified procedure of 
Nair.256 To a 50 mL round bottom flask was added 5-bromo-2-methoxy-cyclohepat-2,4,6-
trien-1-one (IV-16) (215 mg, 1.00 mmol) and 57.8 mg Pd(PPh3)4 (0.05 mmol).  The flask 
was placed under an Ar atmosphere and 10 mL of toluene was added.  The boronic acid 
(228 mg, 1.50 mmol), dissolved in 1.5 mL of EtOH, was added by syringe, followed by 
1.50 mL of a 2.0 M Na2CO3 solution.  The reaction mixture was refluxed for 5 h to 
consume all of the aryl bromide.  The reaction was cooled to room temperature and 5 
drops of 20 % H2O2 was added and the mixture was stirred for a further hour.  Following 
this time, the reaction mixture was poured into 20 mL of water and extracted three times 
with CH2Cl2 (50 mL).  The organic extracts were combined, dried (Mg2SO4), and 
evaporated to produce a dark brown oil. Purification via column chromatography (TLC 
Rf = 0.27, EtOAc) provided 194 mg (80%) of the title compound as a pale yellow oil.  
The IR, 1H NMR, and 13C NMR matched that reported by Banwell.254 
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ALLOCOLCHICINE EXPERIMENTAL SECTION 
 
CROSS COUPLING REACTIONS 
2-Bromo-3,4,5-trimethoxy-benzaldehyde (IV-75).  Title compound was prepared 
according to the procedure of Fukuyama.321  The 1H, and 13C NMR, and IR match that 
reported by Fukuyama.321  
 
Methyl 2-bromo-3,4,5-trimethoxybenzoate (IV-51).  Title compound was prepared 
according to the procedure for compound (IV-75) above. Column chromatography (TLC 
Rf = 0.44, 1:1 hexanes/EtOAc) yielded a light yellow solid, which was recrystallized 
(ether/pentane) to provide 2.34 g of white needles (87%) mp 34.0-35.0 °C.  IR (CCl4) 
3009 (s), 2936 (s), 2909 (s), 2847 (m), 1742 (s), 1486 (s), 1341 (s), 1224 (s), 1114 (s); 1H 
NMR (CDCl3) δ 3.89 (s, 6H), 3.93 (s, 3H), 3.94 (s, 3H), 7.16 (s, 1H); 13C NMR (CDCl3) 
δ 52.5, 56.2, 61.0, 61.2, 109.6, 110.0, 127.4, 146.0, 151.5, 152.3, 166.5; LRMS (FAB+) 
m/z 305 (M+ + H, 100), 304 (M+, 60), 273 (30), 226 (55); HRMS (FAB+, M+) m/z calcd 
for C11H13O5Br 303.9946, found 303.9949.   
 
6-Carbomethoxy-2,3,4-trimethoxy-biphenyl (IV-52).  Tetrakis(triphenylphosphine) 
palladium (116 mg, 0.100 mmol) was added to 305 mg (1.00 mmol) of methyl-2-bromo-
3,4,5-trimethoxybenzoate in a 50 mL round bottom flask.  The flask was placed under 
argon and 10 mL of THF was added.  Phenyltrimethoxysilane (373 μL, 2.00 mmol) was 
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added to the solution, followed by 2.00 mL of a 1.0 M solution of TBAF in THF (2.00 
mmol).  The pale yellow solution was heated to reflux for 12 h.  The reaction was cooled 
to room temperature, poured through a short pad of silica gel, and diluted with ether (20 
mL).  The organic layer was washed with water (20 mL x2), dried, and evaporated to 
yield a brown oil.  Column chromatography (TLC Rf = 0.31, 4:1 hexanes/EtOAc) yielded 
281 mg of a white solid (93%) mp 67.2-67.8 °C.  IR (CCl4) 3065 (w), 3002 (w), 2940 
(m), 2836 (w), 1718 (s), 1593 (m), 1486 (m), 1435 (m), 1397 (m), 1335 (s), 1224 (m), 
1134 (m), 1100 (s), 1045 (m), 1007 (m); 1H NMR (CDCl3) δ 3.54 (s, 3H), 3.57 (s, 3H), 
3.94 (s, 3H), 3.96 (s, 3H), 7.22-7.26 (m, 3H), 7.37-7.38 (m, 3H); 13C NMR (CDCl3) δ 
51.9, 56.1, 59.9, 60.0, 108.9, 126.4, 126.9, 127.6, 129.3, 130.7, 136.7, 145.3, 151.5, 
152.3, 168.1; LRMS (FAB+) m/z 302 (M+, 100), 271 (79), 256 (20); HRMS (FAB+, M+) 
m/z calcd for C17H20O5 302.1154, found 302.1148.   
 
6-Carbaldehyde-2,3,4-trimethoxy-biphenyl (IV-76).  To a 250 mL round bottom flask 
was added 2-bromo-3,4,5-trimethoxybenzaldehyde (5.00 g, 18.2 mmol), Pd(OAc)2 (204 
mg, 0.910 mmol),  and PPh3 (1.19 g, 4.55 mmol).  The flask was placed under argon and 
100 mL of THF was added via syringe.  Phenyltrimethoxysilane (6.75 mL, 36.4 mmol) 
was added to the yellow solution, followed by 36.4 mL of a 1.0 M solution of TBAF in 
THF (36.4 mmol).  The reaction was heated to reflux for 18 h, at which time, the reaction 
was cooled to room temperature, poured through a short pad of silica gel, and diluted 
with ether (100 mL).  The organic layer was washed with water (100 mL x2), dried 
(MgSO4), and evaporated to yield a yellow oil.  Column chromatography (TLC Rf = 0.24, 
9:1 hexanes/EtOAc) yielded 4.66 g of a white solid (94%) mp 91.2-92.4 °C.  IR (CCl4) 
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3085 (w) 3067 (w), 3009 (w), 2960 (m), 2933 (m), 2857 (m), 1683 (s), 1587 (m), 1328 
(s), 1193(m), 1141 (s), 1096 (s); 1H NMR (CDCl3) δ 3.59 (s, 3H), 3.94 (s, 3H), 3.99 (s, 
3H), 7.30-7.35 (m, 3H), 7.42-7.43 (m, 2H), 9.63 (s, 1H); 13C NMR (CDCl3) δ 56.6, 61.4, 
61.5, 105.6, 110.2, 127.5, 128.1, 123.3, 128.4, 129.9, 130.1, 131.4, 133.2, 191.8; LRMS 
(FAB+) m/z 273 (M+ + H, 100), 272 (80), 255 (42), 230 (24), 214 (19), 151 (18), 135 
(24), 119 (25), 85 (29), 55 (34), 43 (25); HRMS (FAB+, M+) m/z calcd for C16H16O4 
272.1049, found 272.1045. 
 
6-Carbaldehyde-2,3,4,4′-tetramethoxy-biphenyl (IV-77).  Title compound was 
prepared according to the cross-coupling procedure for biaryl IV-76.  Column 
chromatography (TLC Rf = 0.25, 4:1 hexanes/EtOAc) yielded a pale yellow oil.  
Recrystallization (hexane/EtOAc) provided 5.12 g of a white solid (93%) mp 68.0-69.0 
°C.  IR (CCl4) 3002 (m), 2954 (s), 2933 (s), 2874 (s), 2853 (m), 2836 (m), 1745 (s), 1690 
(s), 1587 (s), 1480 (s), 1462 (s), 1331 (s), 1252 (s), 1152 (s), 1100 (s); 1H NMR (CDCl3) 
δ 3.60 (s, 3H), 3.87 (s, 3H), 3.96 (s, 3H), 4.00 (s, 3H), 6.98 (d, J=8.8, 2H), 7.25 (d, J=8.8, 
2H), 7.35 (s, 1H), 9.68 (s, 1H); 13C NMR (CDCl3) δ 55.3, 56.1, 61.0, 61.1, 105.2, 113.5, 
124.8, 129.9, 132.2, 134.3, 147.7, 151.3, 152.9, 159.4, 191.5; LRMS (FAB+) m/z 303 
(M+ + H, 100), 302 (65), 285 (20); HRMS (FAB+, M+) m/z calcd for C17H18O5 302.1154, 
found 302.1154. 
 
6-Carbaldehyde-4′-methyl-2,3,4-trimethoxy-biphenyl (Table 4, entry 3).  Title 
compound was prepared according to the cross-coupling procedure for biaryl IV-76.  
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Column chromatography (TLC Rf = 0.23, 9:1 hexanes/EtOAc) yielded 4.53 g of a white 
solid (87%) mp 58.0-59.0 °C.  IR (CCl4) 3087 (w), 3054 (w), 3007 (m), 2967 (m), 2937 
(s), 2856 (m), 1689 (s), 1586 (s), 1482 (s), 1331 (s), 1137 (s), 1097 (s), 1004 (s); 1H NMR 
(CDCl3) δ 2.43 (s, 3H), 3.61 (s, 3H), 3.96 (s, 3H), 4.00 (s, 3H), 7.21 (d, J=8.0, 2H), 7.25 
(d, J=8.0, 2H), 7.36 (s, 1H), 9.66  (s, 1H); 13C NMR (CDCl3) δ 21.3, 56.0, 56.1, 61.1, 
105.1, 128.7, 129.7, 129.8, 130.9, 134.6, 137.7, 147.6, 151.2, 153.0, 191.5; LRMS (EI+) 
m/z 286 (M+, 100), 271 (20), 129 (20); HRMS (FAB+, M+) m/z calcd for C17H18O4 
286.1205, found 286.1205. 
 
6-Carbaldehyde-4′-carboethoxy-2,3,4-trimethoxy-biphenyl (Table 4, entry 4).  Title 
compound was prepared according to the cross-coupling procedure for biaryl IV-76.  
Column chromatography (TLC Rf = 0.28, 4:1 hexanes/EtOAc) yielded 5.89 g of a 
colorless oil (94%).  IR (CCl4) 3004 (w), 2979 (m), 2939 (m), 2841 (m), 1711 (s), 1679 
(s), 1588 (s), 1319 (s), 1268 (s), 1145 (s), 1086 (s), 1000 (s); 1H NMR (CDCl3) δ 1.41 (t, 
J=7.2, 3H), 3.58 (s, 3H), 3.95 (s, 3H), 3.99 (s, 3H). 4.40 (q, J=7.2, 2H), 7.24 (s, 1H), 7.40 
(d, J=8.0, 2H), 8.11 (d, J=8.0, 2H), 9.61 (s, 3H); 13C NMR (CDCl3) δ 14.4, 29.0, 56.2, 
61.1, 61.2, 105.5, 129.2, 129.5, 130.1, 131.1, 133.3, 137.8, 147.7, 151.0, 153.5, 166.3, 
190.6; LRMS (FAB+) m/z 345 (M+ + H, 100), 327 (55), 299 (30), 55  (30); HRMS 
(FAB+, M+) m/z calcd for C19H20O6 344.1260, found 344.1275. 
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FLUORENONE RING EXPANSION 
3,4,5-Trimethoxy-2-phenyl-benzoic acid.  6-Carbomethoxy-2,3,4-trimethoxy-biphenyl 
(500 mg, 1.65 mmol) and NaOH (330 mg, 8.27 mmol) were heated in a 1:1 mixture of 
THF and water (40 mL) to 90 °C for 24 h.  At the conclusion of this time, the THF was 
evaporated, and the aqueous mixture was washed with Et2O (20 mL x2).  The aqueous 
layer was acidified, inducing the formation of a white precipitate.  The precipitate was 
collected via filtration and washed thoroughly with water.  The resulting white powder 
was dried in vacuo to provide 399 mg of the title compound (84%) mp 198.2-199.1 °C.  
IR (neat) 3082 (w), 2978 (w) 2932 (w) 2900 (s), 1671 (s), 1583 (m), 1552 (m), 1319 (s), 
1085 (s); 1H NMR (CDCl3) δ 3.52 (s, 3H), 3.91 (s, 3H), 3.94 (s, 3H), 7.21-7.24 (m, 2H), 
7.31-7.36 (m, 4H); 13C NMR (CDCl3) δ 56.6, 61.4, 61.5, 110.2, 124.9, 127.5, 128.1, 
129.9, 132.1, 136.7, 146.6, 152.0, 152.7, 171.5; LRMS (FAB+) m/z 289 (M+ + H, 100), 
288 (M+, 95), 271 (95), 256 (40), 154 (50), 119 (70); HRMS (FAB+, M+) m/z calcd for 
C16H16O5 288.0998, found 288.0992. 
  
2,3,4-Trimethoxy-9H-fluoren-9-one (IV-53).  3,4,5-Trimethoxy-2-phenyl-benzoic acid 
(200 mg, 0.700 mmol) was brought to a gentle reflux in 3 mL of SOCl2 for 1 h.  The re-
orange solution was evaporated to dryness, and dried for a further hour in vacuo.  The 
acid chloride was dissolved in 6 mL of benzene and the solution was added to 467 mg 
(3.50 mmol) of AlCl3 in 3 mL of benzene at 5 °C.  The reaction immediately turned dark 
green.  The reaction mixture was stirred for a further 10 min, then quenched with ice and 
extracted with Et2O (50 mL x3).  The organic extracts were combined and washed with 
 183
sat. aq. NaHCO3 and water, dried (MgSO4), and evaporated to yield 179 mg of an orange 
solid (95%) mp 108.2-108.7 °C. IR (CCl4) 3071 (w), 3005 (m), 2960 (m), 2940 (m), 2867 
(w), 2840 (w), 1718 (s), 1597 (m), 1455 (s), 1314 (s), 1134 (s);  1H NMR (CDCl3) δ 3.89, 
(s, 3H), 3.94 (s, 3H), 3.99 (s, 3H), 7.05 (s, 1H), 7.17 (t, J=7.6, 1H), 7.41 (t, J=7.6, 1H), 
7.55 (d, J=7.2, 1H), 7.66 (d, J=7.2, 1H); 13C NMR (CDCl3) δ 56.4, 60.7, 61.1, 104.3, 
122.9, 123.9, 127.7, 129.8, 130.0, 134.2, 134.9, 143.4, 148.0, 149.4, 154.5, 193.2; LRMS 
(FAB+) m/z 271 (M+ + H, 100), 270 (M+, 60), 219 (25), 147 (15), 73 (30); HRMS (FAB+, 
M+) m/z calcd for C16H14O4 270.0892, found 270.0882. 
 
2,3,4-Trimethoxy-9-vinyl-9H-fluoren-9-ol (IV-54).  2,3,4-Trimethoxy-9H-fluoren-9-
one (135 mg, 0.500 mmol) was dissolved in 10 mL of THF.  Vinylmagnesium bromide 
(0.750 mL, 0.75 mmol, 1.0 M in THF) was added dropwise.  The reaction was brought to 
reflux for 1 h.  The solution was cooled to room temperature and diluted with 60 mL of 
ether and poured into 50 mL of sat. aq.  NH4Cl.  The organic layer was separated and the 
aqueous solution was extracted twice with 50 mL of ether.  The combined organic 
extracts were dried (MgSO4), and evaporated to yield a yellow oil.  Column 
chromatography (TLC Rf = 0.21, 4:1 hexanes/EtOAc) yielded 135 mg of a white solid 
(91%) mp 104.0-105.0 °C.  IR (CCl4) 3305 (s), 3040 (w), 2967 (w), 2921 (m), 2827 (w), 
1593 (m), 1453 (m), 1354 (s), 1313 (s), 1137 (s), 1090 (s), 997 (s); 1H NMR (CDCl3) δ 
2.13 (s, 1H), 3.89 (s, 3H), 3.90 (s, 3H), 4.01 (s, 3H), 5.20-5.23 (m, 1H), 5.54-5.59 (m, 
1H), 5.88-5.95 (m, 1H), 6.80 (s, 1H), 7.21-7.24 (m, 1H), 7.31-7.37 (m, 2H), 7.83 (d, 
J=7.2, 1H);  13C NMR (CDCl3) δ 56.3, 60.7, 61.1, 82.6, 103.7, 113.5, 122.6, 123.9, 
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124.8, 126.7, 129.4, 138.6, 139.1, 142.9, 143.9, 147.4, 149.3, 154.2; LRMS (EI+) m/z 298 
(M+, 100), 271 (25), 267 (18); HRMS (EI+, M+) m/z calcd for C18H18O4  298.1205, found 
298.1216. 
 
9-Ethynyl-2,3,4-trimethoxy-9H-fluoren-9-ol (IV-64).  2,3,4-Trimethoxy-9H-fluoren-9-
one (150 mg, 0.550 mmol) was dissolved in 5 mL of THF.  The orange solution was 
cooled to 0 °C and 1.65 mL (0.825 mmol, 0.5 M solution in THF) of ethynylmagnessium 
bromide was added dropwise.  The reaction was stirred at room temperature for 2 h, then 
reflux for 1 h.  The solution was cooled to room temperature and diluted with 40 mL of 
ether and poured into 20 mL of sat. aq.  NH4Cl.  The organic layer was separated and the 
aqueous solution was extracted twice with 25 mL of ether.  The combined organic 
extracts were dried (MgSO4), and evaporated to yield a yellow oil.  Column 
chromatography (TLC Rf = 0.13, 4:1 hexanes/EtOAc) yielded 155 mg of a white solid 
(95%) mp 134.2-134.9 °C.  IR (CCl4) 3605 (m), 3309 (s), 3074 (w), 3002 (w), 2964 (m), 
2933 (s), 2857 (w), 2836 (w), 1459 (m), 1355 (s), 1317 (m), 1134 (s), 1003 (s);  1H NMR 
(CDCl3) δ 2.50 (s, 1H), 2.56 (s, 1H), 3.90 (s, 3H), 3.94 (s, 3H), 4.02 (s, 3H), 7.07 (s, 1H), 
7.25-7.29 (m, 1H), 7.36-7.37 (m, 1H), 7.64 (d, J=7.6, 1H), 7.82 (d, J=7.6, 1H); 13C NMR 
(CDCl3) δ 56.3, 60.7, 61.0, 71.5, 74.7, 83.9, 103.6, 122.7, 123.7, 124.6, 127.2, 130.1, 
138.2, 142.2, 143.4, 146.1, 149.3, 154.5; LRMS (FAB+) m/z 296 (M+, 70), 279 (100), 
271 (20); HRMS (FAB+, M+) m/z calcd for C18H16O4  296.1049, found 296.1055. 
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NITRILE COUPLING REACTIONS 
 Model System  
2-(2,2-Dimethyl-propanenitrile)-biphenyl (IV-72).  To a cooled (-78 °C) colorless 
solution of 272 μL (1.94 mmol) of diisoproyl amine in 10 mL of THF was added 2.27 
mL of a 0.90 M solution of n-BuLi in hexanes (2.04 mmol).  After 5 min, 2-
propanenitrile (164 μL, 1.69 mmol) was added via syringe to the pale yellow solution.  
The yellow solution was stirred at -78 °C for 1 h, at which time 370 μL (2.02 mmol) of 2-
phenylbenzylbromide in 4 mL of THF was added dropwise.  The stirred solution changed 
color from yellow, to red, to brown during the addition.  The reaction was allowed to 
warm to room temperature and stirred for 12 h, at which time the reaction was poured 
into a saturated solution of NH4Cl and extracted with ether (30 mL x3).  The combined 
organic phases were dried (MgSO4), and evaporated to yield a yellow oil.  Column 
chromatography (TLC Rf = 0.17, 19:1 hexanes/EtOAc) yielded 395 mg of a white solid 
(99%) mp 65.0-66.0 °C.  IR (CCl4) 3064 (w), 3026 (w), 2978 (m), 2929 (w), 2232 (w), 
1483 (m), 1466 (m); 1H NMR (CDCl3) δ 1.07 (s, 6H), 2.98 (s, 2H), 7.26-7.28 (m, 3H), 
7.33-7.41 (m, 5H), 7.56-7.57 (m, 1H); 13C NMR (CDCl3) δ 26.6, 34.0, 41.7, 125.1, 127.0, 
127.2, 127.5, 128.2, 129.9, 130.5, 130.8, 133.2, 141.6, 143.1; LRMS (EI+) m/z 235 (M+, 
30), 167 (100), 165 (34); HRMS (EI+, M+) m/z calcd for C17H17N  235.1361, found 
235.1355. 
 
6,6-Dimethyl-5H-dibenzo[a,c]cycloheptan-5-one (IV-73).  A 50 mL round bottom 
flask was charged with 47.0 mg (0.200 mmol) of 2-(2,2-dimethyl-propanenitrile)-
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biphenyl and 6.70 mg (30.0 μmol) of Pd(OAc)2.  Trifluoracetic acid (5 mL) was added, 
followed by 0.200 mL of DMSO.  The reaction was heated to reflux for 12 h open to the 
atmosphere.  Water (15 mL) was added and the reaction heated to 70 °C for 2 h, cooled to 
room temperature, and extracted with ether (20 mL x3).  The combined organic extracts 
were dried (MgSO4), and evaporated to yield a yellow oil.  Column chromatography 
(TLC Rf = 0.39, 9:1 hexanes/EtOAc) yielded 46.8 mg of a pale yellow oil (99%).  IR 
(CCl4) 3071 (w), 3023 (w), 2964 (m), 2926 (m), 2857 (m), 1687 (s), 1476 (m), 1200 (m); 
1H NMR (CDCl3) δ 1.21 (s, 6H), 2.83 (s, 2H), 7.20-7.45 (m, 7H), 7.52-7.56 (m, 1H); 13C 
NMR (CDCl3) δ 25.1, 44.1, 53.9, 127.6, 127.7, 127.9, 128.0, 128.5, 129.2, 129.9, 131.2, 
136.9, 138.2, 138.7, 139.8, 212.2; LRMS (FAB+) m/z 236 (M+, 50), 179 (55), 154 (100), 
136 (80), 89 (40); HRMS (FAB+, M+) m/z calcd for C17H16O  236.2140, found 236.2129. 
 
 Phenyl System 
2,3,4-Trimethoxy-6-(methanol)-biphenyl (IV-78).  Sodium borohydride (45.4 mg, 1.2 
mmol) was added in small portions at 0 °C to a stirred solution of 6-carbaldehyde-2,3,4-
trimethoxy-biphenyl (272 mg, 1.00 mmol) in 4 mL of MeOH.  The reaction was stirred at 
room temperature overnight to consume all of the aldehyde, at which time, the reaction 
was poured into 20 mL of cold 1M HCl and extracted with ether (30 mL x3).  The 
combined organic extracts were dried (MgSO4), and evaporated to yield a yellow oil.  
Column chromatography (TLC Rf = 0.39, 1:1 hexanes/EtOAc) yielded 273 mg of a white 
solid (99%) mp 82.0-83.0 °C.  IR (CCl4) 3613 (m), 3065 (w), 2999 (m), 2964 (m), 2933 
(s), 2840 (m), 1604 (m), 1490 (s), 1404 (s), 1335 (s), 1145 (s), 1107 (s); 1H NMR 
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(CDCl3) δ 3.60 (s, 3H), 3.91 (s, 3H), 3.93 (s, 3H), 4.39 (s, 2H), 6.91 (s, 1H), 7.25-7.27 
(m, 2H), 7.36-7.43 (m, 3H); 13C NMR (CDCl3) δ 56.0, 60.9, 61.0, 63.1, 106.9, 127.2, 
128.1, 129.9, 134.5, 135.9, 141.5, 151.3, 152.9; LRMS (EI+) m/z 274 (M+, 100), 241 
(40), 199 (25), 115 (25); HRMS (EI+, M+) m/z calcd for C16H18O4  274.1205, found 
274.1213. 
 
2,3,4-Trimethoxy-6-(bromomethyl)-biphenyl (IV-80).  Phosphorous tribromide (38.0 
μL, 0.410 mmol) in 1 mL of CH2Cl2 was added dropwise to a cold (0 °C), stirred solution 
of 2,3,4-trimethoxyl-6-(methanol)-biphenyl (150 mg, 0.550 mmol) in 3 mL of CH2Cl2.  
The reaction was stirred for 45 min at 0 °C, at which time the solution was poured into 
ice water and extracted with CH2Cl2 (20 mL x2).  The combined organic extracts were 
dried (MgSO4), and evaporated to yield a yellow oil.  Column chromatography (TLC Rf 
= 0.40, 4:1 hexanes/EtOAc) yielded 180 mg of a white solid (97%) mp 96.0-97.0 °C.  IR 
(CCl4) 3058, (w), 3002 (m), 2957 (m), 2937 (m), 2837 (m), 1608 (m), 1480 (s), 1401 (s), 
1352 (s); 1H NMR (CDCl3) δ 3.59, (s, 3H), 3.92 (s, 3H), 3.93 (s, 3H), 4.27 (s, 2H), 6.83 
(s, 1H), 7.26-7.44 (m, 5H); 13C NMR (CDCl3) δ 32.6, 56.1, 60.9, 61.0, 109.1, 127.4, 
128.1, 129.8, 129.9, 131.2, 135.5, 142.6, 151.4, 152.9; LRMS (FAB+) m/z 337 (M+ + H, 
15), 257 (100), 242 (50), 226 (45); HRMS (FAB+, M+) m/z calcd for C16H17O3Br  
336.0361, found 336.0351. 
 
2,3,4-Trimethoxy-6-(2,2-dimethyl-propanenitrile)-biphenyl (IV-82).  Title compound 
was prepared from 2,3,4-trimethoxyl-6-(bromomethyl)-biphenyl using the procedure for 
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IV-72.  Column chromatography (TLC Rf = 0.34, 4:1 hexanes/EtOAc) yielded 543 mg of 
a white solid (99%) mp 79.0-80.0 °C.  IR (CCl4)  3064 (w), 3030 (w), 2980 (s), 2933 (s), 
2870 (w), 2843 (w), 2238 (m), 1602 (m), 1492 (s), 1405 (s), 1097 (s); 1H NMR (CDCl3) 
δ 1.10 (s, 6H), 2.72 (s, 2H), 3.56 (s, 3H), 3.92 (s, 3H), 3.94 (s, 3H), 7.02 (s, 1H), 7.17-
7.19 (m, 2H), 7.38-7.40 (m, 3H); 13C NMR (CDCl3) δ 26.7, 33.9, 41.9, 56.0, 60.8, 60.9, 
109.2, 125.5, 126.9, 127.9, 129.7130.2, 130.9, 136.6, 141.3, 151.3, 152.5; LRMS (EI+) 
m/z 325 (M+, 85), 257 (100), 242 (90), 226 (90); HRMS (EI+, M+) m/z calcd for 
C20H23O3N  325.1678, found 325.1685. 
 
1,2,3-Trimethoxy-6,6-dimethyl-5H-dibenzo[a,c]cycloheptan-5-one (IV-84).  Title 
compound was obtained via palladium-catalyzed cyclization of 2,3,4-trimethoxy-6-(2,2-
dimethyl-propanenitrile)-biphenyl using an identical procedure to compound IV-73, 
except the reaction was refluxed for 36 h to consume all of the nitrile.  Column 
chromatography (TLC Rf = 0.31, 4:1 hexanes/EtOAc) yielded 58.0 mg of a white solid 
(89%) mp 111.0-112.0 °C.  IR (CCl4) 3064 (w), 2960 (m), 2933 (s), 2860 (w), 2833 (w), 
1689 (s), 1596 (s), 1338 (s), 1111 (s); 1H NMR (CDCl3) δ 1.14 (s, 3H), 1.22 (s, 3H), 2.34 
(d, JAB=13.6), 3.05 (d, JAB=13.6), 3.51 (s, 3H), 3.90 (s, 6H), 6.55 (s, 1H), 7.35-7.39 (m, 
2H), 7.47-7.51 (m, 1H), 7.58-7.60 (m, 1H); 13C NMR (CDCl3) δ 21.6, 28.0, 44.6, 54.1, 
56.1, 61.0, 61.2, 108.9, 124.3, 127.1, 127.2, 129.9, 130.4, 133.3, 133.5, 140.2, 141.6, 
151.9, 152.7, 212.6; LRMS (FAB+) m/z 326 (M+, 100), 269 (40), 135 (25), 85 (20); 
HRMS (FAB+, M+) m/z calcd for C20H22O4  326.1518, found 326.1510. 
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 p-OMe System 
2,3,4,4′-Tetramethoxy-6-(methanol)-biphenyl (IV-79).  Title compound was prepared 
in an identical manner as alcohol IV-78.  Column chromatography (TLC Rf = 0.32, 1:1 
hexanes/EtOAc) yielded 261 mg of a white solid (86%) mp 81.0-82.0 °C.  IR (CCl4) 
3613 (m), 3002 (w), 2957 (m), 2937 (m), 2902 (w), 2833 (m), 1597 (m), 1494 (s), 1245 
(s); 1H NMR (CDCl3) δ 3.60 (s, 3H), 3.86 (s, 3H), 3.91 (s, 3H), 3.93 (s, 3H), 4.42 (s, 2H), 
6.90 (s, 1H), 6.96 (d, J=8.4, 2H), 7.18 (d, J=8.4, 2H); 13C NMR (CDCl3) δ 55.2, 56.0, 
60.9, 61.0, 63.2, 106.9, 113.6, 127.8, 128.0, 131.0, 134.7, 141.2, 151.3, 153.4, 158.7; 
LRMS (EI+) m/z 304 (M+, 100), 287 (80), 256 (50); HRMS (EI+, M+) m/z calcd for 
C17H20O5  304.1311, found 304.1324. 
 
2,3,4,4′-Tetramethoxy-6-(bromomethyl)-biphenyl (IV-81).  Title compound was 
prepared in an identical manner as bromide IV-80.  Column chromatography (TLC Rf = 
0.31, 4:1 hexanes/EtOAc) yielded 201 mg of a white solid (89%) mp 73.0-74.0 °C.  IR 
(CCl4) 3037 (w), 2997 (m), 2957 (s), 2940 (s), 2903 (m), 2836 (s), 1599 (s), 1489 (s), 
1335 (s), 1238 (s); 1H NMR (CDCl3) δ 3.58 (s, 3H), 3.87 (s, 3H), 3.91 (s, 3H), 3.92 (s, 
3H), 4.29 (s, 2H), 6.82 (s, 1H), 6.97 (d, J=8.4, 2H), 7.25 (d, J=8.4, 2H); 13C NMR 
(CDCl3) δ 32.8, 55.2, 56.1, 60.9, 109.1, 113.6, 127.6, 129.4, 131.0, 131.5, 142.6, 151.7, 
152.8, 158.8; LRMS (EI+) m/z 366 (M+, 70), 287 (90), 256 (100), 241 (60); HRMS (EI+, 
M+) m/z calcd for C17H19O4Br  366.0467, found 366.0484. 
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2,3,4,4′-Tetramethoxy-6-(2,2-dimethyl-propanenitrile)-biphenyl (IV-83).  Title 
compound was prepared in an identical manner as nitrile IV-72 (model system).  Column 
chromatography (TLC Rf = 0.24, 4:1 hexanes/EtOAc) yielded 456 mg of a white powder 
(76%) mp 85.0-86.0 °C.  IR (CCl4) 3030 (w), 2980 (m), 2953 (m), 2936 (m), 2228 (m), 
1596 (m), 1486 (s), 1248 (s), 1101 (s); 1H NMR (CDCl3) δ 1.11 (s, 6H), 2.73, (s, 2H), 
3.55 (s, 3H), 3.86 (s, 3H), 3.91 (s, 3H), 3.93 (s, 3H), 6.93 (d, J=8.4, 2H), 7.00 (s, 1H), 
7.08 (d, J=8.4, 2H); 13C NMR (CDCl3) δ 26.7, 34.0, 42.0, 55.2, 56.0, 60.8, 60.9, 109.1, 
113.4, 125.5, 128.7, 129.8, 130.1, 131.9, 141.2, 151.5, 152.3, 158.4; LRMS (FAB+) m/z 
356 (M+ + H, 100), 355 (M+, 61), 287 (25), 256 (42); HRMS (FAB+, M+) m/z calcd for 
C21H26O4N 355.1757, found 355.1753. 
 
1,2,3,4′-Tetramethoxy-6,6-dimethyl-5H-dibenzo[a,c]cycloheptan-5-one (IV-85).  
Title compound was obtained via palladium-catalyzed cyclization of 2,3,4,4′-
tetramethoxy-6-(2,2-dimethyl-propanenitrile)-biphenyl using an identical procedure to 
compound IV-73, except the reaction was refluxed for 4 days to consume all of the 
nitrile.  Column chromatography (TLC Rf = 0.24, 4:1 hexanes/EtOAc) yielded a sticky 
white solid which was recrystallized from hexane to provide 63.0 mg of the title 
compound as white plates (89%) mp 115.5-116.0 °C.  IR (CCl4) 3050 (w), 3003 (m), 
2963 (m), 2933 (s), 2832 (m), 1686 (s), 1602 (s), 1485 (s), 1234 (s); 1H NMR (CDCl3) δ 
1.15 (s, 3H), 1.25 (s, 3H), 2.35 (d, JAB=13.2), 3.07 (d, JAB=13.2), 3.52 (s, 3H), 3.89 (s, 
3H), 3.90 (s, 3H), 3.91 (s, 3H), 6.55 (s, 1H), 6.92 (s, 1H), 7.05 (d, J=8.8, 1H), 7.53 (d, 
J=8.8, 1H); 13C NMR (CDCl3) δ 22.2, 28.8, 45.2, 54.6, 56.0, 56.7, 61.5, 61.7, 109.5, 
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112.1, 116.9, 124.7, 126.6, 132.4, 133.7, 141.8, 142.2, 152.3, 152.9, 158.9, 212.9; LRMS 
(EI+) m/z 356 (M+, 100), 300 (60); HRMS (EI+, M+) m/z calcd for C21H24O5  356.1624, 
found 356.1629. 
 
 Attempted Cylization of Unprotected Nitrile 
1,2,3-Trimethoxy-6-(E/Z-acrylonitile)-biphenyl (IV-86).  6-Carbaldehyde-2,3,4-
trimethoxy-biphenyl (3.72 g, 13.7 mmol), (cyanomethyl)triphenylphosphonium chloride 
(5.07 g, 15.0 mmol), and NaOH (1.10 g, 27.4 mmol) were placed into a 100 mL round 
bottom flask.  Water (20 mL) and CH2Cl2 were added and the reaction mixture was 
vigorously stirred at room temperature for 12 h.  The organic layer was separated and the 
aqueous layer was extracted with CH2Cl2 (30 mL x2).  The combined organic extracts 
were dried (MgSO4), and evaporated to yield a yellow solid.  Column chromatography 
(TLC Rf = 0.22, 9:1 hexanes/EtOAc) yielded 3.48 g of a white solid (86%) mp 87-91 °C.  
The E and Z isomers could be separated, but were usually not due to the hydrogenation of 
the double bond in the next synthetic step.  For the Z isomer:  IR (CCl4) 3068 (w), 3006 
(w), 2961 (w), 2940 (m), 2836 (w), 2219 (m), 1587 (m), 1487 (m), 1335 (s), 1156 (s), 
1100 (s); 1H NMR (CDCl3) δ 3.59 (s, 3H), 3.97 (s, 3H), 3.99 (s, 3H), 5.26 (d, J=12, 1H), 
6.84 (d, J=12, 1H), 7.20-7.22 (m, 2H), 7.39-7.42 (m, 3H), 7.64 (s, 1H); 13C NMR 
(CDCl3) δ 56.2, 61.0, 61.1, 94.5, 106.6, 117.9, 127.6, 127.7, 128.1, 130.7, 130.9, 135.0, 
144.4, 147.9, 151.3, 152.7.  For the E isomer: IR (CCl4) 3061 (w), 3006 (m), 2964 (m), 
2937 (m), 2830 (w), 2222 (m), 1591 (m), 1483 (s), 1342 (s), 1152 (s), 1104 (s); 1H NMR 
(CDCl3) δ 3.56 (s, 3H), 3.92 (s, 3H), 3.94 (s, 3H), 5.24 (d, J=16.8, 1H), 6.85 (s, 1H), 7.10 
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(d, J=16.8, 1H), 7.16-7.18 (m, 2H), 7.39-7.42 (m, 3H); 13C NMR (CDCl3) δ 56.2, 61.0, 
61.1, 95.6, 104.0, 118.4, 127.7, 127.8, 128.3, 130.5, 131.1, 134.6, 144.9, 149.2, 151.6, 
153.1; LRMS (EI+) m/z 295 (M+, 100), 265 (15), 248 (23), 220 (25), 166 (25); HRMS 
(EI+, M+) m/z calcd for C18H17O3N 295.1208, found 295.1202. 
 
1,2,3-Trimethoxy-6-(propanenitrile)-biphenyl (IV-87).   The following is a modified 
procedure of Boykin.322  1,2,3-Trimethoxy-6-(E/Z-acrylonitile)-biphenyl (2.47 g. 8.40 
mmol) was placed into a round bottom flask followed by pyridine (15 mL) and methanol 
(5 mL).  Sodium borohydride (3.82 g, 10.1 mmol) was added in three portions.  The 
reaction was stirred in a 120 °C oil bath for 2 h.  At the conclusion of this time period, the 
reaction was poured into 75 mL of 1 M HCl.  The aqueous layer was extracted with ether 
(50 mL x3).  The combined organic extracts were dried (MgSO4), and evaporated to yield 
a yellow solid.  Column chromatography (TLC Rf = 0.29, 4:1 hexanes/EtOAc) yielded 
2.35 g of colorless plates (94%) mp 91.2-91.9 °C.  IR (CCl4) 3057 (w), 3029 (w), 2998 
(m), 2960 (s), 2936 (s), 2864 (w), 2840 (w), 2249 (m), 1486 (s), 1404 (s), 1103 (s); 1H 
NMR (CDCl3) δ 2.30 (t, J=7.6, 2H), 2.74 (t, J=7.6, 2H), 3.59 (s, 3H), 3.90 (s, 3H), 3.92 
(s, 3H), 6.66 (s, 1H), 7.20-7.23 (m, 2H), 7.37-7.43 (m, 3H); 13C NMR (CDCl3) δ 18.6, 
29.3, 56.1, 60.9, 61.0, 108.4, 119.2, 127.4, 128.4, 129.1, 129.9, 131.7, 136.3, 141.4, 
151.7, 152.9; LRMS (FAB+) m/z 297 (M+, 100), 160 (40); HRMS (FAB+, M+) m/z calcd 
for C18H19O3N  297.1365, found 297.1378. 
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CARBENE-RING EXPANSION REACTIONS 
 Model System 
9-(Methoxymethoxy)-phenanthrene (IV-96).  9-Phenanthrol (1.00 g, 3.09 mmol) was 
dissolved in 25 mL of CH2Cl2.  Chloromethylmethyl ether (1.26 mL, 10.3 mmol) was 
added via syringe, followed by 1.12 mL (10.3 mmol) of Hunig’s base.  The brown 
solution was stirred at room temperature for 12 h to consume all of the starting material.  
After 12 h, the reaction was diluted with 25 mL of CH2Cl2.  The organic phase was 
washed with water (50 mL), 1M HCl (50 mL) and brine (50 mL), dried (MgSO4), and 
evaporated to yield a brown oil.  Column chromatography (TLC Rf = 0.41, 9:1 
hexanes/EtOAc) yielded 0.894 g of a white solid (89%) mp 55.0-56.0 °C.  IR (CCl4) 
3077 (m), 3060 (s), 3010 (m), 2960 (s), 2983 (s), 2850 (w), 2823 (m), 1632 (s), 1606 (s), 
1452 (s), 1315 (s), 1147 (s); 1H NMR (CDCl3) δ 3.58 (s, 3H), 5.48 (s, 2H), 7.49-7.79 (m, 
6H), 8.37 (d, J=8.0, 1H), 8.58, (d, J=8.4, 1H), 8.65 (d, J=8.4, 1H); 13C NMR (CDCl3) δ 
56.3, 94.6, 105.9, 122.4, 122.5, 122.6, 124.6, 126.4, 126.6, 126.9, 127.0, 127.1, 127.7, 
131.3, 132.7, 150.9; LRMS (FAB+) m/z 238 (M+, 100), 207 (45), 165 (22), 45 (65); 
HRMS (FAB+, M+) m/z calcd for C16H14O2 238.0994, found 238.0999.   
 
7,7-Dichlorodibenzo[a,c]bicyclo(4.1.0)-6-(methoxymethoxy)-heptane (IV-97).  To a 
solution of 9-(methoxymethoxy)-phenanthrene (238 mg, 1.00 mmol) in 10 mL of CHCl3 
was added 22.7 mg (0.100 mmol) of benzyltriethylammonium chloride and 2.00 mL of a 
50% solution of NaOH.  The colorless biphasic mixture was stirred for 5 h at room 
temperature, during which time the reaction changed from colorless, to orange, to brown.  
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The brown suspension was diluted with 50 mL of CH2Cl2 and poured into 50 mL of 
water.  The layers were separated and the aqueous phase extracted with CH2Cl2 (3 x 50 
mL).  The organic extracts were combined, washed with brine (50 mL), dried (MgSO4), 
and evaporated to yield a brown oil.  Column chromatography (TLC Rf = 0.32, 9:1 
hexanes/EtOAc) yielded 296 mg of an off white solid (92%) mp 91-92 °C.  IR (CCl4) 
3077 (w), 3037 (w), 2997 (w), 2963 (m) 2927 (m), 2896 (m), 2843 (m), 2826 (w), 1492 
(m), 1455 (m), 1157 (s), 1030 (s); 1H NMR (CDCl3) δ 3.44 (s, 3H), 3.64 (s, 1H), 4.79 
(dd, J=6.8, 3.8, 2H), 7.35-7.49 (m, 4H), 7.86-7.88 (m, 1H), 8.04-8.07 (m, 3H); 13C NMR 
(CDCl3) δ 41.6, 56.7, 62.3, 66.4, 96.3, 122.6, 122.9, 123.1, 127.4, 128.1, 128.2, 128.3, 
128.8, 128.9, 130.4, 130.9, 132.5; LRMS (FAB+) m/z 320 (M+, 10), 285 (15), 259 (100), 
241 (35), 194 (40), 154 (38), 45 (90); HRMS (FAB+, M+) m/z calcd for C17H14O2Cl2 
320.0371, found 320.0367.    
 
6-Chloro-5H-dibenzo[a,c]cyclohepten-5-one (IV-92).  7,7-
Dichlorodibenzo[a,c]bicyclo(4.1.0)-6-(methoxymethoxy)-heptane (813 mg, 2.53 mmol) 
in 30 mL of IPA, 30 mL of THF and 30 mL of 2.0 M HCl was heated to 100 °C for 5 h.  
The solution was cooled to room temperature and the organic solvents were removed in 
vacuo.  The remaining mixture was partitioned between 75 mL of ether and water.  The 
aqueous phase was extracted three times with ether (50 mL) and the combined organic 
extracts were dried (MgSO4), and evaporated to yield a yellow oil.  Column 
chromatography (TLC Rf = 0.41, 4:1 hexanes/EtOAc) yielded 579 mg of a white solid 
(95%) mp 100.0-100.8 °C (lit. 98.0-98.8 °C).304  IR (CCl4) 3100 (w), 3070 (m), 3030 (m), 
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1672 (s), 1592 (m); 1H NMR (CDCl3) δ 7.52-7.63 (m, 4H), 7.72-7.89 (m, 2H), 7.90-7.96 
(m, 3H); 13C NMR (CDCl3) δ 128.6, 128.8, 129.6, 129.7, 130.0, 130.9, 131.0, 131.4, 
131.9, 134.1, 136.6, 137.2, 137.7, 139.1, 187.3; LRMS (FAB+) m/z 241 (M+, 100), 154 
(60), 136 (55); HRMS (FAB+, M+) m/z calcd for C15H10OCl 241.0420, found 241.0419.    
 
6,7-Dihydro-5H-dibenzo[a,c]cyclohepten-5-one (IV-98).  6-Chloro-5H-
dibenzo[a,c]cyclohepten-5-one (75.0 mg, 0.312 mmol), sodium acetate (79.3 mg, 0.967 
mmol), and palladium on carbon (5%, 65.8 mg, 16.8 µmol) were stirred in 10 mL of 
EtOH under 1 ATM of hydrogen for 1 h.  The reaction mixture was filtered, and poured 
into 50 mL of ether.  The organic layer was washed with water (50 mL x2) and brine (50 
mL).  The ethereal phase was dried (MgSO4), and evaporated to yield a yellow oil.  
Column chromatography (TLC Rf = 0.21, 4:1 hexanes/EtOAc) yielded 46.8 mg of a 
white solid (72%) mp 84.5-85.6 °C (lit. 85-86 °C).304  IR (CCl4) 3074 (m), 3027 (m), 
2957 (m), 2927 (w), 2863 (w), 1689 (s), 1596 (m), 1448 (m), 1271 (s); 1H NMR (CDCl3) 
δ 2.99 (s, 4H), 7.27-7.46 (m, 6H), 7.58-7.67 (m, 2H); 1H NMR (benzene d6) δ 2.45 (t, 
J=6.8, 2H), 2.63 (t, J=6.8, 2H), 6.85-6.87 (m, 1H), 7.05-7.16 (m, 6H), 7.80-7.82 (m, 1H); 
13C NMR (CDCl3) δ 29.5, 47.6, 127.6, 127.9, 128.0, 128.4, 128.6, 129.6, 130.0, 132.2, 
138.8, 138.9, 139.0, 139.5, 206.2; LRMS (EI+) m/z 208 (M+, 100), 180 (90), 179 (70), 
165 (39), 152 (25); HRMS (EI+, M+) m/z calcd for C15H12O 208.0888, found 208.0895.    
 
6,7-Dihydro-5H-dibenzo[a,c]cyclohepten-5-ol (IV-105).  6-Chloro-5H-
dibenzo[a,c]cyclohepten-5-one (75.0 mg, 0.312 mmol), sodium acetate (79.3 mg, 0.967 
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mmol), and palladium on carbon (5%, 65.8 mg, 0.0168 mmol) were stirred in 10 mL of 
EtOH under 1 ATM of hydrogen for 24 h.  The reaction mixture was filtered, and poured 
into 50 mL of ether.  The organic layer was washed with water (50 mL x2) and brine (50 
mL).  The ethereal phase was dried (MgSO4), and evaporated to yield a yellow oil.  
Column chromatography (TLC Rf = 0.25, 4:1 hexanes/EtOAc) yielded 43.0 mg of a 
white solid (66%) mp 114.5-115.0 °C.  IR (CCl4) 3619 (s), 3070 (m), 3020 (m), 2940 (s), 
2860 (m), 1482 (m), 1455 (m), 1047 (s); 1H NMR (CDCl3) δ 2.08-2.10 (m, 1H), 2.46-
2.67 (m, 4H), 4.65-4.67 (m, 1H), 7.25-7.64 (m, 7H), 7.64-7.65 (m, 1H); 13C NMR 
(CDCl3) δ 30.1, 41.9, 70.6, 123.1, 123.2, 126.9, 127.3, 127.6, 127.8, 128.2, 128.3, 137.9, 
139.4, 139.8, 141.5;  LRMS (EI+) m/z 210 (M+, 100), 192 (90), 191 (40), 165 (30), 152 
(20); HRMS (EI+, M+) m/z calcd for C15H14O 210.1045, found 210.1035. 
 
5H-dibenzo[a,c]cyclohepten-5-one (IV-106).  Title compound was prepared according 
to a procedure by Jones and coworkers304 starting with 150 mg (0.623 mmg) of 6-chloro-
5H-dibenzo[a,c]cyclohepten-5-one and yielding 102 mg of the title compound as a white 
solid (79%) mp 82.3-83.7 °C (lit. 83-84.5 °C).304  IR (CCl4) 3060 (w), 3031 (m), 2953 
(s), 2921 (m), 2847 (w), 1658 (s); 1H NMR (CDCl3) δ 6.66 (d, J=12, 1H), 7.35 (d, J=12, 
1H), 7.47-7.59 (m, 4H), 7.65-7.69 (m, 1H), 7.88-7.96 (m, 3H); 13C NMR (CDCl3) δ 
110.8, 128.2, 128.5, 129.0, 129.4, 130.3, 131.1, 131.5, 131.6, 133.1, 137.0, 138.2, 139.9, 
141.2, 192.6; LRMS (EI+) m/z 206 (M+, 40), 178 (100), 176 (30), 88 (30); HRMS (EI+, 
M+) m/z calcd for C15H10O 206.732, found 206.0728. 
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6-Phenyl-5H-dibenzo[a,c]cyclohepten-5-one (IV-107).  6-Chloro-5H-
dibenzo[a,c]cyclohepten-5-one (240 mg, 1.00 mmol) was weighed into a 25 mL round 
bottom flask and placed under argon.  Tetrakis(triphenylphosphine)palladium(0) (116 
mg, 0.100 mmol) was added, followed by 10 mL of benzene, and 1.50 mL (3.00 mmol) 
of a 2M aqueous solution of Na2CO3.  Phenyl boronic acid (377 mg, 3.00 mmol) in 3 mL 
of EtOH was added via syringe.  The reaction mixture was brought to reflux for 72 h to 
consume all of the α-chloro enone.  The reaction was cooled to room temperature and 
diluted with water (30 mL), and ether (30 mL).  The layers were separated and the 
aqueous phase extracted twice with 30 mL of ether.  The organic phases were combined 
and dried (MgSO4) and evaporated to yield a yellow solid. Column chromatography 
(TLC Rf = 0.31, 9:1 hexanes/EtOAc) yielded 200 mg of a white solid (71%) mp 136.8-
138.2 °C.  IR (CCl4) 3030 (m), 3023 (w), 2921 (s), 2843 (m), 1670 (s), 1368 (m), 1290 
(s); 1H NMR (CDCl3) δ 7.36-7.68 (m, 10H), 7.77-7.90 (m, 1H), 7.85-7.89 (m, 2H); 13C 
NMR (CDCl3) δ 127.6, 127.9, 128.1, 128.4, 128.5, 128.7, 129.2, 130.4, 131.0, 133.3, 
135.2, 136.2, 137.1, 138.4, 143.4, 144.4, 196.2; LRMS (EI+) m/z 282 (M+, 30), 254 
(100), 252 (60); HRMS (EI+, M+) m/z calcd for C21H14O 282.1045, found 282.1036. 
 
 Phenyl System 
2,3,4-Trimethoxy-6-((E/Z)-2-methoxyvinyl)biphenyl.   Sodium hydride (60% 
dispersion in mineral oil, 2.15 g, 53.6 mmol) was added to a 250 mL round bottom flask 
and placed under argon.  The sodium hydride was washed three times with dry pentane to 
remove the mineral oil.  Ether was added (130 mL), followed by 
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methoxymethyltriphenylphosphonium chloride (20.2 g, 57.6 mmol), which was added in 
three portions over 10 min.  The reaction mixture was brought to reflux for 30 min and 
cooled to room temperature.  2,3,4-Trimethoxy-6-carbaldehyde-biphenyl (3.64 g, 13.4 
mmol) was added in one portion.  The reaction was heated to reflux for 12 h to consume 
all of the aldehyde, after which time the reaction was filtered, and diluted with 100 mL of 
ether.  The organic layer was washed with water (100 mL x2), 1 M HCl (100 mL), brine 
(100 mL), dried (MgSO4), and evaporated to yield a white solid.  Column 
chromatography (TLC Rf = 0.34, 4:1 hexanes/EtOAc) yielded 3.90 g of a white solid 
(97%) mp 105-108 °C as a 60:40 mixture of E/Z isomers which were not separated.  IR 
(CCl4) 3060 (m), 3003 (m), 2957 (s), 2930 (s), 2903 (m), 2830 (m), 1639 (s), 1489 (s), 
1398 (s), 1328 (s), 1147 (s), 1101 (s); LRMS (FAB+) m/z 300 (M+, 100), 269 (60), 238 
(29), 89 (22), 45 (35); HRMS (FAB+, M+) m/z calcd for C18H20O4 300.1362, found 
300.1367. 
 
6-Acetylaldehyde-2,3,4-trimethoxybiphenyl.  2,3,4-Trimethoxy-6-((E/Z)-2-
methoxyvinyl)biphenyl (5.25 g, 17.5 mmol) was dissolved in 50 mL of THF.  A 2.0 M 
HCl (0.600 mL, 13.1 mmol) solution was added and the reaction was refluxed for 1.5 h.  
The pale yellow solution was diluted with 75 mL of ethyl acetate, washed twice with 50 
mL of a sat. solution of NaHCO3, water (50 mL), brine (50 mL), dried (MgSO4), and 
evaporated to yield a yellow solid.  Column chromatography (TLC Rf = 0.28, 4:1 
hexanes/EtOAc) yielded a viscous oil which crystallized upon cooling to provide 3.58 g 
of the title compound as white needles (97%) mp 56.0-56.5 °C.  IR (CCl4) 3064 (w), 
2993 (m), 2963 (m), 2940 (s), 2833 (m), 2719 (w), 1733 (s), 1489 (s), 1147 (s), 1101 (s); 
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1H NMR (CDCl3) δ 3.47 (s, 2H), 3.61 (s, 3H), 3.89 (s, 3H), 3.92 (s, 3H),  6.55 (s, 1H), 
7.17-7.19 (m, 2H), 7.34-7.43 (m, 3H), 9.55 (s, 1H); 13C NMR (CDCl3) δ 48.4, 56.1, 60.9, 
61.0, 109.2, 126.1, 127.4, 128.3, 130.0, 130.2, 136.5, 141.6, 151.9, 152.9, 199.4; LRMS 
(FAB+) m/z 286 (M+, 40), 269 (100), 258 (60), 242 (43), 226 (40); HRMS (FAB+, M+) 
m/z calcd for C17H18O4 286.1205, found 286.1217. 
 
6-(Acetic acid)-2,3,4-trimethoxybiphenyl (IV-99).  A stock solution of Jones reagent 
was prepared by dissolving 5.0 g of CrO3 in 7 mL of water.  The red solution was cooled 
to 0 °C and sulfuric acid (4.21 mL) was added dropwise, followed by an additional 18 
mL of water.  6-Acetylaldehyde-2,3,4-trimethoxybiphenyl (3.76 g, 13.1 mmol) was 
dissolved in 130 mL of acetone and the colorless solution was cooled to 0 °C.  Jones 
reagent was added dropwise until the persistence of a deep red color.  Isopropanol was 
added dropwise to quench the excess Jones reagent, forming a dark green reaction 
mixture. The solvents were removed in vacuo and the residue was dissolved in 100 mL of 
1 M NaOH.  The aqueous layer was washed with ether (50 mL x2) and acidified with 
concentrated HCl.  The aqueous suspension was extracted with CH2Cl2 (75 mL x3).  The 
combined organic extracts were dried (MgSO4), and evaporated to yield 3.76 g of a white 
solid (95%) mp 108.0-108.5 °C.  IR (CCl4) 3528 (m), 3060 (m), 3007 (m), 2960 (m), 
2933 (m), 2840 (m), 1709 (s), 1489 (m), 1395 (m), 1147 (s), 1104 (s); 1H NMR (CDCl3) 
δ 3.43 (s, 2H), 3.60 (s, 3H), 3.90 (s, 3H), 3.91 (s, 3H), 6.68 (s, 1H), 7.22-7.24 (m, 2H), 
7.35-7.42 (m, 3H), 9.20 (br, 1H); 13C NMR (CDCl3) δ 38.1, 56.0, 60.9, 61.0, 108.9, 
127.2, 127.8, 128.2, 129.9, 130.1, 136.4, 136.7, 151.6, 152.7, 175.0; LRMS (FAB+) m/z 
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302 (M+, 100), 257 (25), 226 (20); HRMS (FAB+, M+) m/z calcd for C17H18O5 302.1154, 
found 302.1144. 
 
2,3,4-Trimethoxy-9-phenanthrol (IV-100).   6-(Acetic acid)-2,3,4-trimethoxybiphenyl 
(3.76 g, 12.4 mmol) was dissolved in 36.0 mL SOCl2 and brought to a gentle reflux for 2 
h.  Excess thionyl chloride was removed in vacuo.  The residue was dissolved in 50 mL 
of benzene and added dropwise to a stirred, cooled (5 °C) mixture of AlCl3 (3.31 g, 24.8 
mmol) in benzene (80 mL).  The reaction mixture was allowed to warm to room 
temperature, at which time 100 mL of a 1.0 M HCl solution was added in one portion.  
The phases were separated and the aqueous layer extracted with EtOAc (75 mL x3).  The 
combined organic extracts were dried (MgSO4), and evaporated to yield a brown oil.  
Column chromatography (TLC Rf = 0.31, 1:1 hexanes/EtOAc) yielded 2.19 g of an air 
sensitive off-white solid which was immediately stored under argon (62%) mp 130-132 
°C (decomp).  IR (CCl4) 3609 (m), 3064 (w), 2997 (m), 2960 (m), 2933 (s), 2876 (m), 
2856 (m), 1746 (m), 1609 (m), 1469 (s), 1221 (s), 1101 (s); 1H NMR (CDCl3) δ 3.99 (s, 
3H), 4.01 (s, 3H), 4.02 (s, 3H), 5.22 (s, 1H), 6.91 (s, 1H), 6.92 (s, 1H), 7.59-7.66 (m, 2H), 
8.29 (d, J=8.0, 1H), 9.52 (d, J=8.0, 1H); 13C NMR (CDCl3) δ 56.4, 60.9, 61.9, 104.1, 
106.8, 115.7, 122.3, 125.5, 125.9, 127.3, 128.0, 131.2, 131.9, 141.6, 149.9, 153.2, 153.4; 
LRMS (FAB+) m/z 284 (M+, 100), 154 (30), 136 (40); HRMS (FAB+, M+) m/z calcd for 
C16H16O4 284.1049, found 284.1050. 
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2,3,4-Trimethoxy-9-(methoxymethoxy)-phenanthrene (IV-94).  3,4,5-Trimethoxy-9-
phenanthrol (2.19 g, 7.71 mmol) was dissolved in 40 mL of CH2Cl2.  To this dark brown 
solution was added 1.88 mL (15.4 mmol) of chloromethylmethyl ether, followed by 1.67 
mL of Hunig’s base (15.4 mmol).  The light brown solution was stirred at room 
temperature for 12 h to consume all of the starting material (TLC).  The reaction was 
diluted with ether (150 mL), washed with water (100 mL), 1M HCl (100 mL), brine (100 
mL), dried (MgSO4), and evaporated to yield a brown oil.  Column chromatography 
(TLC Rf = 0.27, 4:1 hexanes/EtOAc) yielded 2.13 g of a white solid (84%) mp 91.1-92.5 
°C.  IR (CCl4) 3074 (w), 3000 (m), 2963 (m), 2933 (s), 2903 (m), 2826 (m), 1632 (s), 
1612 (s), 1502 (s), 1462 (s), 1351 (s), 1144 (s), 1064 (s); 1H NMR (CDCl3) δ 3.58 (s, 
3H), 4.00 (s, 3H), 4.01 (s, 3H), 4.02 (s, 3H), 5.47 (s, 2H), 7.02 (s, 1H), 7.20 (s, 1H), 7.55-
7.67 (m, 2H), 8.36 (d, J=8.0, 1H), 9.50 (d, J=8.0, 1H);  13C NMR (CDCl3) δ 55.8, 56.2, 
60.3, 61.3, 94.6, 104.5, 106.0, 115.2, 121.9, 125.3, 125.9, 126.6, 127.2, 130.6, 131.0, 
141.3, 150.7, 152.4, 152.7; LRMS (FAB+) m/z 328 (M+, 100), 297 (20), 283 (25); HRMS 
(FAB+, M+) m/z calcd for C19H20O5 328.1311, found 328.1318. 
 
1,1-Dichloro-1a,9b-dihydro-6,7,8-trimethoxy-1a-(methoxymethoxy)-1H-
cyclopropa[l]phenanthrene (IV-101). 2,3,4-Trimethoxy-9-(methoxymethoxy)-
phenanthrene (2.13 g, 6.49 mmol) and 148 mg (0.649 mmol) of benzyltriethylammonium 
chloride were dissolved in  65 mL of CHCl3.  To this colorless solution was added 13 mL 
of 50% NaOH in one portion.  The vigorously stirred, reaction mixture was stirred at 
room temperature for x h during which time the reaction changed from pale yellow to 
orange to brown.  The reaction mixture was diluted with CH2Cl2 (100 mL) and water 
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(100 mL).  The layers were separated and the aqueous phase was extracted with CH2Cl2 
(75 mL x3).  The combined organic extracts were dried (MgSO4), and evaporated to yield 
a brown oil.  Column chromatography (TLC Rf = 0.26, 4:1 hexanes/EtOAc) yielded 1.95 
g of a yellow oil (73%) which was used without further purification.  IR (CCl4) 3137 (w), 
3064 (w), 2997 (m), 2957 (s), 2937 (s), 2846 (m), 1596 (s), 1492 (s), 1328 (s), 1161 (s); 
1H NMR (CDCl3) δ 3.45 (s, 3H), 3.56 (s, 1H), 3.85 (s, 3H), 3.93 (s, 3H), 3.96 (s, 3H), 
4.78 (qAB, J=6.8, 7.2, 2H), 6.80 (s, 1H), 7.26-7.42 (m, 2H), 7.84-7.85  (m, 1H), 8.94-8.96 
(m, 1H); 13C NMR (CDCl3) δ 42.1, 55.9, 56.7, 60.4, 61.0, 62.4, 66.6, 96.2, 109.8, 117.7, 
125.1, 126.9, 127.0, 128.5, 129.0, 132.5, 143.2, 152.9, 153.8; LRMS (FAB+) m/z 410 
(M+, 10), 349 (100), 331 (70), 283  (90), 154 (65), 136 (50), 45 (85); HRMS (FAB+, M+) 
m/z calcd for C20H20O5Cl2  410.0688, found 410.0687. 
 
6-Chloro-1,2,3-trimethoxy-5H-dibenzo[a,c]cyclohepten-7-one (IV-103).  1,1-
Dichloro-1a,9b-dihydro-6,7,8-trimethoxy-1a-(methoxymethoxy)-1H-
cyclopropa[l]phenanthrene (757 mg, 1.84 mmol) was dissolved in 12 mL of THF, 12 mL 
of iPrOH, and 12 mL of 2 M HCl.  The reaction mixture was heated to 100 °C for 5 h.  
The solution was cooled to room temperature and the organic solvents were removed in 
vacuo.  The remaining mixture was partitioned between 50 mL of ether and 50 mL of 
water.  The aqueous phase was extracted three times with ether (30 mL) and the 
combined organic extracts were dried, (MgSO4), and evaporated to yield a yellow oil.  
Column chromatography (TLC Rf = 0.26, 4:1 hexanes/EtOAc) yielded a light yellow 
solid.  Recrystallization (benzene/pentane) provided 407 mg of colorless crystals (67%) 
mp 141.1-141.8 °C.  IR (CCl4) 3064 (w), 3007 (m), 2963 (s), 2927 (s), 2850 (s), 1733 
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(m), 1672 (s), 1592 (s), 1492 (s), 1338 (s), 1151 (s), 1121 (s); 1H NMR (CDCl3) δ 3.44 (s, 
3H), 3.96 (s, 3H), 4.00 (s, 3H), 6.75 (s, 1H), 7.50-7.59 (m, 2H), 7.57 (s, 1H), 7.78-7.80 
(m, 1H), 8.02-8.04 (m, 1H); 13C NMR (CDCl3) δ 56.1, 61.2, 61.4, 108.6, 124.7, 127.8, 
128.2, 128.4, 130.0, 131.7, 132.1, 133.1, 137.0, 139.6, 144.1, 152.9, 153.0, 188.3; LRMS 
(FAB+) m/z 331 (M+, 30), 307 (22), 154 (35), 137 (100); HRMS (FAB+, M+) m/z calcd 
for C18H16O4Cl  331.0737, found 331.0733. 
 
5,6-Dihydro-1,2,3-trimethoxy-5H-dibenzo[a,c]cyclohepten-7-one (IV-104).  6-Chloro-
1,2,3-trimethoxy-5H-dibenzo[a,c]cyclohepten-7-one  (36.5 mg, 0.110 mmol), sodium 
acetate (22.6 mg, 0.275 mmol), and palladium on carbon (5%, 11.7 mg, 5.52 μmol) were 
stirred in 5 mL of EtOH under 1 ATM of hydrogen for 1 h.  The reaction mixture was 
filtered, and poured into 25 mL of ether.  The organic layer was washed with water (25 
mL x2) and brine (25 mL).  The ethereal phase was dried (MgSO4), and evaporated to 
yield a yellow oil.  Column chromatography (TLC Rf = 0.21, 4:1 hexanes/EtOAc) 
yielded a colorless oil, which was recrystallized from hexane to provide 26.0 mg of white 
crystals (72%) mp 79.0-80.0 °C.  IR (CCl4) 3067, (w), 3000 (m), 2957 (m), 2933 (s), 
2863 (m), 2836 (m), 1689 (s), 1599 (s), 1405 (s), 1348 (s), 1114 (s); 1H NMR (CDCl3) δ 
2.64-2.67 (m, 1H), 2.88-3.09 (m, 3H), 3.50 (s, 3H), 3.90 (s, 3H), 3.91 (s, 3H), 6.61 (s, 
1H), 7.37-7.41 (m, 1H), 7.51-7.79 (m, 3H); 13C NMR (CDCl3) δ 31.3, 48.4, 56.5, 61.4, 
61.6, 107.4, 124.7, 127.8, 128.0, 131.2, 131.7, 134.4, 136.2, 139.9, 142.0, 152.7, 153.5, 
207.5; LRMS (EI+) m/z 298 (M+, 100), 283 (10), 241 (10); HRMS (EI+, M+) m/z calcd 
for C18H18O4  298.1205, found 298.1203. 
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5-Acetamido-5,6-dihydro-1,2,3-trimethoxy-5H-dibenzo[a,c]cycloheptene (IV-93).  
Title compound was prepared from 114 mg (0.380 mmol) of 5,6-dihydro-1,2,3-
trimethoxy-5H-dibenzo[a,c]cyclohepten-7-one according to the reductive 
amination/acylation protocol of Wulff and coworkers288 to yield 73.9 mg (57%) of 
product (mixture of stereo and atropisomers) as a white solid mp 184.3-187.1 (lit.  185.2-
187.6).291  The 1H and 13C NMR, and IR spectral data match those reported by Fagnou 
and coworkers.291  
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